var title_f1_0_1024="MuSK-LRP4-ColQ complex";
var content_f1_0_1024=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F50624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F50624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 598px\">",
"   <div class=\"ttl\">",
"    Schematic view of MuSK-LRP4-ColQ complex",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 578px; height: 471px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    At the postsynaptic membrane, muscle-specific tyrosine kinase (MuSK) is associated with the low-density lipoprotein receptor-related protein 4 (Lrp4). MuSK activation through agrin-Lrp4 binding triggers a signaling pathway, which includes Dok7 recruitment, leading to AChR clustering. Acetylcholinesterase (AChE) binds through its collagen Q (ColQ) tail to perlecan and MuSK.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Evoli A, Lindstrom J. Myasthenia gravis with antibodies to MuSK: another step toward solving mystery? Neurology 2011; 77:1783. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1024=[""].join("\n");
var outline_f1_0_1024=null;
var title_f1_0_1025="Determining BP cuff size";
var content_f1_0_1025=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Determining appropriate blood pressure cuff size in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 505px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The width of the bladder of the blood pressure cuff should be approximately 40 percent of the circumference of the upper arm midway between the olecranon and the acromion. The length of the bladder of the cuff should encircle 80 to 100 percent of the circumference of the upper arm at the same position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1025=[""].join("\n");
var outline_f1_0_1025=null;
var title_f1_0_1026="Montgomery-Asperg Depression Rating Scale - page 2";
var content_f1_0_1026=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F67951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F67951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 631px\">",
"   <div class=\"ttl\">",
"    Montgomery-Asperg Depression Rating Scale, page 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 611px; height: 749px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Montgomery, SA. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1026=[""].join("\n");
var outline_f1_0_1026=null;
var title_f1_0_1027="Inflammatory acne PI";
var content_f1_0_1027=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F70916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F70916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inflammatory acne",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acne can cause the skin to become inflamed, turn red, and swell.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1027=[""].join("\n");
var outline_f1_0_1027=null;
var title_f1_0_1028="Strawberry tongue PI";
var content_f1_0_1028=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83203&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Strawberry tongue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAH4AXoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3aNtrYpzOfMGDxUMY5OetTxKM1xo9NvUkRsNkj8aS4kx0JBP5VBNcBW2qRUE8wBBLZPWr5khKDbuWZNxBwajScxgjg/U9Kga7zgKRn37VRnuCGPPOeaObqi4wbVmaEtwACQfyNVRffvOvNZks+WwzYqCe4WMA5HI71LlbU2jR6WN6S+Dc9+4Jqu15uyA2B/Kufa9LtgfzqaHLHrj1rL219i/q9lqa5vQvAOT9apXF/I5xzj3pgjBwSRxShVHXFHtHsNU0uhRl8ySQ8NjHOKqSRTM5G75QeMitn5A/Xj60jvEAAxBrNpvqbxduhlw2jYGQM9yRT541iyMnd1z0p1zqCJkKelZ8995gPJx2ArOy2ubxpyk72IrqZ8grjb6+tZF3O/IJx7/0rR37znFZl7EVffkbSeMVMqbaudcIpOxQMh3YOT9KgkYbiATntzTmY7m9exNQHCkEdaxcTflI5SQMsCB6YquZAMgHg9BVi4mDcAHgYOapHqcA/Sly2Y0hXXc/PTHSqc/BwPuj0qyhy4Xn8aZcx4X/AOtVpDUktGUjyOOvrQc896lwFXiox61ViZMiZjnnj61IkmFPWklTLEnJP1pqr1HrT5UZSAyEtt65qZLngqDmoCMtwMjuRSbVA689R70+UwaTLyXeMc8Z5q3Fcow4IIrB3dcHpTllZR0wM5pcpjOC3OlEo2YHA6ZqEvjkscVjpdkdSauwzblOTx1B7VLTRk42LbyY9cjuKuW9wFKkjDDH0/8A11jKqtIPvdMdanMwBIOQMcU1dakPU3TKrMHUnOOtOW5Kcscn2PWshblSgIJz1xT0l3uCxAobs9CbG5DJglx09DSiV3Ut2FUEnChV3Db6etT+YUHPCnmqWuhL01LTNhUcry3FRu5D4wSe4FUlvVnYCNt0YORipJJCCd2QO574pu19ATezJWcupUAnJqPzWjBJ5PSlEyAfKCd3I4wajOWjORyTms7PoaJkkchcjeduOlMnlLv8pCIBjGOc+uajUCPa4YE9waJGUhiB8vQilrazKVhVZvJUMx45HNJs/wCmn61DkogB5BOR9KrkDPVqnQZ9BMzJhscdPrSxz/Kd33vb0pkrlcKeh9aoXcwH3TjFelKXK7nmxhzaCXNwu88jdngVmXV4xY/NwOKZLPknJrLuJTkgVyzqnoUqJde/dVAUkHP1xVb7a0j5J+pqhIzZyScGqj3Ox8A8+lZe3kjsjh4s2hOztnNKwLtz3rJtrrL8nGelaDyBU3Fsk/pSc3JBKlyscGWI9s1bi1CMAgnH1HWsKWUyE8k4z0qESBOWbGehpQcuhq6CktTek1HaG2nIJ4qpJqDsxGSCazy4K9Rn1zUsaZ+atY3e7H7GEehfa8YKO9QyXDk7R6dKrszKScfnTVkBY881rZmfKlsJIN33yT+NOh2swGBkCiYgrgGoBIUOQatRSZXM5LQfKQh9eazL24LbgVG3OR9fWtRsMuTwxGRk8GsW/KxvnKgn04qpxtEum77mbcShWGMc1G82/CjHy8ZFQXJV5Mg55xS+S8WOcAcmuHudErJIJcswYdu+ab8uMt1psjnYAvKjoRTrUNK4XjcfShK5m5NCBMOpI+WruoQxG2O0FXXGPei5txEmc59az5JGYFWPAPHNbL3LpoyT5rNMqFcgjjOOfrUOwr1649asSA7SC2D2Pp71C+dnLdAOfWkkU2NdgcYJBPWmcZyB16+1ML85oLgDBGSadjNuw4nk4/H3qNyccDJzxSk8n+lNPT6VSRm2RMOOvfmmnIAqVzx0qF8ZOc9arlM2xC2KfFcMn0qJz7VE1LlJbRoLcnO496cZC44zxWWXIBGTT45ipI3cetLkMmaSTFD97/Gr0N0NmOprF87IBGD3qaObj3ocCGb8NyN2CasPdPJ8i9CcYNYUM4wpNXoZQrbiwLVHK0S7GnbqIwxwN1I9xuDq/wB72qvPMrgEMQR1x3oidduR8zEd6TTvYFqrkwlOEJPI4xntUsR8xcAnr0qpFsQjc2WNOWYrKDwAp7UrNMrctsm0HcOnNQu5RGYnGaka4DRnb+dVxIzycADA70pRXQItskWQ+Vs6k9MdvpUOJ+w4/CpXysC84bse9Q+bJ61L03Kv2PeLqY/MSwCgcetYN9cn7obC1NdEsDuPIycis6RN3Xk1vUk2RRhGO5G0rZJY4HvVS6m2Zcjj2qxcOIl5PIrFvZvM+7keormldHoUo8zCW6ZiMc5Hc1VkclueahDkvtpzLk4xUJXO5RUSZZihDKPzqybpnTBHuapxpgc9faljO0jHXpirUWgaTLVhtMjEfMCOS3akuN4JAIIz19KYCVJI/HFMW4fLAhSO/vWyaSsNRu7mj5SCJCu1T3GackmMDsKrLIGiLgYI61H5pK5GfxrZaGElfRk11Pn7pGRVdpdp9D61We4/eHg1FcXSsQeQDVOasSoFv7T2Jyahe62tnuOtU5mXC/NwemaryFup6EVk5tIcVG5fe8ymMkAVmXkwbPOc9/SnMSB7iqkp+bPODzxWUqjaszoiooiVvnDbRipZZjJGFX5eeaiUAE+lNmfGAOnaknYU7NioQPvHH9aQyeXKpGQ6nPFV/MG3BI/+vUTy5IAPPrTRlLc0pbx5k+b5QOeO9U5JNw5GQaiWUEfMMj07VFJL6enSrvfVmafREpbgZzkVG5GMk9f0qEynaPeoZHJXOetWkS5BI3PHShXPrUOcmgttHSrSMnInVxnnHFPLgj5eQe9VFcZHoetKJPmx2qlEhzJmcY9/SoH+6c8g9waGbHAppbNMhyG7sjntSMP5UcY96jY5Iz0607GbYvGDk1E2B0pHOD149KjZ8/WlZkOSZIJCBUyScVSLEDOQfWkM+DlsY9qLGblY0kmPTJGen0rRjKtbjLYI96wvM3Z6VctG8xQGYbRS5RcxuKDF8zPkHg4qeSVUGc4bGMZrNE2BtGSu3qKY0hB5JIX154qXEE77mkJPOAMZPHX0qYYiGf4ic8VVtJE8ksSFzxiiGViyo/OT1qHGxSbLqyl1byzlu644pqtuA6q4PJHaqauwEiA/NmpGk8uMMG4PXFRYfXQsJOWdjnpxknrUm8VWiy/yxjPc+9XNiejVKVwbseuMQ6tk9elVmjC2zylgAo6Ut45htySwz2rnLu/kddhbBPUVrUajub0abnsNvrouWweelURKDk5NK5Dg88HvmoJAdwIPTg1y26nq04paD2wTnt29aQN04OP509CAnrQ304rRKyujTcVHJIB+X61es40O7dgvkDnpiqaxnqecfypd+0deD1qk7O7RLV9C5cwqrsY2wPTtmqkrARMVC7lPJpryOQQM49aps78784Pb1pykr3sNJrqSNclYm6ioYrxioIbIPAyOTTZCWT5cH2NNVF2dc55x6UnfoDaYTyOzcNyegFQHdvB745qUqQDyc+1NyM4P51D13Ib7CB5DjjvT4xv+8RxTt4ABCk9qQuAR04qlFmDmkLPBgdeoqo8e1eMA9uaklmCgVXacOPY9abigVRohl2o/PBIzVefGM7utSSvvbjBB6YqCXIB4A9jSsUqmhWkk4PTg1WklBJ9aWd+vp1qjJJzVJESqJFkzYHBpPN3EdRWe03HWhZSvUmtFA53WL8koGcfhURck5NUzKScVIj4HzHNWosj2qJSc4pu9j1IxUbyce1VmmBHB4q1EylULjSY701GyetUfOyuTyKkilAGeMdsGnymftdS8DnvTieKqq578CpGcetFi+dA701WyKhaT5jSI/vx6iqSM5TFk6jJGD1BpMjOQQRSFgD8xx9KY5AUbcA9OnFFmZ8wsz4XIA9sVQkIVweg75p7sdx7g1RuJcs2OMDg1aiYzmXIr0Im324NX7O4UMAcBW61ysh4O5iOnSrUF268Mevem4mUauup2qzJ/yzJwfTtSSS8Kzc+9ZdhfRrD83GR+VW7SdSCWGUPINZSVjphJMvqytDlWAB60+3YJ8zMeOmKpQSHmPGQeRU8ysNrhQPXFQ4miZaW4MjsB0bvU3m7S0ZQe1Uw6xhWU/Mec1Lbzhwxf6Csmi0W4ZSsbu33x6VMHYjO4VTicrI4PKdwad5Kn+Nh+NZtX3H6nq2p3odGCsG5/KuddjkdeeaddTlpDjoTUTNkcnms5S9oz1KcPZrQA/PzetPUBmAHPtVcZ8xj68VJG+3Pp0JFOKtub3JiMEZ4J9eKCxOdp+vtUTPuKkknjAzSZIHYCqZcWTiVmXavUUPyvt3qE9RmkEhdgWPOetFxNk6SBWXeRjoTT9Q8sxhk2g8Yx3qpK4IO0YA61X3gYIzmnz2TRm9XcnACctjPXFMlbLDbjntUbzqRgDn09aiLEEsRjPvUuV1ZE3sWsc9cVC7KCcimmXaME9e9Zt1eKCy7xn1Bp6GTmy5PchR1wKiScMMg5rDluiejGkW6YdGx7CqTsyXBtGpcyjJ+YelUHuSDt6D0qrNcszAq2AOvvVaSXPWh6vQpRstTQFznv+FNe44IPWswy4Oajkm4JzWiiYTnYsTy5JOapSyc81XubgIOvPvWdNeBgShO361pGByVK9tCzPOFPUY60JcZ4IO49B61kyS5OM8e9Txj93yxwemDg1tyJHJ7VtmnHMCR0qYygLk9AazSwIOPy/wDr0sVyNvJz6jqKOUtVC5LI2eOPb0qnK208Hr2ps9wvO3Priq8lxhRz979KdjOUyQybckH73SrduxKFiv8AhWWZSOeoNXVmxF3xVWIjIvLNtHOfyoN2uzAPPrWZcXK8gYzjI4qj5u5/lJOaFDqN1raG6JgQTnj2qKS4AwQMfjWaZxGqrwce9RfaS8mQentT5SfamwLgBScj3piXCkY3ZOOv1rLa4AT1YUwXBxx060covaGhM2EHPOcdapStxwetK1wGxgZOM5qs7ZPXOKaJlJDGJOehzUZbavJqVwAuQOap3D5JH8qtIxbsX7aYFgpYjBzXQ6fdgkRkrkc8CuKSXaQc4xWxp1wEIbdwRUyiVTqWZ16uqyhozk+lW3uDLsxwD1NYlvdghXiO45xg1bjkkD5ZcKRnFYSVjsjK5fYggMOVBqa2ILMAR0zVGB8KV7E5walt2w787QO9YtG6kXk5cszEHuKf9ob+5VSCUhtxIP19Kteen/POoaRWp2xO45/nSZwaYMluOWFD5A965Io9rcsLGSNwPXgA1GykHio0m2ZGePeniTIAxn3rVtNDSaYnAPUnI79qer/L90nHB/xqOYSKoLqQuajWY7cZA59aaVmHN2LL98dKpvJgZBokkBBAPAqo0gQ8kBSMAClIV2XWfegySD296qmTbnoT6ZqtJcgAjr6VnyXW3PUE9ah6iuackgXkd6Y1yvtmsWW8bGA3FVHvWB681Sj1MpPTU6F7rIbJOaxLpMOzRnqeQag+2ZHX3qu9wWY4Oa05UZKXYlMvHzDkU0TYPtVdn3U0vgYOCKOUt1LFh5PyqB5KjL7emajeQkCqjHUyqVtCZpDiq8syquSSPSq80pVQSetUpLgZJYg+wraMLnFUr2HXU3m5AAx6VTPGMYqOSZVb5Tz1oV1IGeSK6ErHDKXMwc85wTg9KnDtjAOMfr7VXdt7KNv0xT1jfdhVPHXmqJLDSHYMjj0NMh+dsHIXpg9qWWJ9hXJBNLAixOGOdvTnmkVrcmePHXjH61SuCATgD3Fa0k1uIyXboOlZF3IpPytnHQ4oi7hUViNnG8c4zxipg7bQM8duaoqTuNK0hwcHkVpYx57E0rZ/GljG1Q+cnuKpo5ZsZ6VZTpgnoKLEp31EuXGM8A+lVPNYc5AFPuD2HNV92OlNIiT1JvOPr1qTzFHy9e+aqE5foKaXIbHWnYXMaIfaCP4sUqZK57H+dVI8lcZ5qwCASCcGlaxalckchhleMcVnzEZODkdc1Ozs3JOKryA4waaJk7kLE/iO3rU1rMAw6j19KrscuQOtNBIfPpTtczvZnT2NwFj2cbyeK3bafzYsvkMBjHrXHWd0uBu4Yc5Fatvdu+GDDIP51jKJ1U52Okt3DoWC5x29KlZwuzaOvGazY7z5lCjY56jHFWEfIRAc7jzWEo2OqM7l6Mlzk8c1fwvv+dZkJZSQx6HkVZ2n0rJo3jqjvEOTjuKkVh+HSoht2jnp0o3AHJx7ZNciR7PMPZM/d4P86YrmNwf8mlabAPCkkc471VlnwMriqsh8zLM90zgoVwDx9TVfIxz1xioTOO+MH36VWllBBw2D6Zqr31ZF7aD5JSrZzkDtUM1wSpGM981EJV85TJ9zdzitWa/sFg5MO727Cqp0lUvd2M6lVwe1zBnkO0kkY9qpTSnkBvzrV1W9s3hxCEzt4Cjoa5+Rie/Wq9kovTUz9u5LsRSuQeKru5J6c0+QkDFQE4PODVqJzzqNj1YkcGlDH1H4VHvxyeBTDOo6nH9aOUSqJInzk8kimlhwM81Tkuh0UE596jzLJg54znNUoGcqy6FqST5CCwBI4+tRSTlYl6FsckdPwqFVPABIPc/4Va2ZHHUevenZIz5nIy53dwSeAehxVV4XfHJ561stCoOW6/TgVWeZY+AvOc/WtYy7GEofzMzTaFl/ugdM96csarwSTUryyyHIG0Cot6RFjKQSOnNWm2Y2RZjAXhh2/GnlmUDb93oOe9ZN3qShcIKz5L+VwOeapQbJlXjHRHUq/AZ2UH69Ka4jcFg+QRiuV+1yngsaVLqVMEMfzp+yYvrK7HQTRN/Cx57VSfCS7SdwzjB/XFVYdTlz83T1q0buOUcqBRytA5xktCQzQBcYIAHfg5qvKV2/KfoaCYycmmbQScYxTsQ2EacZyM0sisDwSQelJlu55FAYE980yeliKVyBhutQbu9WJlTjkdO1VmGCQOlNES0Avk9afGepH4VGI/UnHtUhxHwOTTESxvj73UUoOTn9KgDcc0B8Hgk0DuTby3ToaSTGRg00Nnp9cGkzlvloC5Hjk1GRg5qwecrzjOailUA00SxkTfvB0/GtuyuAsillBXvisHvVhJQOmR70pIqErHVSTqBG0ZUsTyPStOByItqEFuuc1zVjIFj55Pat61RUMckjbOa55o66cupro4ZCSfn68VcWRdo47VnKyi4PGUx1HQ1N5o9BWDOyL0O8izjOD+NOYFuM+9IOEyOOKjml7/dOK5FGyPY59BJP0xyapSPtIwSNufoRRNOMcEEj8KpTThQdzZHpTsCZYMwOAcVWmft1qvJKASQc+tQSSblGMk+5pxTZMmkSyucdetUZic0ryHOT39KhlY4z61pyIw9oRO3PJJNI0pK4HUVG7c0BwBz25ppWMpS7jWLVCTn096kkfJ9Paq5XcwPUZrRGMmKCA3HB7A0eWGIOOBUiIqkk9u5NI0sMYyzqv1NL0Dl7ieRtIK7Rn0HalMZ6ds1C+p2yA/OCR6Vn3mvRKGEfPvVKEmyZVKUFuaz+XGu6Rgqjuaw7/WxHIREAffrmsHUL2W4P3zt9KqIcg5Oa6IUUtzz62LctIKxuPrrk4K8ULrQCHemSaw9uKK19mjD28+5oz6m752DZVJ5pHPLVHjpS4qlFIzc5S3Yh560ClxS7TTJExwDTsfLQqnnPanv8sWfXigaK4OOvSplGT8r4GKhNA9qBJlgSmM/MQaVbsgnjiqtFFh8zRpRX0ecSL1FWU8t03Kwx2NYlPjkaM5Uke1S49ilUfU1fKUk7aa0SjkqOnWo47tX2hjtarJJA9V9anVGiaexXePJO30qJ1ONxOavqoI61HJESQRjFHMDgUBkUvB7YqQqeRxxSBM/X61RnYRQNpAJzSou1cDrmlUANyeRUq7cd6BojIboveonGTnBGKsMMDIHIqGRt456+1CEys3WlR8cHkCkYcmk4BFUQbOnmERSSLIA4/gbvWtasZLcSEn5SMjNcpAS0oBIAz3robCVY4wA5JYcgjispxR0UpHTRPHgbRn1xVrantWbpPzOUbK5AwO31rX2j++v5CuSUXfQ74PQ7jdleOmM1Tkk9OR2NNWZgQGx06CoGf5TnnPbpXM1c9dMgn53En/65rOnbng/n61PczH/61Z8soJOfyquW4nNIV5DzTN57GoZJVA5OBULXKDuD9K1jGxyzq3ZZd+uaqSz/ACkg9KikuAT14qpPIk4KA/eGBjiqtcylUsTmRSN5Jye1JDNuJ9KqxwsqbQ5bb6058xAEDIBo5UR7SXUu4UjdzVW5uUtVJfB54GazL6/aPlXOcc4P5Vg3N1LOwLOx79a0hRb3MKuJUVotTT1HWHYkREhelZE11LI24sc+5qPqOaQiumMFHY4J1ZTeou4t1Y4pCpPU8UqinhaZBHKDs47VGnB5qd8bCKrd800hPQsMp5BpPLP1p8TB1BPbj8al2nbyeTRcdiAJ680eXz7VMFqQRlueABzk0XDlKwi6AfrUvl7Rk8D1qSSSKMZGGf0qjJK0hyeB2FCuwdkWB5QPzPgD0qvK/mNkcDpimYHpS07EuVxMUUtFMQhopaKQDaKWg0AJ/KpIpXjOVY/SmCkoA1rW+SQgSfK1XfK3j0rnOp960bG/2KY5skE9T2qJR6o3p1Okiy0SoSW4FRbQ4+Tn3q9hJEyp3D1qjcQtGdyE/SpTLkraoRtoQfqaYDwCOtCyhsrIME08oTyOlWZ76obkk+1QuPm46epqQtjPFMJG7v8A0oEyB15qOrM2McVVNUjNjkJDDHWtGxeQMoBOQfwrOjOGzjOO1XrZs4wwGT0NKWxUDsLCch0VjuI6j0rU2MeeOfaub0iQx3HOCMY471tfaV9GrjktT0actDrjcZYkfdx+tQTPjnJJqtPKAffOeKqyTnBwcVzWPXchblzyd3HrWXczEFuealnn+Ug1l3BIbJbHrnvWsI31OOtU7Fd7tlYgnr61XluiOSWJ9BSzJubcx59Aaq4z1ORntXQkjgcmiX7QZGGDtIFTxOqsMHAPUntVRF2jnBxU6bMYYZbtSaHFvqa9vLGV+bbntVe+uF8ogHgZzTI4G2mQg4zg1kaneFnZE5GecVMYamtSryx1M+7k81yT+dVghyalwG60uMd66Voec9XcixzilC84HSpAO9KAcAkH8KYhgXHFKOtPKcglgB3zTHmhU4QbvegNhXH7sk8D3qn9KfNK0p5Py9hTMVSRDdx8L7H+blanaVO24iquKcOTRYLkvnYPyLj60kksj8FuPSmqp54p4TPbFA9WQng9KKsCP160vl+1Fw5WVqXFTGMg9KQofSmKxDRUxTj3phUgUBYjoxUm2mkYNMQ2ilxQRSASijFGKACkNLiikBNbXMkB4OV/unpWnFKJ0BQA+xrGqS3maCQMh+tTKNzSE7Oz2NKWAPyw2tUB3xDDZ2+tXUmjuY936+hpskQfOM/Q1KfRmso9UU22gZ6kDio0VnJCjJxVh4ggAI4FREbVyD19KpENEEhxwetRdqkcZ6moz1IqjNiA1ZtxllP5iq6gdamRsOuck+gpMEbliyk5GQQeOa2vMX3/AErmbV93y4wcVsqr7RzWElqdlOdkdTJJx+NU55cDrj3pzyLgnNUrhww9xzXNGNz0qlTTQY9wDLg4qOcjZlP19arPkENjr/KoAXJbLYC9Petkjjcn1EnwWwQSD2HenRIp+8DuA6imB23ZA4HrUjZb5lUDPoarYjTcYIzkgHcPXpitC2tV2qSDuJ4qnGRuyWO71q1JcGK1ZuAAM0nfZFwUVqylrd+LSEwxH5yMVyodsk5yT1qa9mM87OfWoK3hFRRw1qjnInWVSORgj0pfNX3quKWrsZ3ZYa4/uJUTyu55NNxSgEmiwXYmSepzSVIFoMZBpisR4pcVIFz2pdtAWIsVKiZp6pkdKu20BIwo5pNlxjdkEUBOPlIq1HbMSNq/nWnZWBcck7T3I61tW9goAwuPp3rCdVRO2jhJT2RzItS7AKOT1GKlbTnJXaO1dYtgF5EeAeuBUyWLNwF/ECsPrK6HdHK5vc4p9NfOdue1QtYuvG3OelegR6XIzgBCeOeOlI+kHccx5I5GBVquyZZWzzySzbGduOKrvblRnGfpXp0WhPMMLFk9az77wwYixMTIM5OBxWqqt62OeeAktjz8weowfQVE0PPFdbPojocx5PtUSaI7A54NV7WJzvCTvaxyvle1IVx2FdLLo0qNgDcPaq8+myKOUIP0pqpF9TOWHnHdGDszTWTFbX9nyEH5GH4VFLZyAElD7cVXMjN0mtTIxSEc1cMBz8wxTTDjtTuTylXikxVjyTjpijyuuBTFyjbaYwyhh8y9xWymZQJIBvQ9u4rFMeBnFWtOvGs5ueY2+8PSokr7GlOVnZlyRM9Oc/wntVGRdpJH41sThZgGQ7gRwQKzp0OWLDnPWlEuaM+Qc0yp5ExUW3mrMBUX0qWIYOaWNOCewqQLiNSKllJFuEKzJtz0rQ8/HG7p7VQs2VQwZQc9G9Kk89fT9Khm0Xobt3NtJB/AiqfnluOPrnrUVzNlSF9elVWbgMSRxzis0jeU2X5Jd3yr19T2NRnJXG3BJ6mqO85wGqXzn2EZPHQU7E8/cniiZ2wBkdx9KsSAKu0KAeuBUemykqSc57VY4kf5cbu1S9zSK0Fhg3EMRjHOPSszxDdhB5EeDxn8K3ZG+z27u/RR271w97M1xcSOTnJ49qqmuZ3IxEuSPKupXxS4oFPC8V0nBYZipFWnImamSM4zigaREE5qVIiasxQE9vetex00y4LADiolNRNqdFzdkYa25PY1J9mY9j+VdZFpUQB25z61ZXTlzygIzn8axeIijshl9SXQ4n7OQOhzU8dg7gHBA9a7UaSh+byxQ2mDcBtwfyqPrUdjb+yqq1aOMW0IbDKT7VuafpucMRwO1bQ0sRsQyA98+tbml6NLOQRGdnftUVMRfSJ04bLHzXnojNs7HdgKufoOBXUaX4blkiIkjwrDhvSut8O+FlleOK1G+RuoIzj2rqbbTWs2ewlTa/G7IpU8PKTvM9e9Ol7sNzkdO8HGZIbcoJHY5HHWrtz4X+zS7Ftxn7pAHC/Wu20+CSzmEvAUD5T121JdyyPazyecheV8FSvSu6FKnFaI55VpuVlscCnhsj95sABblgOPpVkaIZVk+yQLKIhlyB90V0iSbh9mZz5eeQBilZpbCyuoLTBaXgt3x6VooxS90T5mccmlRReXJBjA6jvVu60uGePKxllbggjpVu0tHKSMV2t3UjnFayxm2tfk6gYJbnP4VVGd43aM61H3rJnnd54ZhWVgFyrcjAqN/DMEg+QBTjGO9dp5pMp3gH0OOlRXEEjyZgiIxg5Pes5ODV4opUZJ+8efXXhlbdiwbcoHpVeTw40uCqAdwMda9Bl0ySVyTgZ5wRV2OziiRCQGHp3rGOHjJ6otqy01PMf+EVcZ3Y3emOgpG8Hu4YAL7AivTpoYy29QcHj3oWxJgyyfL6k4JodCGyDkutTxW68KNFIQ1uGPU8Vl3vhkvgrC0bDrgda96GlopLbgRnvUFxpNsBuKjB4zUKjLe5jPDU3pynz7/wAIyxb5gRjrgVHN4dIHyE9O4r6AGmRJCymEMCOG255qhJoSMDmNNvXninyzvqzGWBpW2PAJtBnVSVUn2FZVzp8sX3kI9yK+ipPD1tNHIRHtI7AVzet+ESYmaMbtw4XGTVWqR13RyVMDBr3XqeM6bObaUxSZ8tj/AN8mtKaEZOTkdQccVJ4m0OXTX3spVD69QaNIm+12hST78fBPr6UN395HCoOD9nIyZLcljjGKia2O7cBW/JZsj9BjHJ7GhLKNgME9egoc7CVK5ipD1HOcUJEd/JwlbRscMQDx+tVZICqjjpxx1o57g6TRVCBGwDkGp/IPr+lSW8O77wIbOMk9alNk+TyPzpXBRK1zcxvhYxVCR/lI5prABuh5psmNvXJFUkZybYqOC/JIFXISHx1I9azlPOfSrdnIC2CSM/rQ0EXrY1UOzjoD+lW4V3SLgBR3J71nx4IAJrTidYIS7ZGO/XNZSOyn5lLxNeCGH7Opw7cn6VyoB6VYvp2ubt5Dnk8VGq1vTjyxscNao6krjVXmpVXIpyIMirMcJPtVExQyKIngCrtvbE4GOtWbS1dsAA8itzTrHAVsZOaynVUUdlDDOo7JEGnWA4ZgMjoDW3BakfKAK0tL0qS4IVUJYmu98PeF4njLzxbguCM+tcajUrP3T6GhhKdCN57nJaLoL3xBxtUjrXYaP4MSWFpJVXk4GT0rsNK0yK3EkkMO2TGMEcV02j+H2utPju7eZTNvIMR6AV1U8LCFubVmlbFqnG97I8+TwXDaybmjBAGcA5qDUfClq8Kyqm53PIXtXqC6dA0d8bwt5qL8hTpWXp1pHImTMCvVuORWrpQfu8pFPEuScm9jhbTwpbRzqHhLLjIzWlFopgYPFtAB5XsK66GOFLkrHIHX1NR3ELyFkhUMQcnHpVKlCK0Q/bNy1K+kRrbSCaA/6QCG9BWpqYe8u/MnCpIyjcemaq+WEhj3odwPBWkmnfJMgLR9M+lD91GXJzT5luD28mwhGOQemetLJYs6Rqjssp6gjoPrVoPDNtFvE8hC/Ng1Pp10AksbjDNxhu1JJMiVSaWhm6LY2R1CePVJMBUOzB71iJKwv2WIF0ycfSum1KC1G1tPUtJj5j3rBEUqwzTBQFVuT3qZLltY6aMlUvJ9baPoW7dY1lYtwfT0qQmJopVR1yByGqohS4iUxnjGWo1q5N15ItrLyUjXazDq5rb2to33IdJuaX9IpXGnxxMrqjnGBgHqTTnUhiMZJ6c9K0+WsvL2neBngdaxyX88JKrIpPzVLahqluawUql7vYnEcrxghd5GeB1FNs5rZplE0QO05YHqasqwsyfLl25GM+oNZNxDGkzSRyZI5x2pVJuKTHTpqd0O1BXlvXFvEUjzlQD0qzCrMR5kmSvUUsDNLt3DYDzkVsaFpEOpi7zKUZI9429z71MVrddSqs404e/okYVyQd4SJz33DoKSBN8X71SGA4z0qOGUi4aMPtUcHNXchA4bO3tnvWSak7mso8qsQwwldythWPbNRSW4kGMMD71aM8eA7ZV+mDSebv5jdXq1JbXMJQd7meIgrkKqt2zUV3Zp5O7dk4zjvV8o0bnbgH26VA2JMo4xt6U1PlXKZTp3dzzLxnpKz2zs6bsA9fSvN9A094Lm8jlQjBGMjqK971ayMsJ3EY54Fectb/8AE08rHqBx2rmqTav5nPPCqclLsYN1altrfwjtiq6WuJMjHTpXbajpm2FHjXCgfN71hPblXO0ZwMk1M5NaGEaCvcyvJVAWC81lXi7zhSeO3rXQzR5U+lZ9xCSnbFTCRnXpWMFHaP5NhwOAKmEUuP8AUg/jU86qsgDAnIIyO1R+aBxh/wDvqtzhtY59lDxnjGOah2Y2+hq2Nu4AkZNQOjDKng9ga2RytFcjDFR0qxag9elIIssvv1q1bph1U9ScDFD2CMdS7YoXlXK5JPWn+Ibg29ssCsAzdeO1WYlERD4PyDJHrXO6pctd3juxO0HAFZwXNI6akuSFurKajkVMkeT70RoSRV61gZm4GT6Ct2zkjFsbFB0LHOea2tP08v8AM/Qcj3qxp+mliNwwBzyK6fTtMkmZVijJ9MCuSrW6I9XCYF1NXsZ1lZ7fujtjpXYeHvD8t5IrbCIx1wK6XwZ4MluZSPJaVwMsuOgrvLbSEtWCRJtwMdMCqo4Z1XzVNj104UPchuYOlaEYRC0QALHaFA5NdWlk9pKEki2MAMqR+tV5EnguYWh/1isNp9xW/czNdqJLlwtzj5iK642TcUrImo5e63qmZ8khtY8gZEhxk1oXenz6WtqILksZ+cxnp7VnzRLdqY3JJzgGuikmWTTbeBouYcfOOoo1crmFaThy2+f6C2FlJLp8jE4QfeDdayJBbWgkEbLnPAPeteZ82JjtmkLOOeeKwLwTSmG1+zfvQeo70SdtTPD3lJ3ejJtZngh01Eit189+dw/Ws7TroxpKBJh9vSrsNjcSXKK8YbA+7npVXWdPXz2e1zlR+8x2qJc3xI7KXskvZN763FtL0m3SCUYdmzkimSSi3kbc5dAc4qtbmR4l27i3uKW4h3TAM2CRUOTaN/ZxUmWIbgyXbPaholI6etTwNOQ7HqvSobGXydyTAEY4Iq5BIqqpbcAx6GnFd2ZVNNEhYpY9295RE+OTVDVbVGkULMfLl5baevvV+FrW0vXm1CEvAV+U4yM1g/aWlu5BEjlATtGOgpSkvhY6EG5c0dl939Il08pa3axA7o+5rSjCytJ8pKE8VVSSKO2PnQ/P2IqqNQaI+YyP5A4zVxapqzNJwlUbaWpsWcslvMQUBjPTcKivYXeUlFBB56UttM0sXnuflPQYqSSeQKFiBZuvyjtW2jRy2cZXS1Ky3MFva3cMtkZp3XCHj5feuat4nLssqbQOme9dAt9FczMG+WTOMHvVe9hZ58Dgjp71hOKnZxO2g/Z3i1a5Xgc7NsajHp1x9Klid0DOjvFkYbacZ9jTYIniRt/yyDpnpmpnfZJG7oGQEEgdDTSaRcrN2RAix4GMbxyeOtTGJCqswIU9R6VHJOZtU3xwiJGGcGp5nMr8geV0x6GoT3FK+jZQuoyk37tdyD1qG5iJljkgj8oDtnrWhLHHG42NnjPWs65mHnZC8Z5bNY1IpXbNqbbtYcrGQYf05561FKuNmQVP51DPKAgKnOTyBSRzF16fN2J7VnzrYUqbWqIbxiyHYTnoRiuG1i2eDW1lYAK3Qiu0uJVWRojnJ5zmuL1a4L36wlT8hz16VhiZ6IKVO52NrpsF9oDzK2bqJsmMjGF9a861WNVlfYxBBIIr1fwTMj2t9BLG5MtuQh6jI96851+Dy7k7ypLqGGzn866MQ06UJo82nB+1nB9DlmYBiGzj2qrcYkQ54q9dIOowKpscLgjnvXPBmeIgYd9FtQFt2c4B9BUGxR2z+NaM0Ky+Z5hIX+EVQ2xjjmupM8iaszn0Hzgnj0qzcIJIQ4zkdarj5gNw5q/ZJxgDJIrdnJHXQrQgMoOMEdquWqD7SpK5wPSmNA8MwzgAn1rasrcPIuRnaKiUupvSptuxS1WXybTaD87fyrnkiJ7V0OvI0l4kQC4UZJpbTSWZAx4Ge3enGSjG7FUpSqVLLoZdpbM7fcOOn1rpNN0sIoZz8x5wO1aGnabuChFLH2rutA8KPcNHJJnZnkYrCVWVV8sD1cLlyiueoYGhaU93KoVSU4zXrnh/w7HbWq7gmSAR8vNWtL0q0tkVYol3DpxXRQy4CqVHTn2row9GNP3pas7qkn8MFoivoovdKvFlsdq5B3hhwRWkISzmRs4Y7iB05pREAFySffPSpI2zFIuQV6AiupJLY5p6vm6g0cUkyHaQq8nHYU2U2jNJ5SyNGx2hyOM0yVJUjYITnoD6inaJcXEkZ02OFZjyynpj61LlrYdmo86e3nb5liCzaG3ExwQDgAVo6be+VbyIIkZpDjntWRKzrujdHWVGwV7Zpxlt443M+UcDIGepp6WMalP2itLU2LdVtY2ikDM+d25eQKzNQkmE63VuMInQnvWxpyl7SPyLiNzIOc8kU1dOle7EF0f3J5JXig5o1Ywm3L+vkYlvfGCM3E+Q79DUrzWNxbMrxSpLIM5HeneKJIYrmCyVFBXksOhFZF1N5gZ4pwJYhgAdCKlux206aqpTStf+kUGuhE/2W2yeeT3H1qG8YmXLSYwOPeqlvfXNpdPtgEjyjGAKaIJN4e8DIc7gp7VxOpzaI9qNLld3/wAObOl3EckH7wYPQmrMypFfw/ZHNwqruYdlqihMyedFsRQQpX1ra8PMlk1zE2xBIMl+preDvZHBX9y819xBdyTX8Ye3TdHGcsPpUDJJeTyz2LRKwT51PfFS2j7NRmh05tyNyUrDvLeeK4nKF4pHPIHFVLRXHShd8qaXb590WYHF8TGW2uOMCnSaZO862CS5gxvk74qjZQ/ZZBIxJf0FaltdS2wnfgvKP4hyKiC5175tVUoP92/+HIrmK50y0ilMitbbtoAPNTi9Jtnlt1/eMMD2Fc7Lb3r4MjM0QbdgkkD8K29OuTCwbavTG1u9FKbbtsiqtFKN3ZsyoYLhLkOVBJbP1rdQyu6LuCnoT6VObOe8DiExqwXeazYvNSQpI3PTJrSEFTehEqirdrobrKx2mpxRRT+cp5JqfxFZraRwNaziYyLuIU9DVfyg7EuBkdzREZpC2xhsHbHFS1v5lJNOLT238xI0d7VWmXDH35p8e949hwik85pkl19l3G5Ukn7tWQsU8CFyVJG761Ks9ExybWrWhD4js4NLuYFguPO8xATg5xWPcJIV3KvB45q60S7icKWJ+Uk5qK4L7WXeBjqvpWE43b7G9FuEUm7vuZ93GEAXzAfUCq5lwnIyB0p8qpktuzjrkVSlYE8YB6gVyN2dkdDSaG3MgQ7vvEdT6Vx2rMh1klTuyoJ9M10FxM4chujVztyEa6jQlVYvt3dqyqS5tEKnG2p6f8PrSfV9Mlt7VVLW5Dl89M9j61zvxH8KzeH5Ld3nimiug0iFO2O2K7H4FxzQaregPGsez58n7wzxisn41Mj6yI4MpBF8gXsD3x6Cu+S58L73Q8SNWSzB0l8O545dAbj71RkbA55JrRuupyCDVCQjawA+Y9D6Vx0mbYuNjPvmIXKEZHGDWZ5jf3m/KtO9XMQKgF8nNZBdgT8zV3Q2PBqu0tTIh+YjPArUskxGT3HX6VmpGDyD+FXrR/lI4Jxg1tLU46ejLl5bM0YkAOBznFX9JO50UKQTwSamtAlxZINwBAwwqG1/cs4XnnaDWTO6EeVqSJY7EPqU0jMGUfKvvXZaD4XuL2HzduyMDPIqTwVoK3siyzHEKnqeleryxx2dvHBAg8sgDj3qqVD23vz+E9GjFUmoxV2zktF8Mx22Gzn0Ndjp+1UCAFSB0FOt0YKqBFy3GMdKtRW+wNgEA9c962VOMPgO6T5laRLEFcssYAfGSe2Ks2yuWIyAh61HYu9s0gVkKSDByKnQ9l6E0LXVmUtLroSTMqTxJKxWEsN5HpWvq6W1vNH/AGdsMToDgHNYzBGGXBJzUsEeHCWy7pD0UVa3uznnC7Ur7fcXcFnRCAzydOwFR/ZLjTrsy2kyxzqOnqD2pmZI1dmjYsvBHcGs/wC1Ww0/fI8v27zOSaJyXUUacnotVttc1tQEywxuQwkk+Z2bqTVPTdRsbG4uDq0LSoVwjbc4P0roUk+0aErSRPJKRgMRVW/0qKGOCSMGRjgsGolFtaHPCvBp0qi8tP8AMo+HLC7lilvY4XjidiYwTg7fpWtqt1cw2qIr7Vl+VnPVav6ZcXkaGJrf5B9zsKy9RnW7Y29+qxoTkc96cU0rGDqSrVuaSVl89Dk7hJ31ny0drt++OTit2eG0l0Z4Y4PJuU5LEYNUdJmj0XUrmVFDhxtBParn9q2aSk38Db37gdc9KmCtdyPRrOcpR5ForWt1+RgWN2LO8SaWIOF4Oe9aN60b3vmXKqquMqBWdNHAuplp1ZLdjkKfSotQhVtQRGlKR4+U57VF+VM7HCM5qW2gs0ESys6BtoOeDS3CSyQCaAMABzmrFnE1qrm8J8snKt61r2xh1WORPNEUajjHemqaku1xVK7p67pdTltKuLmHUVuUGzseM1u6hOL0M/Af6VUEZWYG3XcVJGB3FV737SsLSQJscfwmpgnTTW5U+WrNSSsxLXyU83zZCk6cqhp80wddx6nisK5murqf7TOuNvBI46VdiSeSIOscjQnk4GazhWvdJHRKha0pMvzzswijjYjnnHHFWb57cNFtjIIXk1zEMzy6iIbYtljwD2rWuFkjhIvCQqkZYelXCuppuxE6CjJalyK6QQs4Zt7Dgg4wKozyYRirOXz3qr4juNOjlthpMjNuHz8mrdgs96Eitow0jDHPFL2vNJw7FRpqMFVeiffQk1mJrFbYi6SVZ1yQvarFusksaCIgA96zJtEktL1EnYiUsMqfeuo1XQjpdrDcxyNIGIBC1UFK7urGNSrTgow5rt7abmJq1ubudFZwuwcmrKsktvhZg3ljAGKtNHaXI+0Xsi28XTy+hJ965W33yXk0VrMfJDEK5FROSpyvbcdJe1jy7cpofZriQk2ltLMV+Y7ATiqEt4WlPnKQ+QNr+tamgeJrvw9cTwCOO4Vx1Jxg+tUrcweItTumvJ47SX7wAxyawlNS0i9X0NYucJSdSPurZr/IyLt97Mznk8fLWXeTLGm9iMqOmKv6gFtkaMOrlTgEHg1z2oN8q5bP06VxzfL6nXHVFS7uG8wnkbhxzXPXbl7vPYVq6m+VQI3Xv6CqlnZxvqUKTPhH4OTisYx5mKUrHongSa4s7aWGyw0lxb55BJU+me1YutzNdafK95OxngfYyOMkn616b4H0mOK3wF+bYpDY6fWuC8UQR/2lq8FsoVnO8IvIz3r2atKVOgonjUq8KmIlprpqed3KnLZNZc/PTjnk1rXgZWwx7flWTNjJNeZS3OnGbGdfMu4rG2ME4rKIfJyorSvIwVyeucg+lZuW/vGvQjsfOVfi1MpGwdwA56ipTiNw6k7WqKWFo0LADGeDTI3bG1vu+/rW5w3NqxvPKJQ4wfStHSB9rvI0U5O6uagiYsD1rqPCcbQ6uqbgzfLgjoMmsqq912OzCy5pxT2PcPCUEdpbxQqNzEYI7V0kkTs69Qq1m6HbCKMO+CRjGO4roreIEsxB+hrrgmoKLPbTSlzIZBFtQs7YJ6Gh5G4Ck+X606YOxBI+Re1Typb3DhbdWVQASW9ayld6I3TS1ZWY7WVsEqelW1Y+WOMU3aB9B2o3qAVHJqYrlBvmJEUlhltufWnQTS2d/HcwkAA46ZFVml8zGzLfStGytS8DytIBjjZWm5lUtFe910L1ut1cTSuSGRzuY0sOnfabCVdiFEbdnvVLTJUl1L7LcXRt4mB5Bxk+lbdroc/lSCG8fymJxjgEU+ZHBWn7F2bttbQr3eox29hHFZuxxwc9Ks2+pq0KPNG5YDkEd6i1XQY7TSVMUrGZHDfMchvaqGqa2wtSzRCMYxkDrTUurM4QhWSVJX1evU1NX1SeOy3oduRgY7VyWpK0kVu8NyZ7iQ48sVNPdw3cEK2cjOcZKk1vRrb2+kRStFEso4yMZFRpU2OimlhErLVszYfIjsvLuIj9tHzZrJ12a71FoWiiESxcbq6O61CFrWNRAXO7LuB0/Gs+9PnL5dmpyw/OtJRTjY1oTcZ88o6+exgX/nTRp9rlVnOFBAxgUqWayRvGcyqOQ+elVb5h5wtAD9o5Dhq2bmeCDw+kdsNsg4Ygda5oJOT8j0pOUIxUer/plwwtcaYquN+wYGe9UJA506RwiQ+X1U9TWPZ6zIIJFa4KnPyrU0Ik1BBlmD9x61arRmrR3I+rTpt8+iudF4Y1CIxkmMAY5JFZOqzSSO8qDYm/gnpjNSy7PsYThNnYcGsLXNS3WiRRv/EMqKdWahD3hUMPz1nOC3IdRm/f+Ssu8NywHauh0fUntLDoHQDGCK5S1hXzEdssT2/rWimoRw3KO0ZMCnDqOcVy0ptNzbtc7cRRU4qFr2LmjrFBq813dREeZkqPxrXMC3JcXUg2NyPWuevtQS7nEltwq8qOlWGjcAXU2NuBgA1tCajdLVHNVpSk1Nuzt/wxWGm2zG4aM7njb5ane8msJ4ZYQY5gBt29DUUry2y7ZIHhWY/KegNR3SzXMZWLlohndWS5Yp8iszezn8bujR1C8vnu4pr5dkjLlSe4rUn8QJNbQRMZU2jPzjrXES6jfancQxXBDKhwPb3rS1W6aeCFFKeYhxgDrxShieZSlEzqYJe5GaWnboXjrFtLcTMYhJIRgAjjFZflSRJcmN1CyD7ufuishZma8+7tx19qtXNwDlsMq4wT61z+39prJbHSsOqekTPkmeN/mVjnoc1WmJySCMjnOOldFomgT69MyxzRw7F3ZfnIrEnjj03Vil6BPHC/zKp4b8a5ZUpJKT2Z0KtCUnCPxJaopSyOQHZiyjnHY0sl1DPE7LGFAHTHWur8V+KdG1HS4YLCxFusa5YlQDnHQYrzT7YFyRwueB7VVRRpaRlc54TnXjzThysp3Mn+kEsTtzwKTTrvfrFsWKiNX53DtVe9mWSYsvAq94MsRqXiO1hKF0Zs4FFKF2kjnrVbbnufh29MP2eBiYLa5GCW6J6H6V57fLb6Z4quVuZDdLHMwaRG4ZT3r0jxnaRR2kVvFL8y2xIKDJyB0rxS2fzJchiHOcufWvYx0+VRVjyMBFVOaotLr/hitrBglvZ2iASFmJWuZuTt3YBOK6LUMIrEkFgeo7+9J4jVba4tIrPTkCQqrpJsL/aMgHLevPGK8yGrbOnEy0UTlNTRISgSaO4UoGJjzgE/wnPcVj+anoa6HxdBFbaiFhiEDyQpLJADxG5HI/z0zXKEJn7/AOtdsVoeDUd2TiEnG9SPVcdaY9opy0agg9R6VtSRsxLDJ7DtVmC0WZMEKkgH8XGafPchUrnP2tqwkKuN2ORiul8J2yQ62qMB+9IxzSRwJhdi7SOCfWtiwtgZYZQxTa2GboBS5uY6KNPkkmz2TRV2W43Hc46Dvit+1mQg/KWPriuX0KRYoFCEPgY3g9a6W1dgrEcGumN7npNpolKblxg7QenenFgigIPzqN5Oqq4LD0oUFiWc/Ljmm/I1j5g5ySB1xRZ3TWNwtwsSy4HKtUE+5Zx5WeetTWNn9su/Kkl8njI96ybu9DWSioPn2Ll3qKTt5kFsId4zhhyDTdPd5mMKMPMbrmqN1G1nIyN8xBwD6j1qxp+m3V1bPe2zgFOMZ5PrV8zvYycKcKd72XcZe2tu7MszYkj4BHrXV+EdYlliW2lQZQfez1rkryGa1CpKp3v3YdaSG6NrkjIc9MGhpc1ya+HWIpcu/Y72/v47uaSyEZZsdR2rC1QRyaebC7UB1Hykd6qaJq3+mfZroiB9ud7nlq0rKzW8ubiVZ1YJnDHvWkbNaHnKj9VdpaJWfzItJ0C1h0c3W8iZVJ57VykmrRhpIZ42eViQgHNaWp61PNdx2sNu7rGx8wR/xf8A1qLbSReXiX+BCEPCEc1lK/ww6Ho0U6d54l3vqvLsiFbu5jtSmzYr/L8w6VUsLqe01RIXkDgDIIrb1nybhHXIwi54rO0DRUkAuY2bz26FvSqlGXMkjWFSn7KUpq1ytqFm1zfvcbSrDnPemuA1k0DN+7YEFgcH86m8RXUttcLbk7ZWO3pWYw8u4VJ5gyY3Y7VE3GMml8zopKU6cW9uhNcaVbTRRuqmIxjk9zU1o6rIghkVTjrVjVWAscwtv3jBA+lcqblVjCkMsg6+xqak4UZJ23NKUJ14as3bvBvYo45RIZDg/WsnVLVLe/8ALlCnPIIqky3UsoaAFR13Z6VLBbzXF3i6ky+M5f2rnnVdTTlOuFP2evN0Na7e3htA8K/Oo5I7VBFps97ZGS0ZSrcnNQFbifzLSxVXxncSelO0a3urW3kL3JhRTgrnpVt+0lbl0M7OELqWvmTWlhbW2kTPNPi8VsFM5yc0kzwnSgY5pDODkq3b8KZqMNuLBrpbrfMSPlz+lUsTTR/u0XBGTzUytD3UugRTn78n1/pEl/qGo6ktvC5Q+X90juKit4ZmufIWUwyOcMQeMUWLxOE35UqfmNSsYY7l5bebc5PHOD9Kw5eb3m7/ADNr8icIq3yH32mf2XdbY5fM4yST0qe/szZWUc0sRkeVhghuBTNbtLuO1jmukKpJwpHP51Q0m4H26NNQmd7ZBwCeAauXLCfJa1/wMk5Tgp817b26j7eFZdRjjkyFY8joat+ILGwgBCSFTt6Z61R1WSzjvi9vK+w5II7Vg3s8kzlpHYr2JNY1KkKalC12awpzqSjO9lYtDU5IoGSKTaem5WxxTNElsZNUjOtsxtP4mHr6mixGmNDi6ZhIBWDeSKsjCMkr2rmcnHlk3fyNXBS5oq68zf8AGUWjKQdHZmjzgA1xV1lflIwo71aWcmQb2+UetM1q4jZVVNuRwcVUpKpLmtb0OZp0oqF7+pjS58skVoeHr6XS762vYCyNGwJI9O/6VkyuXcIvY9PWux8Pah/Znh7UrS901ZI7tP3czryjexrpow1WtvM8upVu20r9D2u7e01y40KfRHCpdRtGzg89Ocj8K8P1m3k0zXL21YgmOVkJHTrW98KdZtNP1jytVkdbVgWRlb7je1YHil0fXb2SOVpImlLKzdT9a6sVUjWoxl1uc2DpyoVpUt42/VlC7J8khV6c5z1q4Zk0lRZya3fRSKoZo4IgypkZwCapw2N9fRl7a2mlQcblHFaV1bXFwyNceGZJJFQJv88gtgY59a5KaaNMU1t/kcF4lWBrhntbiedWGTJMuGZu9c1sHo1df4otzFdFPsJsflH7ln3H65rkWjmyeR+ddkHoeDiF72h2lwgXBIw3cdiKYpIyQBt7itR4AzvvUNgcexqh5TIxyvWudSudvLZ3LBRVjLk4jAGSPWtWC3Wezf5hEoXkk4zWbZukcgil5Rucnt6VoXZ8mNSFV2b724ZyPatqTjd3HOMmrnW+ENTU26W4ZSy9vWvQrGYGIE8+mO1eGrefYdQgkhIEbAfd/hr1LTdRVoI5EcMNvOK3pz5W4y6HTD95FNHWWmpQxWFxaS2W6V2ysx7U2OUFcAjBrIjvGuECBgH/AKVKC8UQx1z1oVR7bnXCkvRs0HIcbvyxURuArKTjcp4NSXVjdadCj3RQrKNy7TnHsaZp8Ftc3gjuplhQjIJxyfxobd0i4yjyuW6GXN4906mQDjio7a7uba6D20zLGGG6M9G+opt2qxXTpAwkQHAb1qpI21iM+5qZOx0RpxlG1tDp9d1sa01vHHD5Tp95if5VQtYP+JjCtw23ByCOc1k2WpLC5Xy924/erYiuliljubnllOVz0NXGSmrnO6H1ePs4Ky6GZ4kW4utSJdNix8LgdRWpp93JH5UFshkklG0KDUOtXFxeQvqKoiRKpAUHnHrWl4XbS7+C3dZ/s97F82c4OfX6Uo2VR2erJq1LYZOUdFpprZ+ZDbtLYXsyXEQjuMbsHkEU6y1VRcSi4BZfRegNZutPcPqc8slwJm+4rAY4qrfQ3mjJEzPG63Ldv4SaqVRw6bDjQjUS5muaS/qxb1aSTy5J1QCJj0B7UtprqwW6PHj5CMjOM4o1PTIk0xDLctvI+4G4rnzbRCJlLY5qZTqRlfyN6NOlVhZ62Zt67K+uXVuyqI9/A9ai1DRBpm0yuZJMZqPRJY9LYzXrMxA/dbucfSl1bVZ70LJgbeeO9TeElzz3HGNSE1Sp/AiXRLpZ5mgcgYGQSOMVFd2Nv9rlklOUPAPqaqWJnbS5YEs5GLEkTDirLQveaIY+Ekj+9xzxThLnjZq5co8k3JOyen/BEWEQRtG7qo6gjrWXrdrNaxRyvKCWOFKnBq/ZxPJlppw7JxtNYt9O890C+4qrcL1FYVpL2eq9Degpc+9+47Snnt1eSOQqxzliOtWvPngTzZU3xtnPGc+9T3D2Ulihjba6jBXv7DFP0fTb/VlnFqA1vAMsSe/oKUY8tqcXcc6sbOpPRdbmdpsFte3Ukl6xiiDAhemR61Jq4QTg6Y7CPbg+hqF7qO1llR4jzwR05p2gW3nzSyH/AFYPK+prONnakt3u+pcrxftW9FsuhStLeVi+4HAG5mB6UXnkBo3t1bJ4J6dP61b1KWWxlbyxtikzj1FNnl86wTMIWMD7w/nWbpxScE9UaKTbUnszRu9Ya502GB28wp2PtXP3M3nT740w3QD0NJbq7mUR7nIyeBnAq1YlYZoppY/kVufepnOVe12TGEKKfKR3aCF4ReRHaOWGKzb9opJT9lVhGegrqPFWsWl5s+z24UldvA/nWJYTu0Ys7S0Mt25OOP60VYR9o4J3/rYmlVl7NTkreRjJY3FwrPChZfXp+lZdyjR5R1Kt3BrWubu/0nUJYbhTDID80Z6VSe6t7n7Q86/vCOGrncY7bPzNZVJrXdeRnRQefHIwfBXoPWsa72iU8nHbPari3Mib0UgA8ZFZdz8xOTk54FawXQ8vFVNG2OQBpwy8Ef5zXQwarc3NoljcyB7fjAI5/OvSfDvgnSL74chTCI9Z2GYSfxP3GPavJpInhmdGBDodpHQjmu6pSnh4p30Z5dCtCu5RS1TH7ntZ2GcOp4NS3F0Z1G77x6mqjZyBzn1J60bgK4m9TvT77mpHqt4dFbSUf/RQ/m8dVP1rBkmmI/1sn/fZq5b3ckMc0YK7ZBg5FRR6deTypDFbyGSVN6A8ZX+9z2962u5KPkc02o3MLUndl3O7MemScmsXP+y1dVr7SIGtZ9Pt7WWLaDsXDcDqT3zXLkc9666Wx41d+9dHpM6HzVEfL981DdxsXwEIHrmtJreONwXO04zkdqWQxmVkzv4+Vsda89aHVzGBcRgozr1AyKt294t5ZoyKwKDHNTSWoZuWAyOCKr2yBGMb4RTnOKtSaldGyakhqnerW/y4k745H0rqvCV4sTPZy5EieveuejUDbGiAS9Varlq4i1JbxcJtASRCec+orpu5Rut1+QUZKFS3RnoNpI0bvKeAavzTAW+SflPPNY8EolhRM5GM5HcVpXAEkSKpAAxnFJfCz14tNq5dF5LNHGWlaUIMAMfuj2qrep5suCSVqhcSBAoRiG6YHerdnIEOWYMAOc0OXOrM6Yx5PeQsc7BliwTjgY61pPpl6LeS4eLy1UZ2ucEisTz9k5mVwGVgy/hVvU9cv9UCh38uMLtKp0b61EKsbNSuVOnUclyWS6tl3w9d20N7uv4RJBj+7nB966HUrQ3dibi1WNbc8on8WK42HMNoJi6HH8NbXhm/S6ln+23Lxwqvyx7sCt6NRaU31OTF0Xf28On9bEum2E93LbQXfnRafNIATn5T+Nb3jbQ7HTbCK40yERSq2CF6EetZN34qF9af2ZbxqgiYHzcdceld7p9uuqeG0ScDMyEZzn8c1rFQeidzysXXr0J061Rcqvt3XdnkVneTvCTJH3yD61t6ZANVu0S6cqka5AY/oK2m8Iy26+XEF3L0J71zXiKOKIRxQ70vQ2xlQnr70oxdON5O56KxNLFS5aLs+/bzKmtzNa6rkN5sURx1yKbZSR65qm1lEC7eM9zVm30LWWgKNZlYevmseMVQ+xNZXox9xDztPJrJ89+Zr3ep1wlTceWMlzJbo273w5etaGaeaMwIcgL1I9axrqwFi6SK5mQ84qW91udYjDbSO0B6q/Q1u6pc6XP4ZhuNOHmXQUZUdR6g1o1Snfl3Rip16PKqmqk7aL8ylN4jMtpFHaW4SM/fbb90Vk306R3IW2nYo/L4JIFN0eaQQ3LBUZHPI6Y9qn0m8so/PQQ5Zx1J6+1JTdVLWxoqUaLfLHYzNaijhaFbSYsHHz4NRW90tujxPFuDc7gefpVlpbZrdrYQE3DHsO/19KQWkDWqvIziQHDDpiuaUW5OUDrUkoqMyBgptw4iK/7WK1vDOs3mmw3NtC6xCTuw6EjrWZd3gtzHHBh41wT7/jTrPUrcXxluYWIK44GSKUJRhUXvGdaHtabUo3RCsRvbssy7lAOT/WqbTyW106WzFFPUVphAhmkDPArZKJmmaXpkl7Yy3isMqSMH260nTbaUd9S1UileW2iILW2F8zGebhBxzzWnr8NjbaVbi1uvMdhhgTnjr/OsqGWGK1cjJuBkYp+l6M9/bz3cs6RBWPyHrxz+FEHpyQjdtE1N1OcrJPbuN0x5raN8IPnHSqkU7FXDnEeelE13JEzxQsGxxVX7Q8CFJU2q3BOKxc0koroacrd2+o+eQEbwd3PCnvUUd/eWuoRSWsflXC8LxVW5mW3lSSF92Dkemaq6hqb3EiyHCuvQisufW99fIHC+lrrzG63f3F3qRn1Eb3z84FUtYktGw1mDGuMEEdar3ly07lmOT3JNZs7EgnJwKSbm35mVSSglboRSyYyBz9aqxwyyt5mxggPXtWn4e0a/8SazDp2lwPNNIfmKj7g7sT2Ar3z4oaFo+ieArPRbCGKO4i2kEKNzEDkk+pNelh8M5I+axWMTqxj3ZzPwi8ZwRS2ul66BsjGIpyOg9GrkviYdOk8YX7aSc2xbII6E98Vze57eUAZU4xmopJPMUEk7h6miriXOn7OW5rRwsadV1Y9egw4yVY89aTOE+79KaTk54z70m7A/xrkSudUpWRGzD3NdBqOo2j293LDcubi9jjt9pQ4tkGN3PT8q5yRhg9vp2rq71bptMv7eziY2Yht2tBEmQ53ZJ46tnr6VrFHJWktDkfFV3FPcItoxlhhhSHzWGDJtH3q5XcfQV1PjphHqaBwi3LQobhV4AkI5/HpXHGTnrXVBaHk1mro9jupXjJDRgDGCCeTVYz5A8pSW6H/Zp8jebMglYbsZOe1VoysUoA3dwfSvPO1EkoySSSQeBj1pGWNuc7W4yD3qZGJxgZxnGOlRTMCu1l256baSKTHLAEuEfdgdQfQ0+6tUvpHe2bbIqkkt3YfwioTIz4GD8tIsrh5dkvl5Az9RXTRkk9RO9rrc6bQn2WysXORwyt1U+lbYulFtnqGOMjtXnFpetDqkTySNslPzYNdyZ7b7OoR1wepzV6axR6eHqXSbLHmxqFaMZ9M0W7tufd/F0B7VXmdIoU8rLE+vekkkdPndhyOlc9uV69D1oTUlp1LLOuMr27GprZXmGYRhh1yaykuSQSeAKv6SslzOkazGIE8uewqYyu7G8rxjdkEofzSrk9eg5q/YxzSfuYQSTxWvrmgDRJ7fFws6TnbluoP9RWd9rk0yc29uVd5cEEdQf8Kv2PsneehmsSq8E6WtyvfWUlpMvmSDf1Gw13Hw41e9toikgZ7InapJ+6fb2rnxpUb6PJdT3H+lgdGbv6VF4Sku7mVrMTGO2JydpwR7A+9a0oeyqrTRnJjOXFYaUZWdt/8AgHofibxQ9vNHbwMI5z8wI5yPSuGn1AT37y3R8uQHKnHPHf3re1DVbEXlutvAs9xbEFtwGVHcZ9ajuPE9jcal9q+wMFRShYgbh7V2z3tzWPNwlP2MEoUntq/67j5/Gd42nxo8CqhG0yqOv4dq4W8u5JJnMcrlWbJJ6muqsfE0TNJHFYjyQxweBwfWs+/uLWWeRILbfLKDgKB27k9qxqrnjpM7sJBYeTSp2v5mVe6cy+SVLFXHcYFaPhW+i065MV4m6Et8zen19qmknvtYsYbCG1EEkQG92PTHH60zU9Lm0+3jjiBuJifnHH44qVT5J+0gv67HRKoqkPY1Xq+n6m9rGgadebrrRroQoy5dU5Vvw7VxyWc8M58rDhDtIB/I1BJcsZgsXmQKOG6rk+ldN4W1Kyhs7m0lX97y2WA5z0/KnenWkktGZqNbC0nduf8Al6mEySQXoYsgJyMkZA9RSy6gqI0MZilRuRgd6o3Allv9gfcC5RWPSpF0icTkblJwNvOOTXPeTuoI62oKzqMbLJuhyYSyocn3qnczCSdWjQqn+7ip7+6ms0MK4Ytx9DVV/P8As6xsozjqtc9SWtkbQWlzXSeG7tTDOxM/O0Ac/hVQyyabJtEjCKThkB6n6VTsL02zeYAGfG0hjWpfOlw63HG4gkit1LnjzJ6o52lCXK1ozNjkRpPuHJbjI4pdSZo5Am/IZeQDUy3SCwaNolG4nDD+ZrOjKfadhJZuik1nJ2SSe4+a7cmthUtZozGyx43HC5PWlv7a6NzHFcsoz0I6CtNWWC+SHVXEcJXKEHGT7mue12+VrqRYZTJGrfKx9Kc4KnBmaqucrFXWrYWcwUShlxnisp5FyB1zU1xNvg+clmHc1kSy8iuV6yukU52j7xPdbOWBAFYOoXeDsQ9alv7tYULO34VN4O0C58S6qsaApFn55duQg967cNRcmm0eFj8Xf93F+p7t+zTFpem+GtW1S4uEW8L7JCxwVjAyMfU1h/FDxDa6vdwzWU8kiqpyW4yfSodZ09PCunfYrMiSNxnzOm6uDupWkfPQ969Kq/YQ5er3PMw2HVSr7ZPToV5nZyS3NV35BqWQg9ODUDnBryXq9T2eaw3djO7pTXI28nvQTn1qJm7dqpIxlIRmGSysTxjGa6Cd9P0jFs2qavCxVWkSHbtQkZx/+quabGPT3rpXs7q9tYp9Q0KO5mMahZDc+UZBj5S61rBXOOtKyOe8TaXZxJePYXVxNPBEt0VnUYljbHzKw7jPINcMXJP3R+ddX4o1K9tJdQtry2t0vLpEjLRtnyYR0iAHToM9643I/vfpXXFaHlTlrqe1MU3q2MsOcHr+NOU+YGZgoXBBJqEqRKWOW3D+Gnx43BsbiDgCvMPU6D4FlDqI25x1HSnTx7o+BwvfNOJydisI1Pen79q7QM85z60rWFfqVJxlcI/Uce9RGNEjBB3sRzx0qWVQTgD3HtUe3YNw+7046Zq0UnoZV/G4tpGUAA9D6Gs3w34naO5MF6+GU/Lk8GugueEKyqSW6L7Vw3iPSmTNxGAMdRW6jGorSJdapQkpw+49d0/UoJpBvbgj5RnvWvqccENrCyT+czDkdRXgeieJZrGRYrnLxD+LqVr0vQ9Uh1QJslBUjgg9a56sZQTjJXv1PawWNpV7OLs10Oiil3IBjAFRzajj/U5B9QaqbJIiQMuPboKgaZAy4AyDiuWV1oe1TlGWu5fF5cSlVeSVwOQCScfSr+nIWdpWlIdRkE85qXw7qlrp8UsksHnb1xk9ayPtXm3LsflQtnaOg56VbiklJyu+w1Ucm4qNkupfubu5uXLlnK/dJUcGpbHVbvTbhlsyGeTAIYZzUusavBPZwR21uE2g5OAMA9qpwuiuk5cAp8wA9aJK0rxnd9wjJShacdOxckfUreRpHBjmkJP+9nvWpFoWsHTxcSny43wTnqa5641We9n82V12xn5VAxgf1rsovF8l/YW9ps2KuFZwOmK6aMaUpNSk/I58ROvBRcIrz8jFs4541nZnChcryeuOtS25fToxdRurM3BUjgg1TuJVj1KSJZsQv8xGec//AF6tado/9ol1huQoDbQCenvRBO/LTV2vMcpJK9R2RZOsXaTedFIqO/BwODUjT6npgW/uELRSn5s9f/rVHq3h+bQZI5rlmlhcYyB901W1HxBLdWX2d4i0Kn7wTn8a3dSUL+0bT6GUYxqWdFJxe5oSXNvql3H+7GMZJJ49qo3MUdtLKRC5TOAy9Kq2V+qWirEhWRjgYXvWkt1cpbtYmDzpHBy/p65FPnjVV3v/AFoDi6ekdu1/xK1qrSQKMLsB4z2H+NWZ9SFvOfLUqGAxtOSDWS1tcw4aclYAQGAOOKi1S4tY2T7I25z1wc1l7SUI3Who6cZytuPuoDcFrl3IJOcGqDXMrMyRgvxz7USXSzMqSblTuQam00Rx3oEhBUDn0NcvxyXK7X3N1Lkj72tivpziO5ZrhcnB4Iq1Pci9l8tR5QHIwcZqpqd2n25zGuFXgY5AqpbtFcSSLI5jHbHHNCfL+7T6kSfN+8egsxmw8YLOicn0q/8AYgNLW5SXa/XA7fjWdAZraGcKyugY8nqazftjjKBm2emeKItQ3RE3KSsmXdRvZ7khrl9+zgdqxppxuPJOfWi4nJYgng1QkmUHk5ArLWbuyJTVONkSS3O0HP5Vi6tqS20LYP7wj5R6H1qHVNXhgYqCGk9BXNySvdSs8nrmu+hh/tSPncfmN7wgydJJbmUtIxZj619Z/s1pDH4Purd7YGWWYneV+8MdCfSvnvwR4Tn1xXaCWJZFGQj8Z+lfRnwLspNN0nUbC/t7iO5jfcMAkBcdq9GnF3vbQ8WtC1KTb10OZ+JjousPC5BMRI2joK8vueJSQehrtviHdwDVb7Zud3kyCeorhW5PsehrHMJ3nynr4CPLSRFISDwKgb71SPySO/rULHGTXnpHXKRHJyOuBUZYDg9aSSTJ4qIvxWyRyOeok7YjJH61e1LU7K8vb1DqCRRajaKoaTIFvKmMK3twcEetY11JmI7eV610GpnX/wB02iWUa6c0SGFfITcOOd27nOc1tTRw4id9jjfF11b3GoRtbTrcmOCOOWdOksgHLD17c+1c55v1/I1r+JZNR/tI/wBsRLFc7F+UKF+XtwOKw8n+8fzrpSPOlLU92RPvcMj+gPOfWiFt6yOQWbPH/wCqpYiZIxGkYVgMmQHJxSeXjYFU8c5B5NeXbsevce4JBJUIg6n1oiUSD7+2Ne/emyvhgTy3Q9wKYrAo5QA44z60rahrYZMx2hos5H8qhB82PLt8wPC9zU8OSjScjIOfaqhaXeCvGB1AqloPckkLv5asM7OASMfhWVriC5tnjCjIFasksckag+YZs/OT0qnPAd5ywOelaKTTCya1PKr63e3mZHB61PomrT6VdrLCxK9GXP610/iLTlIVirbnO0ELn864u7t3t5djDGPSupWmrM82SlRnzRex65pfjW3ubTaJEWToQ3BpY7pZHB3gqe4NeNZxzVyz1O6tSPJnYKD0JyK5amCv8LPYw2fSp6Tjc9whV5Ytqbto5yKaymNtq59DXD+G/GyhvLvCIz0znKmunj1eG5bdDIrdzg1xVKUqejR7+FzCnX+GRqxMAwVz8p65NTXckfm4hyEx0J71lyzhsMMbq6v4d6no1hqkk+vRq8fl4jLLuCnuSKmnBTkoN28zsq13Sg6iXNbojGgdfLYE5OM1Jb3zwwFBxnv6ZqTxJf6fc6/dzaZGYbNzmNcY+tUTG32TzC3Geg70Sjyyai726msaqnFOa36HTC104adHPJOXnbr83J9az7O4kjn/ANHd92RjH1rY8H+G7TUtFury+mCFCQq56YHWuUjm8m/DROQgbgg9q3qQlCMKjVr9tzCnVjUc6ad2u56hca4daa2024Uq3DM2egHpW3fabotvZiHzkV8HJ3jJ46kV5HLqEou1lWX5wBgg07Ub83Dqz/fPUg8nNdkcfGzcldnC8DK8VCXKt9C/dYtJXETeZGpyOe1afh69aS/EkhIXO3BJJquukxTeHWvZLgrMELgcYHsa5s3ciRr8zDj1xmsm3QkpvZ62OtcteLit9rnTa9cyG9EcEgkSRssBz+FUDBAZzuJjdccZx171kG+uIZY52BK/wk8Zpt7fNK2+ZQCw4x6VlUqxm3JoqMXFKKZrW9xbAq00RdUf0HI9ai1O8sTNK9sCpOOcYOPasZdTdYlhfAjz1PUVUupow42En15rN1PdshclpXZbYhNsrNvGeauWup2EXnCWIlmHynaDnjp7VzrTELgng9qgMwBqITcHdBU5WtWXZbliWRWIRjnaOlVHm2jrVeaYKp7H3Nc9qmuRQKwicPJ046CnClKb0OPFY6nQWptXNyApywA9a5jVNaKb47d9xP8AGe1Yd5qVxdOTJIcZ4FVwSevNejSwyhufMYrMp137uhMpMjkscknPNemfCHwlZa/qrtrFx9ntIU3jd0Y+lcFpFi95cRxxKfm74r07wy66fY3Vrd/KvbjBz6V103HnSlsc1KlKUW0d7qlrZXVm8mhNHafYm2xPHwWI4zVew+IviPREnRGgd5Bgs6Zx71y8ettGkaQxqiIeQe9UdQunmcuTjd2qsTiotXg9Tuo4W65aiuvMLy7mvZ5ZbiTc8pLMT6mqbEg4zwOlObgfMfmxUTnjHTPevJk3J3Z6SSirIYT71BMRjjvTpG6e1VZn5ySMU4oxqTQ1zgiq0shUEDjuPekluAM88gVRlkxu+YnP+eK3jE4alTsR3M+FIGFHatHXRpOq3K3b+IhFM8aCRPJcqGAA+X29qzLPU0spXaSytbveu0LcAkL3yMU+bxPbE8eH9Iz0I8s/41vGJwVZXMHV4reC5Mdpei9iwD5oQrz6YPNZ2KvateR392Z0tLe0G0L5cAIXjv8AWqHzelbJHK3qe5DKTLvJbHQVahn2yfuyM7SGyeRVGGVnlUsgG3Cj0zVgyIX+YHzMbflFeV6HtFnKAE43R4zx3NQJnp0XOQvvR5jMwO0jHBA4/Go7qMq+B165BzQlYBzTNGzAndt5A7E05EZ13thA/JHTNUndgvUE9x61KsjEAMc4HBqkDWmhM7JlgcFjQADMhZei+tRlg2dxXHoKkICwpuKE54C9xVRQnoZ1ypbcSenB965PXNNjlDtGpz1zXXzmOUkRhiv+161RuoBhc5z3NXGVmKcFNHltxEYnIYEY45qEmuz17TE2GSMZJrjpUMbEHFdcZXR5dSDgxuc1PaXc1pIHglZD7VWJx70ZptXIUmndHR2fiu/gcNKVlHcEYNbMHjSOWRVmidAeM8GuDzSg81hLDU5bo7aWZYil8Mj1i11a1uMGKZMHtnmtdZwIRhwRnPNeJK5XkMc1p2+v6hAqqtwSo7MM1zTwP8jPWo5+/wDl7H7j2aHVZEtWhSV0Q8FQeCKpzuM/KcVwml+K/MnjjvECZ43jpXWm5jKBhIpB6c9a5alGcdJHtYbMaNZOVN+pdiZ2kAU81YeSRJEDncRWfFc4OQRSPdHzN2TzWXKkdftr7M2L3UpJVCSfdHUDvSLLHcj5nK4AxjqTWPLciU5yc1FLLgZByfSi7b1BzjFaG1cagzw+SxDKh4P/ANaqkt40gAduntWetwDHzwx7VBJP9av3pGMq8Ial+SQEg55qvNNg8HJrMu9Ritot88gA7CuY1LxJJKpS2GxT3PU1rTw0pnn4nNadJeZ191qUUajzZVUe9Z0/iGzhUkSbz2CiuAknkkOXck+pOaZnPWuyODgt2eHVzmtL4Tc1PxBcXgZUPloew6n8axtxLEseTTN3tS966owjFWR5lSrKo+aTuyRcGrVrEZJQq8ZqG3iLsABnJrptG07ZtdzyOoxSnLlLpQc2dHoDw2ltGoQB0YMrd61dSuPtUv2gnlgAQKyguMDipUf5SM9655VXy8h7FKCViwHzjjijOc8nHvUYYDjoaQtkda53qdashzHk81G79c9MUx2wBzVeWUJkscD1NNRM51ELLIADweKzpbjJIOAPfmnzz/LkHms65kA9Tg4JraEUcNWoJLLs6tkg1TmuMljjr6VHNLnJUAAHp61VdiwIGPoK2UTinMvWLae7yDVJLqNAMobdAxJ981P9k8Ouu5JdbYMeot1NYEshKkdq9Fk1HVGnu7TTZ9sUljHNpawkfNt27gB6nnIPpWqRzylc8+1eG2t7vbY/avIKAg3KbHJPt6Vn4966Px0Zm1pHu2P2t7aJp4yciJyOVHp649652qRmeyx/K6B/lWTLEjqBVyDY7yEOARwuOeO9UTxCDuUux+7ySAPWnwsQ6hCC55JHb6V5zVj2btlxkYkKQCQM800KQMRkbl6Ed6jjfcMl8PnDA8Y+ntTwd0jbFyMc+w9akpMjaUNECqD5T973PrSzZ2YXnkZP+elMlk80CJcYXpg4BPvUZkIt9qkhc9O7VQNdh6yNv8zuOKjLSZJILMT+OaUxs2SAQfTtihHEJ3jluh55z7UWC/URWdCyH5R71FKJFVWJyp5FEu1SQzZPUn0ppuJBAsbkFAcgY6VaQrlO9TzUz/F/drkdU04h+AAx/Su2lUsrODujBweMYNUryBCVx949GIq4NowqwUjgv7OckjrVSeExHDV2UsHlO20deDism/tRITjkit1K5xypWWhzwpanltnXPyk4qAgjqCKowaYUUlFAhc8VJ9pmAA82TA6fN0qGigd2jRtdXvYD8lw5Ho3NacHii5G0TKre44rnKM1EqcZbo2hiasPhkda3iWIMrKj5Hqarv4okLHbENvua5rNAqVRguho8dWf2jop/E07piJFQnv1qgdavTJuMpx25rMzRmrjTitkZyxFWfxSJ7i4knbdK5Yn3qGkzRmrtYxbvuLRSCnBST3pCEqaCMyPjmnRW7t0BrZ0+ywwJzjihuyNYU3JljTLMhgWA4rpIAFXGBVS0TbwCPqatqNjdc1zTlc9WjTUSUt8q00tzkdaQt2HSo5JAOc81ha51XSLIYYPJz2qPeRweveqpn+ue/NVLm5yDsbnI5pqDIlWSLc9yBwDzWfNebgRkfjVKa4YkljgdapSytzk+xzW8YI4qlZsum63D72T0z6VTnlySMn3561XMq5GOvoKiZyT179q1UdTmlU0FaTJPoKhaQ8noaZOzKSCvPvURatEjByFZyRyea2dfitNG1e1toIJGFsiPKzyEeexAYlcfdHOBismCGKWK5eS5jiaNNyIwOZTnG0Y7/Wu0sL7yLOCJ/EejTCNAIzc2jSPEPQEr2pk3uc74osobTUUa1Eqw3MEdyI5Wy8e4fdJ79PyrGrT192k1KWRtRTUXkAZ50BAJ9OR2rN/EUCZ65E5DE7uBxk8/hT84wVXJ6ioYVI4kLMgJfBYUqTCRhzt54XPT0rgaseupFs5UBtylsfdB6GnNN8hUHaxHzY/iqCVvJby9yF8YIH8J7896ebgliJQHCjhTStYd7jH3FQpA2rwPalO0hQxyccBe1MkLAohIYf7PrQudu8ZwelFi2yXdgKCNpUfxN1qNnO8ADLetOO1cFTu6cnt7fWiZtwZmJZh/D6VSIehTlLbfnPyZ596Z5ocqMAAk8k064dRg4yD0Ge9VGd4pB905xlV6U0iWzQbBQqgyw96geOQqWB4HGD29qczrJMrDPAw49B2pUfcTggp0waFcbs9zIuUC5B6nj8KqGLKg4ABJPFaE/ktIywnp1Y1mTkxEkZ7jJ71qtDnbKkyKThl4PWqk1smeR3x0q7vDHpyBQpG3AyM9v61akZtJmJNaNuO0VGbRx19PStwgBsAE4p5UNt3HAwaq5n7JM5mSJk69qZ0Ge1dFcWykYI561RubQ7cKPlouRKk0ZVFTSRMnbPvUe0noDTMrDaKcUYDJVseuKSmAlFOAPpRg88UwEFFTJbSMFIXg9KtW9kfMUsKGUotlWCEyNgA1r2tl8oyKu29imQSu1iOgq7HAFI4PFRJnRTpdymlqChVwPw/StCNTs4AB6GoXwJFzgHPrTww25Tg9M+tZt3OiMUi9A4WIDHOaeZATnOM+veqSyAZOcEe9DSEY6YP6GsnE3U7IuNJgZJqlNPydwHoDmkMo2k54HpWdcyKe+SDTUSZ1CeW4JGc7R/SqkswJOw/jUDzN0ByAfyqu8hKkg8fWtVE5ZVLkjucEsc+lV3bLYz1qMyAjDHjNQliWB/OrSMJSFY857Uzec+1IzHGB0plWkZtj3Yv1OT71HRQOTxTJA5xmu316/wD7KvobSHQtNkRYYyJXtc+eSoO4Y7VxR6cgkV3cF+nh62isLzWtVE6oGeO1RGS33DO0FskkA9sUhoPEFvbXMOpxNp1taPa2Ud4jwx7Gic7cxORwc5781wOR7V0OtG502WWza9kubS6CXavk4myPlZh69eKwt/8AsfpTQHpFtIRH85CgnGcZz+NWgQqbi6ZI42jtWdCjTqM7VTk5Ix+VSLKxjMeV287ZdvP5VxuJ6EZGgnzSHaw29Tjv70qsWZyxDHqGPaqcfyqqsdpPOeuanZAkZbGRnDECpaNVO5OJW3bcKQR07Z9aZG42lcZUcE4yfwprsjL8pJbHIHSkDjeoO0gcZH9aTQ07kouCZMkYAGAvsKeG+dShC7uvoKjZV8t/mb0XPc/4VGbhSUjcd+oHSiwXFdfmdQASOfb86zJlLzfJ8rZ78DFaN1KuXCnnAAyP0NNeMoFMigkjgEZOD3q1qRIypZXJ2RkhM8uD39DSNcbiqKWRScO6rnAqa8tgRhSoOOcDk1mOrn7x2hehz0rSKMZNosCVASivnsSRjNQ3NwWQx5GB04quZSVIKhuetRyyDaRkHHBHTmqsQ2NkUwoGc5Y9h2pFnDID3WosAcShyDyMelVbgFSjKHCuMqD3FPlvqTzWLjTErnABB70ROACc81RVyrhZRg0skwQMc8e1HKHOaBk3nuQOnFMZzg/kRVVJQeuT9Kfv4I5/GgfNckaAHnjJ/Wj7Mp6DB9Kasm0hRgirUUgON2CP50x2TJ7KRoYnieOOSJj82RyKcdNsrqWPyD5LMcEHoKRZYw/yZIPTPGKsRFXbI259e9U6rtZlKmijc6QLaWRF2yBTwy9DTUtEbIKgH6VrFWAK5JB6DvT0X5BgLkng1HOUqSKlvZouzZkknkVcNpE4UhenGQOtBRlPy45/SmmQ524wB3B61PNc0UEhkkJRV8vPX8aY0rAbTkj19KkmmDnPpxVSSQZwc4HoOKkG0tiR5Aw46frUbSHcT0z1qoWAJ+bpzmop5ixzj5T+tNRIcy59o7HG2l+0MUIZvasszdTxUT3HYgY+vWq5CHVNJ5geOw6896pTSg9/yqq0276VFJIapRMpVLkrS4J4x6VE0uQcdPSod2etMzzxV8pi5seWzSFj6mm0Uybhmik9h1pyr70AAXNKBgDBxSn1FNyPXmgB2c9a6GTWdJvljm1nTLiW9VAjyW8+xZgBgFgRwcDtWVpFlbX0siXeowaeqruDSqWDHPQYrbg8K2E/yp4msDn/AKZPSbQ1d7GX4mmuZ7+KS5gjt1a3jMEMbbgkWPlFZoikI+6fyr0y68NQ3d9bFJkuYre1iiMkYIDFQc+9bK+GU2jCJ0/uVnz9kdUMK5K8mcpCJA87xqX8schv4R71LZ3TyxRvJAmerIBkCsy3lD/IPMZgM53YLeua0LOd1YuHdSuM5H3h6elS0CZeilaS5VpOAOik05naPdt3ccKpGRjuTVJSxLM7MWJJ4GTn/CpAXhJRdjseSCfu/jUNGikTmXcpCov0HOPekeQGMYYA8fKB196j3ScSKOvUjjjuabJLGsaADcckk55xSsVcsNIpVcglm6HODmnM6KuCuTjOSe9UGky435Azk5zkD0zU7KHWSQAIueADn8KVilImHLfKdwLYJxxTHmZVzGQXHHPJAqMAglQN3Oducc1C5kUFnGCOg7imtBNi3BQKpU5LD5vY1VulztjCkvjuMZqZ22nJOWYZA68VUkUtmT5mbv8ANjFaIyZQuEaPBQhf4f8AGoZZo3kG5FjVRtz6n1NWXV1bGBhugPJFU7uMeW0m0kZIGO1WjJ6EMsxZyI3J29CO1RgyGJwpBVccnqPpTCDGCSCcDtUbN8xBX3BpozbFIOXZmyfVqrl9gwDu96e75RVGMd/rUbuxXG0AZzjFUS2SLMQamEvdc/Q1RAOfrTyzADJ+lFgUmi/v6kZpyyEAEng+/SqKSkDrTvN46Umiuc0hOCF68nmraTbWBQ49vSsRWOeTgVKkxUjB4qGjRVDoI7s9CNzepPWrkdyuOoI9D0FcylxjqcVfhuBtR2A4P4UnE2jVNlphnr+PWqzShhkHGOeuKqGWNzuLEE89cc+lRs4OCc/XNLlsXzkzSbcsTnnFQPLtBAPy5yfeo5pBnHY81UeUBjjvT5TJzJWkwG44qrLN83HTHfrTHk96gdhmtFEwlMkZ/TpUTPwPXNNY5700njFUZtji5pCc00UtAhKWkA5pcUAJnnFKBnrS8CkzmgB+AOlJuGelNXcchQeas29m8uMA/lRcaTexWOSeBVm3s5Zs4Xgc9K3tN0CWZl+QkHmu30LwpuOdnHqVrOVRbROiGGb1kcfoPhi4vp0SKBnZ+ijkmvR9H8AXscYzbL/u71J/Kuq8O6XDaRXKO3kebH5Zm/uj/A1sWuhrFlhd2oQ/xBjx7ip5W9ZHTBRh8Jz9rpq2SmN49jKcFTkEVsrp25QweEAjI+er+pBJp0dGMixxrH5h/jI71WFocdR/31Tba0SN4xuj5vZkwzJ90EsF/u+mKuW8pfaQiiTrj+9+FULV7YK29JDIWABVsYFWGdIj82ZIwMAL8rU7HmpmkGYoj5kSUEoWJwPpjqKEZ02jCFskAE5x7mqkM2HKnEpPDBjz9c1ZSJpWPkqAigkF2xux3GahotSLMbt/Aw2nhvm/WowPLLCLJJ5bkYqKXgq5/d7mzgDjHrikSaIAMNx2nII7/nRYq5IZnJO9wgA4Q/ypTIViTjDcnZnjnpUJLS+W0ghLEltif1NRSu0eBEQ7bsjB6H60guaCymJg0gGRwGHJH0qtJKzsVOSMYz3qMNLJ8xyWxliTnFG/E6MdpB5IJxmiw+YkkZVVVDqzA9+Bz71HMSFfGBjnAH6Uky7pHBGR0bHQfSoT80bMxPzfdbtxTQm9BFfLDIyQvIHBNVZXfcqIu4AH5B39atbgoYfMGPII71XkQsqnBxnlgKozZnSAOCq5JAyeentVIgFiGyu0cVoTRclSP+BJ/I1AYGKggZI79cVdzNopBwgIVeveoyTznrjirX2fJbbkMOtVyp6tyM4yOKogjHByODQWJznknvQeDSUCFBNHakopAOV8EDtTy/Xj6CoqXNA7ku/uOvvThP7moODSgds0BctfaSe/vSvcfKcMQfY1VIZT6/SkOaLIfOy0Ju/I5qN5ie9QnIFJg4ziiwuZj2bIptJS0xBRSZozQAoGaXHTmkzgZ60OOmDnPXFACjkZpCaRc1LDA0r4ANAEfJq1b2bysPlODWvp2jySbcR5J7Gu88N+DJroqEt5SV5PHBH1qOa7tHU3hR0vI4nStEkkflMjPJFdvpXhjCoSiDjPrXoGn+GYbFDuiUOuA38Rz6Cta00+NZDsByV+XeQK0+ryesmaxqRj8Jz+keH4kXKxgMB1xXSwaciYVMAY56j9KsRb4NivG2TxuDda1IbZRbM88cvnBsh944H0rRQjFWQpVJPVlS1sbe5cwXJKxthc7e/oasvaWds7K8lyrA7SpQYFW7W3aZJGWXEY++zDJ/D1pZWtPLCGaVH6b2jx+dTJFwkzMuIY43BiLFRghiB1qMnn7qfrT70Lb3GzByVDKyNkMKr4U84j/Ksb9jsiro+VC0JZtoKMOSxHzH6VdVpPMBdlJZc+azD8jjvxWRFu8sksqhT94jBHp9a0PPnjhMLNwoGImGRjOcj+dU0eQmXluQ0pCrtDAAbx0FWNkggOAGIOAc54HWqUdyzWmyXb5BY7QwyVY9wev4HigySpAOQYycAj19alo0TLyOr7XmWQLgqSG5J9Kjky7IVAXtuJ4+lLJLBEPkXzBjC7+3vx3pIngZSGJJABUkck9x7Ck0O5MEDpGYiN/Q7+Mn/CiJXJLS5YqcALjn15qN2KTEn749BkLx+VKZdpIJkclQWKYIqbFJkzR+WSRMRhOFzks3YVDIFBVNvzYIPbJNSbCHQcFj94df1pOEjV1iyu7JJHBxSHcbxgBhgnjCj7v1owrnJPyqP4jkfT609GTepaMeYXzu3YGPTHp70iKskzOVCxgkle3tg0xdCrImISrAAt0BOe/WmOA6Iqk7AMMTx3qYhSodo8DdgN03H0ptwqeawBBjwDjsQPWmIq/N/Cuw9yOlOuCGQxyYVQTwOKkI2wh3YgE4UYwfrTDGhPCyMST8uccYpp2FYzJLc7TtUkHk/TNMmiVcBH8xQORjofatIoSrSLJhQcdPbpVGYITtVTgnPNVczaM2RCqgsepwBTCuOtaNzGgcqcZXjIHeqksZxnqPWmQ0V6Kk8s9MjI60zHXHShiEoozRQAUHGM7vmJ6UUUAFLmkooAUknvRk+tJRTAKKKKQBRRRQAUDk4FLWhpdk9xMoC5yfyFD0CKbdkNsbJ5nHyk56ACu50HwvJMy7k4IHFaeg6GqoNihmPO4ivSNC0wKkaLFuJ+8cdKhXqOx2xpxpK7M/Q/DdpaxAzMgIXOAMk+1dTZWpiiDq5WHsm7GR74rWh06K3QySglepAXoPaq10YBKpX/AFK88jFdaiqSMVP2ottF5s37zckQGVIHBNXZrWNdshMZTPTAyazLnU1Bc5KnGFxwMVkX2pswLGRRxyxOeKxnioxRtDDOXkdVdPamAhHfJHOMBRWVNqhEhLyrwAMhe1c82poBhX3HPQniqV9q3kvvWNWUDGCa5J4zm2OqnhlHVnaWmrCG4X7IHmLjDJjlvpVi51i1aXZexXMDAdJXxn9K4vQtba6e4ijljglki2xMx2gHPIz2yO9TW+qLOHsdRYBCSI5Sdxib2PdfWo+ts0+rrextarc+fcrJKyxMEGyJeqp2/OoxcT446fSqWtPGl7GAUYi3RWZWyCR6VU3t/eej21zSMND5oQY+4SWPA+noatLKZFjUu5y3LMemf89KoI5xhuc1diGxGaN2jlxxleJPp6Gu48AnQiKQoCHkB6YIBHrmr0beZExkmOO4OB+BrLiuJkbLHJIxjFWbfzFl3wW4aT7rBhuA9amxaZaExyqov7kHJXAzn61oNMsUm+VUdjgFvvYwOAB0xWajN5YKkqDztxzk9APWpFZoAElV1QHJBX7x9MdqVmi0y7G0bAnzAx4JUDnPfmppnaVXMe0An7qnn6n0rOiVHDOrlZPvHnj8KnR1MoCyYkYcse/41LKuSxwPhFVmZupHYY7A+tTHDRFd4kwNoUHpmoG+6ArnySQCR3xTpJmKMrZUdAFwOexzSSHcRt0rrHLlIwOqj7tKcKWR/MIQHgfMM9hmnZxuACkPhO4XPbmoRK8cbRxsQGONueSelDQEj7HjzgnAwF68nqTUJUrgMAN45PsKed0WM4U/xHPJpmHbZxlTgAL15oAaFUljJkkfdC9B9ag3tsAwVz+lW+M/vVypIGV69fSmHbKQX3ABiAw9KAK+xQpLklQuFwetMKJGoZ1zzjA4I96knPlhdwIA647D/GmFMAu+cN+YGe9AiCZBkMG3c8gDpmoXibeQm5tvzYbtVxgFC4YsXyTmoBkDAO4g8EdR9RVXJaKghdm7qG7Dnj1qOS3VWIB+XHHHI+tXViyCxYgjoD1NSJHHKAqggn7x65p8xPKYzxHy8471GykY6ZIzWwImLhEOGf5dxGMZNRz2yq7qoPHcc/hTTJcTJoq0bbcjOhBA9TzVd0Zeopk2G0UUUgCiiigAooooAKKKPp1pgWLK2NzMEUEgelepeFdBSMKAnzt94nqa5/wZpfzLKwPTn3r1LRrNUcHBCnmsJyu7I7qFNRjzPc2dGsFXYiL83pXdR6YtnaI6nAK5PP6VR8NWiW6LdXDZjUYGepratbG98TSkwHyLOL+Mjj8K66cVGNznqzu9XojBvJJb+ZbeAEjpgdh70280d7aM+fcjIxhFFdndafb6dbCO1RA38TEck/WsGZdwO47zgfhVumt5asmFRy0hojkbjTRMfkDAZ7ng03+xFAX5Qx9O1dNJGFJKgkCqssjHJHHOB2rlnRT3PRptvYwRpUIbG1SRxgVDdaRbTKVKc9jittmyCq8sKYQrKahYaPY6lJ9zlm0BfNQQkMp+XkdfYYp83hq5RQIUJ55XeCw/DOa6uxA2zODsKhVDf3QzYJpqWyjUpENu0cYyN2TlAP4s/hmplhIPoJ1ZR2ZwTSXNg5O8gDkkdKsjUmIB3pzz96t7W7ITOkjJ80kau46fMe/49a546TBn7v6VjLD1IaR2NFVi1do+cxnFSo+4gSMwQHnvj1IoortTPnSTzFB+RmY5xluAR9KuRzSRF2h2uh+Vtvy/rRRVeYEltMXkZZ3zxwQelW2kDf69nwSNqDnd75/nRRUt6FofCBJHMDsTZ8wTHzE+w9qfCELfKQzAZYy/LgdML/OiihopCiclTGH3L1Hb8KmM3kgFsZyBsXnbxyaKKnoUMmk3pufdHjoOuWHrUXmuTluOcbv7vrRRSYX1JDw5dWRgCMbhjNCTbmUg/Lu3HjBAoooGIzbXJVg6kg8evpTsGRXKkDB4QGiikA24KpMyIcpxkdckdqikMReRjGAT0BOdpoooYCFxHGTEvGAGJPUntUUiR4/dOWbg7gMAZ/woopiBEQ7mwAwxU0aLtPJUHA46kUUUDHSx+YV6LsGMf4mkWAiDcEVkJwfmoooQEBtlJ2jIOeQKfJZqYlJVSCSFA6kj1FFFUhNIzbmzJYFQR+FVZLWRRzkkHpiiimZtIhKMDgqQaQgiiimQGKMUUUAGKnsYTPexRKM5YZoopPYqKu0j2Lw9arDAqccc46V3OixBmDOMA9uwoornpay1PUqKysjpUlFyURsi1j4Yf3q7Cy8Qm3sxbWsAWFRgBTiiivRWiR5c4KT16FW71PzTgpg9jnOKyLi6yGIHNFFNtnTRginJPu+8AO/B61VMpDkjoOlFFYSbPQgkhryjkEjkVE82Bjr7dKKKSbLaCO7MDkoQexQ9CD1BqRtQgEYGydx2iebKf4/hRRVpmbRlXV40twzSsCze3T2qmZRn75ooqXqStNj/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A person with scarlet fever might have a bright red tongue with small bumps, like a strawberry.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1028=[""].join("\n");
var outline_f1_0_1028=null;
var title_f1_0_1029="Upper cervical spinal nerves";
var content_f1_0_1029=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F58357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F58357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 576px\">",
"   <div class=\"ttl\">",
"    Upper cervical spinal nerves",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 556px; height: 339px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posterior and lateral views of the upper cervical spine, showing the leading articular sources of cervicogenic headache, the related nerves, and where needles are placed for diagnostic blocks of these structures. Red labels and needles point to target sites for diagnostic blocks.",
"    <div class=\"footnotes\">",
"     AOJ: atlanto-occipital joint; C3 DMB: C3 deep medial branch block; C4mb: medial branch of the C4 dorsal ramus; dmb: deep medial branch of the C3 dorsal ramus; LAA IAB: intra-articular block of the lateral atlanto-axial joint; LAAJ: lateral atlanto-axial joint; ton: third occipital nerve; TONB: third occipital nerve block; ZJ: zygapophysial joint.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol 2009; 8:959. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1029=[""].join("\n");
var outline_f1_0_1029=null;
var title_f1_0_1030="Posterior and medial ankle tendinopathies not involving the Achilles tendon";
var content_f1_0_1030=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Posterior and medial ankle tendinopathies not involving the Achilles tendon",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1030/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1030/contributors\">",
"     Robert P Sheon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1030/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1030/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1030/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1030/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/0/1030/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior ankle tendinopathies often result from repetitive strain injuries. In some cases, subtle skeletal structural faults (such as limb length discrepancy, joint laxity, pes planus, and malalignment of the lower limb) predispose to such disorders or injuries. It is therefore important to look for such defects. Other factors that can contribute to ankle tendinopathy include chronic rheumatologic disease, such as osteoporosis or spondyloarthritis, enthesitis of lower limb structures, and improper footwear.",
"   </p>",
"   <p>",
"    Tendinopathies of the posterior ankle other than Achilles tendinopathy are discussed here. Achilles tendinopathy and tendon rupture, ankle sprains, and other soft tissue disorders of the foot are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=see_link\">",
"     \"Achilles tendinopathy and tendon rupture\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34296?source=see_link\">",
"     \"Ankle sprain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44681?source=see_link\">",
"     \"Plantar fasciitis and other causes of heel pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31050?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features and management of ankle pain in the young athlete\", section on 'Peroneal tendon injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TENDINOPATHIES OF THE POSTEROMEDIAL ANKLE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6822620\">",
"    <span class=\"h2\">",
"     Mechanism and clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eleven muscles have tendons crossing the ankle, while four major ligaments provide ankle stability (",
"    <a class=\"graphic graphic_figure graphicRef72462 \" href=\"UTD.htm?0/9/159\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef51952 \" href=\"UTD.htm?34/57/35728\">",
"     figure 2",
"    </a>",
"    ). Acute inflammation or chronic degeneration of a tendon or tendon sheath may result from repetitive activity or unaccustomed heavy workloads (eg, new or more intense athletic workout).",
"   </p>",
"   <p>",
"    A chronic nonspecific tendinopathy can affect any of several ankle tendons. Tendons at the posteromedial ankle that may be affected include the posterior tibial and flexor hallucis longus.",
"   </p>",
"   <p>",
"    Some researchers suspect that an acute tenosynovitis precedes the development of chronic tendinopathy, but patients frequently cannot recall the acute injury or episode [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/1\">",
"     1",
"    </a>",
"    ]. Occasionally, an underlying systemic disorder predisposes to tenosynovitis. These may include rheumatoid arthritis, spondyloarthritis, or more rarely oxalosis, xanthomas, giant cell tumors, or tuberculosis.",
"   </p>",
"   <p>",
"    Acute tenosynovitis can occur where the tendons curve around the medial malleolus when friction at such sites causes inflammation. A bulbous swelling can occur distal to areas of constriction. Mild to moderate pain may be felt but often increases gradually over several weeks. Calcific tendinitis is an exception; onset of pain with this disorder is acute.",
"   </p>",
"   <p>",
"    However, in most cases of tendinopathy of the posteromedial ankle, the patient does not recall any acute event and the initial complaint is of chronic, worsening pain. Depending upon the time elapsed and the severity of tendon degeneration, the patient may also complain of weakness or foot deformity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6822629\">",
"    <span class=\"h2\">",
"     Clinical and radiologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination of the patient with tendinopathy may reveal tubular swelling of the tendon sheath if acute tenosynovitis is present. In patients with chronic pain, findings generally include tenderness along the involved tendon, pain with passive stretching of the tendon, and pain with active ankle movement, while palpation of the ankle joint is unremarkable. Comparison with the uninvolved side is often helpful. In patients with long-standing symptoms (several months or longer) and significant tendon degeneration, weakness and structural deformities may be apparent.",
"   </p>",
"   <p>",
"    Plain x-rays in patients with posteromedial ankle tendinopathy are usually unrevealing. New bone formation over the posterior aspect of the medial malleolus may occur in some cases. Magnetic resonance imaging (MRI) provides excellent definition of tendinopathy with or without rupture, but may not provide a cost benefit. In a randomized controlled study of 500 persons with acute injury of the wrist, knee, or ankle, MRI did not expedite the workup or change treatment of wrist or ankle injuries when compared with plain radiography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Improving transducer technology and portability make high-resolution, musculoskeletal ultrasound (US) a useful tool for evaluating tendinopathies. US enables knowledgeable clinicians to obtain high-resolution imaging of tendons, ligaments, and nerve structures at the bedside without exposing the patient to ionizing radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. US also allows tendons and muscles to be visualized while examination maneuvers are performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6822700\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of mild to moderate posteromedial ankle tendinopathy can be treated by partial immobilization and support of the ankle with bandaging or an elastic support for three to six weeks, depending upon severity, and home exercise therapy.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    or nonsteroidal antiinflammatory drugs (NSAID) can be used for pain relief. The treatment of tendinopathy and the effect of NSAIDs on tendon healing are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20089?source=see_link\">",
"     \"Overview of the management of overuse (chronic) tendinopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=see_link&amp;anchor=H24#H24\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\", section on 'Possible effect on tendon injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This nonsurgical approach to initial treatment is supported by a randomized controlled trial of 36 patients with posterior tibial tendon dysfunction assigned to treatment with orthoses wear and stretching (O group); orthoses wear, stretching, and concentric progressive resistive exercise (OC group); or orthoses wear, stretching, and eccentric progressive resistive exercise (OE group) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/5\">",
"     5",
"    </a>",
"    ]. Foot Functional Index scores (a validated measure of total pain and disability) decreased in all groups following treatment. The OE group demonstrated the greatest improvement in each subcategory; the O group demonstrated the least improvement.",
"   </p>",
"   <p>",
"    A number of exercises can be used to help patients regain ankle mobility and strength. Foot-ankle circles are a simple exercise to maintain range of motion and strength (",
"    <a class=\"graphic graphic_figure graphicRef68033 \" href=\"UTD.htm?16/36/16974\">",
"     figure 3",
"    </a>",
"    ). These can be performed several times daily with increasing repetitions and intensity as healing progresses. Stretching and lengthening of the calf muscles and plantar fascia begin gently and progress as activity increases. Strengthening exercises are added as pain subsides. As with Achilles tendinopathy, preliminary studies suggest that a strength program emphasizing eccentric exercises may be useful [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. At least initially, a rehabilitation exercise progression is best carried out with supervision from an experienced physical therapist. Massage of the involved muscle and tendon can improve tissue flexibility. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=see_link&amp;anchor=H21#H21\">",
"     \"Achilles tendinopathy and tendon rupture\", section on 'Eccentric exercise rehabilitation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complete immobilization in a walking cast boot for a brief period of time may be necessary in severe cases of tendinopathy. Referral to a clinician with experience managing tendinopathy of ankle tendons is best in such cases. Patients with severe weakness, suggestive of tendon rupture, or foot or ankle deformity should be referred to a foot and ankle surgeon.",
"   </p>",
"   <p>",
"    Injection of the tendon sheath with a glucocorticoid has been associated with posterior tibial tendon rupture and is best avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/1,7-9\">",
"     1,7-9",
"    </a>",
"    ]. The effect of glucocorticoid injection on tendon healing is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20089?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of the management of overuse (chronic) tendinopathy\", section on 'Glucocorticoids'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44536?source=see_link\">",
"     \"Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     POSTERIOR TIBIAL TENDINOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The posterior tibial muscle and tendon are involved in plantar flexion, subtalar joint (foot) inversion, and stabilization of the medial foot arch and hindfoot. The tendon travels behind the medial malleolus and ultimately divides into several branches, which insert on the navicular, cuneiforms, cuboid, and the second, third, and fourth metatarsals. Tendinopathy of the posterior tibial tendon is important to recognize because chronic degeneration can lead to tendon disruption and progressive flatfoot deformity if left untreated (",
"    <a class=\"graphic graphic_picture graphicRef77874 \" href=\"UTD.htm?39/61/40927\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Researchers no longer describe posterior tibialis tendinitis as an inflammatory condition but rather as a degenerative condition with a nonspecific reparative response to tissue injury (tendinopathy) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/11\">",
"     11",
"    </a>",
"    ]. The pathologic changes characteristic of tendinopathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/10/2215?source=see_link\">",
"     \"Overview of overuse (chronic) tendinopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Numerous risk factors for posterior tibial tendinopathy have been identified, including increasing age, pes planus, hypertension, diabetes mellitus, peritendinous glucocorticoid injections, and inflammatory arthropathies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ]. Middle aged women are commonly affected. Areas of the tendon with relatively poor vascularization are more vulnerable, particularly if they are close to the medial malleolus. The forces acting on this tendon can be high and, particularly when combined with adverse biomechanics (eg, excessively pronation), likely play a role in the pathogenesis of this tendinopathy.",
"   </p>",
"   <p>",
"    The presentation of posterior tibial tendinopathy depends upon the severity of tendon degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/1,9\">",
"     1,9",
"    </a>",
"    ]. In the early stages, patients usually present with gradually increasing pain and possibly swelling at the posteromedial ankle and longitudinal arch. Pain is worse with walking or other weight-bearing activity and can radiate toward the tendon insertions. Several weeks of persistent pain often have passed before the patient decides to seek help.",
"   </p>",
"   <p>",
"    As tendon degeneration worsens, patients generally complain of weakness with plantar flexion (toe raise) in addition to pain. With severe disease, patients cannot perform a toe raise and deformities may be present, such as collapse of the arch (pes planus), foot eversion, or heel valgus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/9\">",
"     9",
"    </a>",
"    ]. Examination may reveal the &ldquo;too many toes&rdquo; sign, in which the clinician sees more toes of the involved foot when looking from directly behind the patient.",
"   </p>",
"   <p>",
"    Treatment for acute tendinopathy or tenosynovitis begins with protection, rest, ice, compression, elevation, and gentle stretching as tolerated.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    or nonsteroidal antiinflammatory medications (NSAID) help to reduce pain. Passive stretching is performed with the forefoot rotated externally (ie, outward) from the neutral position, or in a circular manner. Walking in a figure-eight pattern can begin when tenderness and swelling have subsided. If symptoms have not resolved in ten to fourteen days and medications do not provide adequate pain relief, treatment with a rigid orthosis, and possibly casting for a short time, may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/1\">",
"     1",
"    </a>",
"    ]. Referral to a clinician with experience managing posterior tibial tendinopathy is suggested in such cases.",
"   </p>",
"   <p>",
"    Physical therapy is likely to be helpful for injuries without severe degeneration. As with Achilles tendinopathy, preliminary studies suggest that a strength program emphasizing eccentric exercises may be useful [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/6\">",
"     6",
"    </a>",
"    ]. Discussions of eccentric exercise and other general noninvasive therapeutic measures for tendinopathy are under investigation and are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=see_link&amp;anchor=H21#H21\">",
"     \"Achilles tendinopathy and tendon rupture\", section on 'Eccentric exercise rehabilitation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/10/2215?source=see_link&amp;anchor=H32168074#H32168074\">",
"     \"Overview of overuse (chronic) tendinopathy\", section on 'Natural history and treatment'",
"    </a>",
"    .)",
"    <strong>",
"    </strong>",
"   </p>",
"   <p>",
"    In cases of persistent severe tendinopathy, significant weakness suggestive of complete tendon rupture, or deformity, surgical consultation should be obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1030/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ACHILLES TENDINOPATHY AND TENDON RUPTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;These topics are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=see_link\">",
"     \"Achilles tendinopathy and tendon rupture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H657525\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute inflammation or chronic degeneration of a tendon or tendon sheath may result from repetitive activity or unaccustomed heavy workloads (eg, new or more intense athletic workout). Tendons at the posteromedial ankle that may be affected include the posterior tibial and flexor hallucis longus.",
"     </li>",
"     <li>",
"      Clinical findings in patients with chronic posteromedial ankle tendinopathy generally include tenderness along the involved tendon, pain with passive stretching of the tendon, and pain with active ankle movement. In the early stages, there are no palpable abnormalities of the foot or ankle joint.",
"     </li>",
"     <li>",
"      Patients with severe degeneration of the posterior tibial tendon manifest weakness (limited or no ability to perform a toe raise) and often deformities of the foot or ankle, such as collapse of the arch (pes planus), foot eversion, or heel valgus.",
"     </li>",
"     <li>",
"      Most cases of mild posteromedial ankle tendinopathy can be treated by partial immobilization and support of the ankle with bandaging or an elastic support for three to six weeks, depending upon severity, and home exercise therapy, including an eccentric strengthening program.",
"     </li>",
"     <li>",
"      Complete immobilization in a walking cast boot for a brief period may be necessary in severe cases of posteromedial ankle tendinopathy. Referral to a clinician with experience managing tendinopathy of ankle tendons is best in such cases.",
"     </li>",
"     <li>",
"      In cases of persistent, severe posteromedial ankle tendinopathy, significant weakness suggestive of complete tendon rupture, or deformity, surgical consultation should be obtained.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/1\">",
"      Simpson MR, Howard TM. Tendinopathies of the foot and ankle. Am Fam Physician 2009; 80:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/2\">",
"      Nikken JJ, Oei EH, Ginai AZ, et al. Acute peripheral joint injury: cost and effectiveness of low-field-strength MR imaging--results of randomized controlled trial. Radiology 2005; 236:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/3\">",
"      Nallamshetty L, Nazarian LN, Schweitzer ME, et al. Evaluation of posterior tibial pathology: comparison of sonography and MR imaging. Skeletal Radiol 2005; 34:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/4\">",
"      Lee KS, Rosas HG, Craig JG. Musculoskeletal ultrasound: elbow imaging and procedures. Semin Musculoskelet Radiol 2010; 14:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/5\">",
"      Kulig K, Reischl SF, Pomrantz AB, et al. Nonsurgical management of posterior tibial tendon dysfunction with orthoses and resistive exercise: a randomized controlled trial. Phys Ther 2009; 89:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/6\">",
"      Kulig K, Lederhaus ES, Reischl S, et al. Effect of eccentric exercise program for early tibialis posterior tendinopathy. Foot Ankle Int 2009; 30:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/7\">",
"      Jahss MH. Spontaneous rupture of the tibialis posterior tendon: clinical findings, tenographic studies, and a new technique of repair. Foot Ankle 1982; 3:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/8\">",
"      Holmes GB Jr, Mann RA. Possible epidemiological factors associated with rupture of the posterior tibial tendon. Foot Ankle 1992; 13:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/9\">",
"      Gluck GS, Heckman DS, Parekh SG. Tendon disorders of the foot and ankle, part 3: the posterior tibial tendon. Am J Sports Med 2010; 38:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/10\">",
"      Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology (Oxford) 2006; 45:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/11\">",
"      Mosier SM, Pomeroy G, Manoli A 2nd. Pathoanatomy and etiology of posterior tibial tendon dysfunction. Clin Orthop Relat Res 1999; :12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1030/abstract/12\">",
"      Supple KM, Hanft JR, Murphy BJ, et al. Posterior tibial tendon dysfunction. Semin Arthritis Rheum 1992; 22:106.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 207 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-E9920BD3B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1030=[""].join("\n");
var outline_f1_0_1030=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H657525\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TENDINOPATHIES OF THE POSTEROMEDIAL ANKLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6822620\">",
"      Mechanism and clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6822629\">",
"      Clinical and radiologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6822700\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      POSTERIOR TIBIAL TENDINOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ACHILLES TENDINOPATHY AND TENDON RUPTURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H657525\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/207\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/207|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/9/159\" title=\"figure 1\">",
"      Lateral ankle ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/57/35728\" title=\"figure 2\">",
"      Medial ankle ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/36/16974\" title=\"figure 3\">",
"      Foot ankle circles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/207|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/61/40927\" title=\"picture 1\">",
"      Pes planus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=related_link\">",
"      Achilles tendinopathy and tendon rupture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34296?source=related_link\">",
"      Ankle sprain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31050?source=related_link\">",
"      Clinical features and management of ankle pain in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44536?source=related_link\">",
"      Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/10/2215?source=related_link\">",
"      Overview of overuse (chronic) tendinopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20089?source=related_link\">",
"      Overview of the management of overuse (chronic) tendinopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44681?source=related_link\">",
"      Plantar fasciitis and other causes of heel pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_0_1031="Classification of lower extremity peripheral artery disease";
var content_f1_0_1031=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification of lower extremity peripheral artery disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1031/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1031/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1031/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1031/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1031/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1031/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/0/1031/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H909629103\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment options for lower extremity revascularization must take into consideration the risk of the intervention relative to the patient&rsquo;s medical condition versus the expected improvement in the patient&rsquo;s clinical condition (eg, decreased pain, ulcer healing) and the durability of the intervention in the context of the patient&rsquo;s life-expectancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/1\">",
"     1",
"    </a>",
"    ]. Grading the symptoms of peripheral artery disease and the anatomic lesions responsible for these symptoms provides an objective measure by which to follow patients clinically, and, importantly, provides consistency when comparing interventional strategies in clinical studies. For patients who suffer from symptoms related to peripheral artery disease, impairment and disability may need to be quantified for insurance purposes, or in order to qualify for a disability program.",
"   </p>",
"   <p>",
"    Classification schemes that are useful in guiding management of peripheral artery disease are reviewed here. The clinical diagnosis and treatment of claudication and critical limb ischemia are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=see_link\">",
"     \"Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44376?source=see_link\">",
"     \"Indications for surgery in the patient with lower extremity claudication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38921?source=see_link\">",
"     \"Percutaneous interventional procedures in the patient with lower extremity claudication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/58/19370?source=see_link\">",
"     \"Treatment of chronic lower extremity critical limb ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629146\">",
"    <span class=\"h1\">",
"     LOWER EXTREMITY ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knowledge of lower extremity arterial anatomy is important for classifying lower extremity peripheral artery disease.",
"   </p>",
"   <p>",
"    The lower extremity is perfused by the common femoral artery (",
"    <a class=\"graphic graphic_figure graphicRef51298 \" href=\"UTD.htm?38/43/39605\">",
"     figure 1",
"    </a>",
"    ). The common femoral artery branches into the superficial and deep femoral vessels. The superficial femoral artery runs anteriorly down the thigh between the adductor and quadriceps muscles within the anterior compartment (",
"    <a class=\"graphic graphic_figure graphicRef72956 \" href=\"UTD.htm?25/60/26566\">",
"     figure 2",
"    </a>",
"    ). In the distal third of the femur, the superficial femoral artery is in close proximity to the femur. The superficial femoral artery passes through the adductor canal to become the popliteal artery (",
"    <a class=\"graphic graphic_figure graphicRef77245 \" href=\"UTD.htm?41/16/42247\">",
"     figure 3",
"    </a>",
"    ) which divides at the level of the tibial tuberosity into the anterior tibial artery and tibioperoneal trunk, which further divides into the posterior tibial and peroneal arteries (",
"    <a class=\"graphic graphic_picture graphicRef54800 graphicRef65590 \" href=\"UTD.htm?41/60/42953\">",
"     picture 1A-B",
"    </a>",
"    ). The anterior tibial artery accompanies the deep peroneal (fibular) nerve along the posterior margin of the tibia (",
"    <a class=\"graphic graphic_figure graphicRef68629 \" href=\"UTD.htm?41/27/42424\">",
"     figure 4",
"    </a>",
"    ). The peroneal artery passes adjacent the medial margin of the fibula throughout its course distally. The posterior tibial artery is accompanied by the tibial nerve within the deep posterior compartment. &nbsp;",
"   </p>",
"   <p>",
"    The collateral circulation in the lower extremity is derived from the deep femoral artery (profunda femoris) (",
"    <a class=\"graphic graphic_figure graphicRef72956 \" href=\"UTD.htm?25/60/26566\">",
"     figure 2",
"    </a>",
"    ). Collaterals are poorly developed in younger patients who tend to develop severe acute ischemia with arterial disruption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576665376\">",
"    <span class=\"h1\">",
"     ANATOMIC LESION CLASSIFICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629056\">",
"    <span class=\"h2\">",
"     TASC classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerotic disease patterns in the lower extremities are classified by Trans Atlantic Inter-Society Consensus (TASC II) according to anatomic distribution, and number and nature of lesions (stenosis, occlusion), in combination with published outcomes for intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/1\">",
"     1",
"    </a>",
"    ]. In general, endovascular techniques should be used first when endovascular revascularization and open",
"    <span class=\"nowrap\">",
"     repair/bypass",
"    </span>",
"    have equivalent short-term and long-term outcomes. Most patients with peripheral artery disease have more than one lesion, at more than one level, so the classification scheme is limited in focusing on singular patterns.",
"   </p>",
"   <p>",
"    Endovascular therapy is the treatment of choice for type A lesions and is preferred for type B lesions. Endovascular options include balloon angioplasty, stenting (plain and drug-eluting), stent-grafting, atherectomy (longitudinal, rotational, laser), and cryoplasty. The use of these techniques for the treatment of claudication and lower extremity critical ischemia are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38921?source=see_link\">",
"     \"Percutaneous interventional procedures in the patient with lower extremity claudication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/58/19370?source=see_link\">",
"     \"Treatment of chronic lower extremity critical limb ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgery is the treatment of choice for type D lesions and is the preferred treatment for good-risk patients with type C lesions. Surgical options include synthetic (eg, aortofemoral) or autogenous (eg, great saphenous vein, femoral-popliteal) bypass, patch angioplasty, endarterectomy, and hybrid procedures that combine open surgery with endovascular techniques. The surgical management of claudication and critical limb ischemia are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44376?source=see_link\">",
"     \"Indications for surgery in the patient with lower extremity claudication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/58/19370?source=see_link\">",
"     \"Treatment of chronic lower extremity critical limb ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629063\">",
"    <span class=\"h3\">",
"     Type A lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type A lesions represent those which have excellent results with endovascular therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortoiliac &ndash; Unilateral or bilateral stenosis of the common iliac artery; unilateral or bilateral single short (&le;3 cm) stenosis of the external iliac artery",
"     </li>",
"     <li>",
"      Femoropopliteal &ndash; Single stenosis &le;10 cm in length; Single occlusion &le;5 cm in length",
"     </li>",
"     <li>",
"      Tibial vessels &ndash; undefined",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629070\">",
"    <span class=\"h3\">",
"     Type B lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type B lesions have good results using endovascular methods, which are preferred, unless open revascularization is required for another lesion in the same anatomic area.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortoiliac &ndash; Short (&le;3 cm) stenosis of the infrarenal aorta; unilateral common iliac artery occlusion; single or multiple stenoses totaling 3 to 10 cm of the external iliac artery not extending into the common femoral artery; unilateral external iliac artery occlusion not involving the origins of the internal iliac artery or common femoral artery",
"     </li>",
"     <li>",
"      Femoropopliteal &ndash; Multiple lesions (stenoses or occlusions), each &le;5 cm; stenosis or occlusion &le;15 cm not involving the infra-geniculate popliteal artery; Single or multiple lesions in the absence of continuous tibial vessels to improve inflow for a distal bypass; heavily calcified occlusion &le;5 cm in length; single popliteal stenosis",
"     </li>",
"     <li>",
"      Tibial vessels &ndash; undefined",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629077\">",
"    <span class=\"h3\">",
"     Type C lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type C lesions have better long-term results with open revascularization such that endovascular techniques should be used if the patient is at high risk for open surgical repair.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortoiliac &ndash; Bilateral common iliac artery occlusions; bilateral external iliac artery stenosis 3 to 10 cm not extending into the common femoral artery; unilateral external iliac artery stenosis extending into the common femoral artery; unilateral external iliac artery occlusion of the origins of the internal iliac",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      common femoral artery; heavily calcified unilateral external iliac artery occlusion with or without involvement of the origins of the internal iliac",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      common femoral artery",
"     </li>",
"     <li>",
"      Femoropopliteal &ndash; Multiple stenoses or occlusion totaling &gt;15 cm with or without heavy calcification; recurrent stenoses or occlusion that need treatment after two endovascular interventions",
"     </li>",
"     <li>",
"      Tibial vessels &ndash; undefined",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629084\">",
"    <span class=\"h3\">",
"     Type D lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type D lesions have poor results with endovascular treatment, and thus, surgery is the primary treatment. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortoiliac &ndash; Infrarenal aortoiliac occlusion; diffuse disease of the aorta and both iliac arteries requiring treatment; diffuse multiple stenoses of the unilateral common and iliac artery, and common femoral artery; unilateral occlusions of the common iliac and external iliac arteries; bilateral occlusions of external iliac arteries; iliac stenoses in patients with abdominal aortic aneurysm (that require treatment and are not amenable to endograft placement) or other lesions requiring open aortic or iliac surgery",
"     </li>",
"     <li>",
"      Femoropopliteal &ndash; Chronic total occlusion of the common femoral artery or superficial femoral artery (&gt;20 cm, involving the popliteal artery); chronic total occlusion of the popliteal artery and proximal trifurcation vessels.",
"     </li>",
"     <li>",
"      Tibial vessels &ndash; undefined",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576665412\">",
"    <span class=\"h2\">",
"     Bollinger scoring method",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the Bollinger method, 13 infrainguinal arterial segments are assessed and each of these segments are scored according to the severity and extent of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Four lesion severities are characterized. To calculate the additive scores, the individual scores for each of the lesion severities are summed in accordance with the following rules: In the presence of occlusions, stenoses and plaques are not considered; when both severities of stenoses are present (ie, &ge;50 percent and &lt;50 percent), plaques (&le;25 percent) are not considered; for each severity of disease, only one extent of disease category is scored.",
"   </p>",
"   <p>",
"    Arterial segments:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Profunda femoris artery",
"     </li>",
"     <li>",
"      Proximal (upper half) superficial femoral artery",
"     </li>",
"     <li>",
"      Distal (lower half) superficial femoral artery",
"     </li>",
"     <li>",
"      Above-knee popliteal artery",
"     </li>",
"     <li>",
"      Below-knee popliteal artery",
"     </li>",
"     <li>",
"      Tibioperoneal trunk",
"     </li>",
"     <li>",
"      Proximal (upper-half calf) posterior tibial artery",
"     </li>",
"     <li>",
"      Distal (lower-half calf) posterior tibial artery",
"     </li>",
"     <li>",
"      Proximal (upper-half) anterior tibial artery",
"     </li>",
"     <li>",
"      Distal (lower-half) anterior tibial artery",
"     </li>",
"     <li>",
"      Proximal (upper-half) peroneal artery",
"     </li>",
"     <li>",
"      Distal (lower-half) peroneal artery",
"     </li>",
"     <li>",
"      Plantar arch",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lesion severity:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      1 point : Occlusion of the lumen",
"     </li>",
"     <li>",
"      2 points: Stenosis &ge;50 percent of the luminal diameter",
"     </li>",
"     <li>",
"      3 points: Stenosis &gt;50 percent but &lt;25 percent",
"     </li>",
"     <li>",
"      4 points: Plaques impinging &le;25 percent of the diameter",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lesion extent:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      1 point : Single lesion",
"     </li>",
"     <li>",
"      2 points: Multiple lesions affecting less than half of the segment",
"     </li>",
"     <li>",
"      3 points: Multiple lesions affecting more than half of the segment",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576665923\">",
"    <span class=\"h2\">",
"     Graziani morphologic classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Graziani morphologic classification refers to a system for defining arterial lesions in patients with diabetes of increasing arterial involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Class 1 &ndash; Isolated, one vessel tibial or peroneal artery obstruction",
"     </li>",
"     <li>",
"      Class 2a &ndash; Isolated",
"      <span class=\"nowrap\">",
"       femoral/popliteal",
"      </span>",
"      artery or two below-knee arteries obstructed but with patency of one of the two tibial arteries",
"     </li>",
"     <li>",
"      Class 2b &ndash; Isolated",
"      <span class=\"nowrap\">",
"       femoral/popliteal",
"      </span>",
"      artery or two below-knee tibial arteries obstructed but with patency of the peroneal artery",
"     </li>",
"     <li>",
"      Class 3 &ndash; Isolated, one artery occluded and multiple stenoses of",
"      <span class=\"nowrap\">",
"       tibial/peroneal",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       femoral/popliteal",
"      </span>",
"      arteries",
"     </li>",
"     <li>",
"      Class 4 &ndash; Two arteries occluded and multiple stenoses of",
"      <span class=\"nowrap\">",
"       tibial/peroneal",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       femoral/popliteal",
"      </span>",
"      vessels",
"     </li>",
"     <li>",
"      Class 5 &ndash; Occlusion of all tibial and peroneal arteries (below-knee cross-sectional occlusion)",
"     </li>",
"     <li>",
"      Class 6 &ndash; Three arteries occluded and multiple stenoses of",
"      <span class=\"nowrap\">",
"       tibial/peroneal",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       femoral/popliteal",
"      </span>",
"      arteries",
"     </li>",
"     <li>",
"      Class 7 &ndash; Multiple femoropopliteal obstructions with no visible below-the-knee arterial segments",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576665352\">",
"    <span class=\"h1\">",
"     SYMPTOM CLASSIFICATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576666175\">",
"    <span class=\"h2\">",
"     Chronic extremity ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with lower extremity chronic ischemia present with longstanding symptoms of peripheral artery disease that can include rest pain, which is pain across the base of the metatarsal heads at rest relieved by dependency, or with tissue loss, which can be ulceration, dry gangrene or wet gangrene. The Rutherford and Fontaine symptom classification systems are the most widely used [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The walking distance that defines mild, moderate, and severe claudication is not specified in the Rutherford classification, but is part of the Fontaine classification specified as 650 feet (200 meters).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576665360\">",
"    <span class=\"h3\">",
"     Rutherford",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stage 0 &ndash; Asymptomatic",
"     </li>",
"     <li>",
"      Stage 1 &ndash; Mild claudication",
"     </li>",
"     <li>",
"      Stage 2 &ndash; Moderate claudication",
"     </li>",
"     <li>",
"      Stage 3 &ndash; Severe claudication",
"     </li>",
"     <li>",
"      Stage 4 &ndash; Rest pain",
"     </li>",
"     <li>",
"      Stage 5 &ndash; Ischemic ulceration not exceeding ulcer of the digits of the foot",
"     </li>",
"     <li>",
"      Stage 6 &ndash; Severe ischemic ulcers or frank gangrene",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1576665368\">",
"    <span class=\"h3\">",
"     Fontaine",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stage 1 &ndash; No symptoms",
"     </li>",
"     <li>",
"      Stage 2 &ndash; Intermittent claudication subdivided into:",
"     </li>",
"     <li>",
"      Stage 2a &ndash; without pain on resting, but with claudication at a distance of greater than 650 feet (200 meters)",
"     </li>",
"     <li>",
"      Stage 2b &ndash; without pain on resting, but with a claudication distance of less than 650 feet (200 meters)",
"     </li>",
"     <li>",
"      Stage 3 &ndash; Nocturnal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      resting pain",
"     </li>",
"     <li>",
"      Stage 4 &ndash; Necrosis (death of tissue)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      gangrene in the limb",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909633906\">",
"    <span class=\"h2\">",
"     Acute extremity ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute limb ischemia is defined as a sudden decrease in limb perfusion that causes a potential threat to limb viability (manifested by ischemic rest pain, ischemic ulcers,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gangrene) in patients who present within two weeks of the acute event [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/1\">",
"     1",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     SVS/ISCVS",
"    </span>",
"    (Rutherford) classification stratifies limb ischemia based upon the presence and degree of sensorimotor deficits and Doppler findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/8-10\">",
"     8-10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909634102\">",
"    <span class=\"h3\">",
"     Viable",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viable limbs are under no immediate threat of tissue loss. There is no sensory loss or muscle weakness and both arterial and venous Doppler signals are audible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909634109\">",
"    <span class=\"h3\">",
"     Marginally-threatened",
"    </span>",
"    &nbsp;&mdash;&nbsp;Marginally-threatened limbs are salvageable if treated promptly. There is minimal pain (in the toes) or no sensory loss, no muscle weakness, arterial Doppler signals are often inaudible, and venous Doppler signals are audible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909634116\">",
"    <span class=\"h3\">",
"     Immediately-threatened",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately-threatened limbs are salvageable with immediate revascularization. Sensory loss involves more than the toes and may be associated with rest pain. There is mild to moderate muscle weakness, arterial Doppler signals are usually inaudible, and venous Doppler signals are audible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909634123\">",
"    <span class=\"h3\">",
"     Irreversible (nonviable)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irreversible limbs have major tissue loss",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    permanent nerve damage. Sensory loss is profound, muscle weakness is profound with paralysis and possible rigor, and arterial and venous Doppler signals are inaudible. These nonviable extremities require major amputation regardless of the therapy that is instituted. Revascularization may be required to permit healing of the amputation or amputation at a lower level.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629720\">",
"    <span class=\"h1\">",
"     LOWER EXTREMITY IMPAIRMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular disease impairs the individual&rsquo;s ability to function in society. The American Medical Association (AMA) lower extremity impairment grading scale defines increasing degrees of disability based upon clinical features [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. The AMA scale includes symptoms and signs primarily related to peripheral artery disease but also includes chronic venous disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629728\">",
"    <span class=\"h2\">",
"     Class 0",
"    </span>",
"    &nbsp;&mdash;&nbsp;(Whole person impairment [WPI]: 0 percent). The patient does not have claudication or pain at rest or the patient experiences only transient edema but one of the following physical examination findings is present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Loss of pulses",
"     </li>",
"     <li>",
"      Minimal loss of subcutaneous tissue",
"     </li>",
"     <li>",
"      Calcification of arteries detected on radiographic examination",
"     </li>",
"     <li>",
"      Asymptomatic dilation of arteries or veins not requiring surgery and not resulting in curtailment of activities",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629742\">",
"    <span class=\"h2\">",
"     Class 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;(WPI: 2 to 10 percent). The patient has at least one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intermittent claudication is present on walking at least 100 yards at an average pace",
"     </li>",
"     <li>",
"      Moderate edema persist that is incompletely controlled by elastic supports",
"     </li>",
"     <li>",
"      Evidence of tissue damage such as healed stump (single amputated digit) or a healed ulceration",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629735\">",
"    <span class=\"h2\">",
"     Class 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;(WPI: 11 to 23 percent). The patient has at least one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intermittent claudication on walking as few as 25 yards and no more than 100 yards at average pace",
"     </li>",
"     <li>",
"      Marked edema is present that is only partially controlled by elastic supports",
"     </li>",
"     <li>",
"      Evidence of tissue damage such as healed amputations (two or more digits in one extremity) with evidence of superficial ulceration",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629757\">",
"    <span class=\"h2\">",
"     Class 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;(WPI: 25 to 40 percent). The patient has at least one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The patient experiences intermittent claudication on walking less than 25 yards &nbsp;",
"     </li>",
"     <li>",
"      The patient experiences intermittent pain at rest",
"     </li>",
"     <li>",
"      The patient has marked edema that cannot be controlled by elastic supports",
"     </li>",
"     <li>",
"      Evidence of vascular damage such as amputation at or above an ankle of one extremity, or amputation of two or more digits of two extremities with persistent vascular disease with persistent widespread or deep ulceration involving one extremity",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629764\">",
"    <span class=\"h2\">",
"     Class 4",
"    </span>",
"    &nbsp;&mdash;&nbsp;(WPI: 45 to 65 percent). The patient has at least one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The patient experiences severe and constant pain at rest",
"     </li>",
"     <li>",
"      There is evidence of tissue damage such as amputation at or above the ankles of both extremities, or amputation of all digits of two or more extremities, and evidence of persistent widespread or deep ulceration involving two or more extremities",
"     </li>",
"     <li>",
"      Whole person impairment (100 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629795\">",
"    <span class=\"h1\">",
"     DISABILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients applying for disability with the Social Security Administration of the United States must meet the requirement for cardiovascular impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/14\">",
"     14",
"    </a>",
"    ]. To qualify, the patient must demonstrate the presence of a body system impairment severe enough to prevent gainful activity. The impairment is expected to last for a continuous period of at least 12 months.",
"   </p>",
"   <p>",
"    For patients with intermittent claudication, one of the following must also be present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Resting",
"      <span class=\"nowrap\">",
"       ankle/brachial",
"      </span>",
"      systolic blood pressure ratio of &lt;0.5",
"     </li>",
"     <li>",
"      Decrease in systolic blood pressure at the ankle on exercise of 50 percent or more from pre-exercise level and requiring &ge;10 minutes to return to pre-exercise level",
"     </li>",
"     <li>",
"      Resting toe systolic pressure of &lt;30 mmHg",
"     </li>",
"     <li>",
"      Resting",
"      <span class=\"nowrap\">",
"       toe/brachial",
"      </span>",
"      index &lt;0.4",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with lower extremity amputation (any cause), one of the following is required [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Both hands",
"     </li>",
"     <li>",
"      One or both lower extremities at or above the tarsal region, with stump complications resulting in medical inability to use a prosthetic device to ambulate effectively",
"     </li>",
"     <li>",
"      One hand and one lower extremity at or above the tarsal region, with inability to ambulate effectively",
"     </li>",
"     <li>",
"      Hemipelvectomy or hip disarticulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with chronic venous disease, incompetence or obstruction of the deep venous system and one of the following must be present [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1031/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extensive brawny edema involving at least two-thirds of the leg between the ankle and knee or the distal one-third of the lower extremity between the ankle and hip",
"     </li>",
"     <li>",
"      Superficial varicosities, stasis dermatitis, and either recurrent ulceration or persistent ulceration that has not healed following at least three months of prescribed treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909629154\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment options for lower extremity revascularization must take into consideration the risk of the intervention relative to the patient&rsquo;s medical condition versus the expected improvement in the patient&rsquo;s clinical condition (eg, decreased pain, ulcer healing) and the durability of the intervention in the context of the patient&rsquo;s life-expectancy. Grading the symptoms of peripheral artery disease and the anatomic lesions responsible for these symptoms provides an objective measure by which to follow patients clinically, and, importantly, provides consistency when comparing interventional strategies in clinical studies. (See",
"      <a class=\"local\" href=\"#H909629103\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Rutherford and Fontaine symptom scales are the most widely used classifications for chronic extremity ischemia. A Rutherford scale for acute ischemia is a separate and distinct scale. (See",
"      <a class=\"local\" href=\"#H1576665352\">",
"       'Symptom classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Arterial lesions are classified by Trans Atlantic Inter-Society Consensus (TASC II) as Type A, B, C, or D based upon the overall success rates of treating the lesion using endovascular or surgical means. Most patients with peripheral artery disease have more than one lesion, at more than one level, so the classification scheme is limited in focusing on singular patterns. (See",
"      <a class=\"local\" href=\"#H909629056\">",
"       'TASC classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TASC II Type A lesions represent simpler lesions of the iliac, femoral, and popliteal arteries, while Type D lesions represent complex, long segment lesions. There are no TASC II classifications referable to the tibial vessels. Type B and Type C are intermediate lesions. Endovascular therapy is the treatment of choice for Type A lesions and is preferred for Type B lesions. Surgery is the treatment of choice for Type D lesions and is the preferred treatment for good-risk patients with Type C lesions. (See",
"      <a class=\"local\" href=\"#H909629063\">",
"       'Type A lesions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H909629070\">",
"       'Type B lesions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H909629077\">",
"       'Type C lesions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H909629084\">",
"       'Type D lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who continue to suffer symptoms related to peripheral artery disease, impairment and disability may need to be quantified for insurance purposes or in order to qualify for disability. (See",
"      <a class=\"local\" href=\"#H909629720\">",
"       'Lower extremity impairment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H909629795\">",
"       'Disability'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/1\">",
"      Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S:S5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/2\">",
"      Bollinger A, Breddin K, Hess H, et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 1981; 38:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/3\">",
"      Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification. J Vasc Surg 2010; 51:32S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/4\">",
"      Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/5\">",
"      Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/6\">",
"      Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/7\">",
"      FONTAINE R, KIM M, KIENY R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta 1954; 21:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/8\">",
"      Rutherford, RB. Acute limb ischemia: Clinical assessment and standards for reporting. Semin Vasc Surg 1992; 5:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/9\">",
"      Katzen BT. Clinical diagnosis and prognosis of acute limb ischemia. Rev Cardiovasc Med 2002; 3 Suppl 2:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/10\">",
"      Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/11\">",
"      Spieler EA, Barth PS, Burton JF Jr, et al. Recommendations to guide revision of the Guides to the Evaluation of Permanent Impairment. American Medical Association. JAMA 2000; 283:519.",
"     </a>",
"    </li>",
"    <li>",
"     Rondinelli, R. Guides to the Evaluation of Permanent Impairment, Sixth Edition, American Medical Association, Chicago 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1031/abstract/13\">",
"      Cocchiarella L, Turk MA, Andersson G. Improving the evaluation of permanent impairment. JAMA 2000; 283:532.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm (Accessed on October 04, 2011).",
"    </li>",
"    <li>",
"     file://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm (Accessed on October 04, 2011).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16740 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-B007036579-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1031=[""].join("\n");
var outline_f1_0_1031=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H909629154\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H909629103\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H909629146\">",
"      LOWER EXTREMITY ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1576665376\">",
"      ANATOMIC LESION CLASSIFICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909629056\">",
"      TASC classification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909629063\">",
"      - Type A lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909629070\">",
"      - Type B lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909629077\">",
"      - Type C lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909629084\">",
"      - Type D lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576665412\">",
"      Bollinger scoring method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576665923\">",
"      Graziani morphologic classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1576665352\">",
"      SYMPTOM CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1576666175\">",
"      Chronic extremity ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1576665360\">",
"      - Rutherford",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1576665368\">",
"      - Fontaine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909633906\">",
"      Acute extremity ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909634102\">",
"      - Viable",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909634109\">",
"      - Marginally-threatened",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909634116\">",
"      - Immediately-threatened",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H909634123\">",
"      - Irreversible (nonviable)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H909629720\">",
"      LOWER EXTREMITY IMPAIRMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909629728\">",
"      Class 0",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909629742\">",
"      Class 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909629735\">",
"      Class 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909629757\">",
"      Class 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909629764\">",
"      Class 4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H909629795\">",
"      DISABILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H909629154\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/16740\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/16740|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/43/39605\" title=\"figure 1\">",
"      Anatomy common femoral artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/60/26566\" title=\"figure 2\">",
"      Collateral circulation lower extremity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/16/42247\" title=\"figure 3\">",
"      Anatomy of the popliteal fossa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/27/42424\" title=\"figure 4\">",
"      Muscle compartments of the leg",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/16740|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/14/42213\" title=\"picture 1A\">",
"      Anterior anatomy of tibia and fibula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/45/27349\" title=\"picture 1B\">",
"      Lateral anatomy of tibia and fibula",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=related_link\">",
"      Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44376?source=related_link\">",
"      Indications for surgery in the patient with lower extremity claudication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/0/38921?source=related_link\">",
"      Percutaneous interventional procedures in the patient with lower extremity claudication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/58/19370?source=related_link\">",
"      Treatment of chronic lower extremity critical limb ischemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_0_1032="Clinical features and diagnosis of pelvic inflammatory disease";
var content_f1_0_1032=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of pelvic inflammatory disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Charles H Livengood, III, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Mariam R Chacko, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1032/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/0/1032/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic inflammatory disease (PID) refers to acute infection of the upper genital tract structures in women, involving any or all of the uterus, oviducts, and ovaries; this is often accompanied by involvement of the neighboring pelvic organs. Involvement of these structures results in endometritis, salpingitis, oophoritis, peritonitis, perihepatitis and tubo-ovarian abscess.",
"   </p>",
"   <p>",
"    Sexually transmitted agents, such as Neisseria gonorrhoeae and Chlamydia trachomatis are often implicated, although vaginal flora may also play an important role [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/1\">",
"     1",
"    </a>",
"    ]. Post-operative pelvic cellulitis and abscess, pregnancy-related pelvic infection, and pelvic infection secondary to spread of another infection (appendicitis, diverticulitis, tumor, tuberculous peritonitis, actinomycosis, others) produce a very similar clinical picture, and indeed are referred to as PID by some. However, the etiologic differences among these processes have significant implications for treatment and prevention.",
"   </p>",
"   <p>",
"    According to a National Ambulatory Medical Care Survey, the estimated number of cases of PID in women 15 to 44 years of age in the United States decreased from 189,662 in 2002 to 168,837 in 2003. The number of hospitalizations for acute PID steadily declined from approximately 70,000",
"    <span class=\"nowrap\">",
"     cases/year",
"    </span>",
"    in 1998 to 45,000",
"    <span class=\"nowrap\">",
"     cases/year",
"    </span>",
"    in 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/2\">",
"     2",
"    </a>",
"    ]. Visits to physicians&rsquo; offices for PID also have declined, primarily due to aggressive population-based chlamydia screening and treatment programs nationwide [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The last 30 years have witnessed an interesting, if circular, evolution of the clinical approach to the diagnosis of PID. Diagnostic procedures to document PID at one time replaced a primary clinical diagnosis. It is now appreciated that PID represents a spectrum of infection, that there is no single diagnostic gold standard, and that the practical value of clinical diagnosis retains central importance.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of PID will be reviewed here. The pathogenesis, risk factors for acquisition, treatment, and sequelae associated with this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11992?source=see_link\">",
"     \"Pathogenesis of and risk factors for pelvic inflammatory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=see_link\">",
"     \"Treatment of pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical diagnosis of PID is imprecise [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/1\">",
"     1",
"    </a>",
"    ]. Lower abdominal pain is the cardinal presenting symptom in women with PID although the character of the pain may be quite subtle. The recent onset of pain that worsens during coitus or with jarring movement may be the only presenting symptom of PID; the onset of pain during or shortly after menses is particularly suggestive [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/4\">",
"     4",
"    </a>",
"    ]. The abdominal pain is usually bilateral and rarely of more than two weeks' duration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormal uterine bleeding occurs in one-third or more of patients with PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/6\">",
"     6",
"    </a>",
"    ]. New vaginal discharge, urethritis, proctitis, fever, and chills can be associated signs but are neither sensitive nor specific for the diagnosis. The presence of PID is less likely if symptoms referable to the bowel or urinary tract predominate. While it is rare to have PID during pregnancy, the infection can occur in the first 12 weeks of gestation before the mucus plug and decidua seal off the uterus from ascending bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation of the patient for risk factors for sexually transmitted disease and those that increase the probability of PID can be quite helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11992?source=see_link\">",
"     \"Pathogenesis of and risk factors for pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for STD include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age less than 25 years",
"     </li>",
"     <li>",
"      Young age at first sex",
"     </li>",
"     <li>",
"      Nonbarrier contraception",
"     </li>",
"     <li>",
"      New, multiple, or symptomatic sexual partners",
"     </li>",
"     <li>",
"      Oral contraception",
"     </li>",
"     <li>",
"      Cervical ectopy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Factors that potentially facilitate PID include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Previous episode of PID",
"     </li>",
"     <li>",
"      Sex during menses",
"     </li>",
"     <li>",
"      Vaginal douching",
"     </li>",
"     <li>",
"      Bacterial vaginosis",
"     </li>",
"     <li>",
"      Intrauterine device",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On physical examination, only about one-half of patients with PID have fever. Abdominal examination reveals diffuse tenderness greatest in the lower quadrants, which may or may not be symmetrical. Rebound tenderness and decreased bowel sounds are common. Marked tenderness in the right upper quadrant does not exclude PID, since approximately 10 percent of these patients have perihepatitis (Fitz-Hugh Curtis syndrome). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Perihepatitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    On pelvic examination, the finding of a purulent endocervical discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acute cervical motion and adnexal tenderness with bimanual examination is strongly suggestive of PID. Rectovaginal examination should reveal the uterus and adnexae to be the focus of tenderness. Other diagnoses should be considered if uterine and adnexal tenderness are not prominent. One study found that adnexal tenderness was the sign that correlated best with the finding of endometritis on endometrial biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/8\">",
"     8",
"    </a>",
"    ]. However, significant lateralization of adnexal tenderness is uncommon in PID. The presence of a palpable adnexal mass is equally likely to represent tuboovarian abscess complicating PID and other diseases processes in the differential diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24601?source=see_link\">",
"     \"Approach to the patient with an adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=see_link\">",
"     \"Differential diagnosis of the adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36823?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Subclinical PID",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lower genital tract infection with gonorrhea, chlamydia, or bacterial vaginosis is a risk factor for subclinical PID, defined histologically by the presence of neutrophils and plasma cells in endometrial tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/9\">",
"     9",
"    </a>",
"    ]. Women with tubal factor infertility apparently induced by past episodes of PID often give no history of PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. As an example, in one study of 112 infertile women, 36 had adhesions or distal tube occlusion suggestive of PID by laparoscopy but only 11 had a history of this diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, up to one-third of women without a history of PID harbor persistent Chlamydia trachomatis in the upper genital tract despite the absence of clinical findings except infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon these observations, it seems clear that subclinical PID severe enough to produce significant sequelae is common. Subclinical episodes are particularly common among oral contraceptive users [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. This was illustrated in a study in which 43 women with endometritis but no clinical signs of PID were four times more likely to have used oral contraceptives than 111 control patients with clinical PID and endometritis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An indolent presentation of PID with low-grade fever, weight loss, and abdominal pain, has also been reported with actinomycosis. An association between an indwelling IUD and risk of actinomycosis has been suggested, although this relationship remains unclear. The diagnosis of this pathogen is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38452?source=see_link\">",
"     \"Abdominal actinomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Perihepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perihepatitis (Fitz-Hugh Curtis Syndrome) was first associated with gonococcal salpingitis in 1920 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/17\">",
"     17",
"    </a>",
"    ] and subsequently with Chlamydia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. It consists of infection of the liver capsule and peritoneal surfaces of the anterior right upper quadrant, with minimal stromal hepatic involvement. It manifests as a patchy purulent and fibrinous exudate in the acute phase (\"violin string\" adhesions), most prominently affecting the anterior surfaces of the liver (not the liver parenchyma). Thus, aminotransferases are also usually normal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptoms are typically the sudden onset of severe right upper quadrant abdominal pain with a distinct pleuritic component, sometimes referred to the right shoulder. The severity of the pain in this location may mask the diagnosis of PID and lead to concerns regarding cholecystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/22\">",
"     22",
"    </a>",
"    ]. Aminotransferases are abnormal in approximately one-half of patients with perihepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several important concepts about PID that must be appreciated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PID represents a spectrum of clinical disease, from endometritis to fatal intraabdominal sepsis.",
"     </li>",
"     <li>",
"      There are multiple gold standards in use to establish the diagnosis, because no one among them is adequate alone. Older studies defining PID by a single standard, such as laparoscopic visualization of gross salpingitis, are now felt to lack sensitivity [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/6,26\">",
"       6,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following discussion will review the tests that have been used to confirm the diagnosis of PID and diagnostic criteria that have been proposed. As will be seen, none of these tests is highly specific and sensitive. Thus, in many cases, clinicians must have a low threshold for considering the diagnosis and be prepared to initiate empiric antibiotic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Plasma cell endometritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma cell endometritis (PCE) has been identified as an important component of PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/27\">",
"     27",
"    </a>",
"    ]. In one study of 45 women admitted for acute PID, PCE was documented in 26 (87 percent) of 30 women with gross salpingitis; four of five women with PCE and no salpingitis had positive tests for chlamydia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gonorrhea in the genital tract and were also felt to have PID. In addition, the density of the plasma cell infiltrate correlated with the clinical severity of disease.",
"   </p>",
"   <p>",
"    Several other studies have confirmed these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In one report, endometritis was present in one-third of 44 patients with confirmed PID, four of whom had negative laparoscopic findings for salpingitis; the specificity of endometritis for the diagnosis of PID was 92 percent with a positive predictive value of 77 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/29\">",
"     29",
"    </a>",
"    ]. PCE correlates closely with the",
"    <span class=\"nowrap\">",
"     follicular/proliferative",
"    </span>",
"    phase of the menstrual cycle, the interval during which most cases of PID arise [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other evidence, however, tempers enthusiasm for linking the finding of PCE with the diagnosis of PID. PCE occurs among asymptomatic women with no other evidence of PID (eg, in 42 percent of women with isolated bacterial vaginosis and 13 percent with no genital tract infection) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/4\">",
"     4",
"    </a>",
"    ]. Furthermore, one study found a poor correlation between PCE and the clinical findings classically associated with PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/30\">",
"     30",
"    </a>",
"    ]. Whether PCE when found alone is representative of the subclinical cases of PID discussed above or is, in some cases, a benign finding remains to be elucidated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laparoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PID had been almost exclusively a clinical one until a pivotal 1969 study in which laparoscopy was performed in 814 women with a clinical diagnosis of PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/6\">",
"     6",
"    </a>",
"    ]. The presence of PID was verified by laparoscopy in 532 patients and other disorders were diagnosed in 98; 184 patients were classified as normal because of a negative laparoscopy.",
"   </p>",
"   <p>",
"    Almost a generation of physicians were trained to diagnose PID based upon clinical correlates derived from this study since laparoscopy was difficult to justify in all suspected cases of acute PID and was not always available [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/6,31\">",
"     6,31",
"    </a>",
"    ]. Subsequent studies from the 1990s found the sensitivity of laparoscopy to be as low as 50 percent with a specificity approaching 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/28,29,32\">",
"     28,29,32",
"    </a>",
"    ]. Thus, laparoscopy has substantial value in confirming the diagnosis of PID but is not sensitive enough to be considered a diagnostic gold standard. We recommend laparoscopy for the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A sick patient with high suspicion of a competing diagnosis (usually appendicitis, etc.)",
"     </li>",
"     <li>",
"      An acutely ill patient who has failed outpatient treatment for PID",
"     </li>",
"     <li>",
"      Any patient not clearly improving after approximately 72 hours of inpatient treatment for PID",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consent for laparotomy at the same procedure should be obtained in advance for these patients. We do not recommend endometrial biopsy for PCE at present unless the procedure is part of a protocol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Diagnostic criteria and guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The index of suspicion for the clinical diagnosis of PID should be high, especially in adolescent women, even if they deny sexual activity. The current favored approach to the diagnosis of PID is multifaceted [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/28-30,33\">",
"     28-30,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A minimal set of clinical criteria has been recommended by the CDC for empirical treatment of PID, including cervical motion tenderness or uterine or adnexal tenderness in the presence of lower abdominal or pelvic pain. The following additional criteria can also be used to support a clinical diagnosis of PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Oral temperature &gt;101&deg; F (&gt;38.3&deg;C)",
"     </li>",
"     <li>",
"      Abnormal cervical or vaginal mucopurulent discharge",
"     </li>",
"     <li>",
"      Presence of abundant numbers of white blood cells (WBCs) on saline microscopy of vaginal secretions",
"     </li>",
"     <li>",
"      Elevated erythrocyte sedimentation rate",
"     </li>",
"     <li>",
"      Elevated C-reactive protein",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with pelvic pain and tenderness and any one or more of the following are currently considered \"confirmed\" cases:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute or chronic (plasma cell) endometritis or acute salpingitis on histologic evaluation of a biopsy",
"     </li>",
"     <li>",
"      Demonstration of N. gonorrhoeae or C. trachomatis in the genital tract",
"     </li>",
"     <li>",
"      Gross salpingitis visualized at laparoscopy or laparotomy",
"     </li>",
"     <li>",
"      Isolation of pathogenic bacteria from a clean specimen from the upper genital tract",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Inflammatory/purulent",
"      </span>",
"      pelvic peritoneal fluid without another source",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Centers for Disease Control and Prevention (CDC) also has issued guidelines for the \"definitive\" diagnosis of PID in symptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/1\">",
"     1",
"    </a>",
"    ]. One or more of the following three findings are required:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Histologic evidence of endometritis in a biopsy",
"     </li>",
"     <li>",
"      An imaging technique revealing thickened fluid-filled",
"      <span class=\"nowrap\">",
"       tubes/oviducts",
"      </span>",
"      with or without free pelvic fluid or tuboovarian complex",
"     </li>",
"     <li>",
"      Laparoscopic abnormalities consistent with PID (eg, tubal erythema, edema, adhesions; purulent exudate or cul-de-sac fluid; abnormal fibriae)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Standards for the diagnosis of subclinical PID, assuming that it exists, remain to be established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to PID, the differential diagnosis of lower abdominal pain in a young woman includes the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastrointestinal: Appendicitis, cholecystitis, constipation, gastroenteritis, inflammatory bowel disease",
"     </li>",
"     <li>",
"      Renal: Cystitis, pyelonephritis, nephrolithiasis, urethritis",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Obstetric/Gynecologic:",
"      </span>",
"      Dysmenorrhea, ectopic pregnancy, intrauterine pregnancy complication, ovarian cyst, ovarian torsion, ovarian tumor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a woman with right upper quadrant pain related to Fitz-Hugh Curtis syndrome, aminotransferases are usually normal; in contrast, a patient with acute viral hepatitis would be expected to have significant abnormalities of aminotransferases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninvasive diagnostic tests for PID include general laboratory studies looking for signs of inflammation, culture testing and microscopy of cervical or vaginal secretions, and imaging studies.",
"   </p>",
"   <p>",
"    All patients who are diagnosed with acute PID should also be tested for HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing for patients suspected of PID always begins with a pregnancy test to rule out ectopic pregnancy and complications of an intrauterine pregnancy. Blood counts have limited value. Although PID is usually an acute process, less than half of PID patients exhibit leukocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/34\">",
"     34",
"    </a>",
"    ]. A hematocrit of less than 0.30 makes PID less likely, relative to hemorrhagic conditions such as ovulatory ovarian bleeding and ectopic pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gram stain and microscopic examination of vaginal discharge may provide useful information. If a cervical Gram stain is positive for Gram negative intracellular diplococci when interpreted by an experienced microscopist, the probability of PID greatly increases; if negative, it is of little use [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study of 120 women showed that increased white blood cells (WBC) in vaginal fluid was the most sensitive single laboratory test for PID (78 percent for &ge;3 WBC per high power field (hpf) compared with 57, 70, and 71 percent respectively for serum WBC, erythrocyte sedimentation rate (ESR), and C reactive protein) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/33\">",
"     33",
"    </a>",
"    ]. However, the specificity was only 39 percent.",
"   </p>",
"   <p>",
"    A meta-analysis also concluded that there was no single test or combination that was both sensitive and specific for the diagnosis of PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/35\">",
"     35",
"    </a>",
"    ]. However, certain combinations may have a high negative predictive value. In the series of 120 women described above, the probability of PID was only 11 percent in women with the combination of a normal peripheral WBC and &le;3",
"    <span class=\"nowrap\">",
"     WBC/hpf",
"    </span>",
"    from vaginal fluid; no patient had PID if the ESR also was normal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/33\">",
"     33",
"    </a>",
"    ]. The ovarian tumor marker CA-125 is apparently elevated in all cases of PID [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We recommend the following laboratory tests:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pregnancy test",
"     </li>",
"     <li>",
"      Microscopic exam of vaginal discharge in saline",
"     </li>",
"     <li>",
"      Complete blood counts",
"     </li>",
"     <li>",
"      Nucleic acid amplification tests for chlamydia and gonococcus",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"     <li>",
"      C-reactive protein (optional)",
"     </li>",
"     <li>",
"      HIV testing",
"     </li>",
"     <li>",
"      Hepatitis B surface antigen and surface antibody",
"     </li>",
"     <li>",
"      Testing for syphilis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Imaging techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have evaluated sonographic findings in PID with mixed results; a transvaginal rather than transabdominal approach is required [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study of 51 outpatients compared transvaginal ultrasound with endometrial biopsy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/38\">",
"       38",
"      </a>",
"      ]. For the 13 patients with PCE, 11 had thickened, fluid-filled oviducts on ultrasound with or without free pelvic fluid (sensitivity 85 percent and specificity of 100 percent).",
"     </li>",
"     <li>",
"      Another report evaluated 84 patients who met accepted clinical criteria for diagnosis of acute PID; 31 had normal sonograms including 26 with positive endocervical cultures [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a third series, 55 women with clinical PID confirmed histologically or by laparoscopy underwent transvaginal sonography looking for abnormal oviducts, multicystic ovaries, and increased cul-de-sac fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/39\">",
"       39",
"      </a>",
"      ]. The respective sensitivities for these parameters were poor at 32 percent, 42 percent, and 37 percent, respectively; the specificities were 97 percent, 86 percent, and 58 percent. It was concluded that sonography has limited value in the diagnosis of PID.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Sonographic findings consistent with PID, especially thickened, fluid-filled oviducts, are useful to support a clinical diagnosis of PID. However, the absence of findings does not diminish the probability of PID and should not be used as a reason to delay treatment. We reserve ultrasounds for acutely ill patients with PID in whom a pelvic abscess is a consideration. One study compared pelvic ultrasonography in 60 adolescents with a clinical diagnosis of PID and 40 age-matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/40\">",
"     40",
"    </a>",
"    ]. The presence of fluid in the cul-de-sac was not helpful in distinguishing patients with PID from those without, but 19 percent of adolescents with PID in this series had a tubo-ovarian abscess demonstrated by ultrasound before clinically suspected. Given the major contribution of tubo-ovarian abscess to failure of medical therapy for PID, this information is of considerable importance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite this reservation about the CDC criteria for the diagnosis of PID, we strongly agree with their recommendation that \"health care providers should maintain a low threshold for the diagnosis of PID\" and that sexually active young women with the combination of lower abdominal, adnexal, and cervical motion tenderness should receive empiric treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/1\">",
"     1",
"    </a>",
"    ]. The specificity of these clinical criteria can be enhanced by the presence of fever, abnormal",
"    <span class=\"nowrap\">",
"     cervical/vaginal",
"    </span>",
"    discharge, elevated ESR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serum C-reactive protein, and the demonstration of cervical gonorrhea or chlamydia infection. However, if PCE is used to define PID among women with genital symptoms, even the CDC minimum criteria lack sensitivity (65 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/32\">",
"     32",
"    </a>",
"    ] and 33 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1032/abstract/30\">",
"     30",
"    </a>",
"    ] in two studies).",
"   </p>",
"   <p>",
"    To summarize, for all of the new insights into PID and its diagnosis, the practical clinical reality remains that patients will be best served if simple clinical findings (epidemiologic, symptomatic, and physical examination) suggesting PID are followed by prompt empiric treatment. Even patients with minimal findings should be treated since the consequences of withholding therapy are great. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=see_link\">",
"     \"Treatment of pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis for PID is extensive (",
"    <a class=\"graphic graphic_table graphicRef59205 \" href=\"UTD.htm?4/33/4636\">",
"     table 1",
"    </a>",
"    ). However, a trial of antibiotics should not be delayed while the other diagnoses are pursued when the clinical suspicion of PID is high.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?26/14/26850?source=see_link\">",
"       \"Patient information: Pelvic inflammatory disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=see_link\">",
"       \"Patient information: Gonorrhea (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=see_link\">",
"       \"Patient information: Chlamydia (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155838\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pelvic inflammatory disease (PID) refers to acute infection of the upper female genital tract structures, including the uterus, oviducts,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ovaries. Neisseria gonorrhoeae and Chlamydia trachomatis are often implicated, although vaginal flora may also play an important role in pathogenesis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with PID may complain of lower abdominal pain in association with new vaginal discharge, dysuria, or painful defecation. Constitutional symptoms may include fever and chills. Perihepatitis can also occur; thus, PID should be considered in women with marked tenderness in the right upper quadrant. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute PID is difficult to diagnose because of the wide variation in symptoms and signs, which may be subtle. A minimal set of clinical criteria has been recommended by the Centers for Disease Control and Prevention (CDC) for a presumptive diagnosis of PID, including cervical motion tenderness or uterine or adnexal tenderness with lower abdominal or pelvic pain. Supportive diagnostic findings include fever and cervical or vaginal discharge. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnostic criteria and guidelines'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Noninvasive diagnostic tests for PID include general laboratory studies looking for signs of inflammation (eg, erythrocyte sedimentation rate, white blood cell count), microscopic examination and cultures of cervical or vaginal secretions, and imaging studies. Laboratory testing for patients suspected of PID should include a pregnancy test to rule out ectopic pregnancy or complications of an intrauterine pregnancy. We perform pelvic ultrasounds for acutely ill patients with PID when there is concern for a pelvic abscess. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients who are diagnosed with acute PID should also be tested for HIV infection. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of the adverse consequences of untreated PID, health care providers should maintain a low threshold for the diagnosis of PID and consider presumptive treatment in suspect cases, particularly in sexually active young women with lower abdominal, adnexal, or cervical motion tenderness. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Recommendations'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=see_link\">",
"       \"Treatment of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.cdc.gov/std/treatment/2010/default.htm (Accessed on January 03, 2011).",
"    </li>",
"    <li>",
"     U.S. Department of Health and Human Services Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2009. Atlanta, GA. U.S. Department of Health and Human Services, 2010. www.cdc.gov/std/stats09/Exordium.htm#copy (Accessed on August 02, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/3\">",
"      Owusu-Edusei K Jr, Bohm MK, Chesson HW, Kent CK. Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses. Am J Prev Med 2010; 38:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/4\">",
"      Korn AP, Hessol NA, Padian NS, et al. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol 1998; 178:987.",
"     </a>",
"    </li>",
"    <li>",
"     Westrom L, Mardh PA. Epidemiology, etiology, and prognosis of acute salpingitis: A study of 1,457 laparoscopically verified cases. In: Nongonococcal Urethritis and Related Diseases, Hobson D, Holmes KK (Eds), Am Soc Microbiol, Washington, DC 1977. p.84.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/6\">",
"      Jacobson L, Westr&ouml;m L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol 1969; 105:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/7\">",
"      Zeger W, Holt K. Gynecologic infections. Emerg Med Clin North Am 2003; 21:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/8\">",
"      Peipert JF, Ness RB, Blume J, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol 2001; 184:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/9\">",
"      Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/10\">",
"      Moore DE, Spadoni LR, Foy HM, et al. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet 1982; 2:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/11\">",
"      Punnonen R, Terho P, Nikkanen V, Meurman O. Chlamydial serology in infertile women by immunofluorescence. Fertil Steril 1979; 31:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/12\">",
"      W&oslash;lner-Hanssen P. Silent pelvic inflammatory disease: is it overstated? Obstet Gynecol 1995; 86:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/13\">",
"      Keilani A, Boulieu D, Raudrant D, et al. [Role of Chlamydia trachomatis in tubal pathology (acute salpingitis and tubal sterility). Microbiological study of 175 samples of peritoneal fluid]. J Gynecol Obstet Biol Reprod (Paris) 1989; 18:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/14\">",
"      Shepard MK, Jones RB. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertil Steril 1989; 52:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/15\">",
"      Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection. JAMA 1985; 253:2246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/16\">",
"      Ness RB, Keder LM, Soper DE, et al. Oral contraception and the recognition of endometritis. Am J Obstet Gynecol 1997; 176:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/17\">",
"      Stajano C. La reaccio'n frenich en ginecologia. Semana M&eacute;d 1920; 27:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/18\">",
"      M&uuml;ller-Schoop JW, Wang SP, Munzinger J, et al. Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J 1978; 1:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/19\">",
"      W&oslash;lner-Hanssen P, Westr&ouml;m L, M&aring;rdh PA. Perihepatitis and chlamydial salpingitis. Lancet 1980; 1:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/20\">",
"      Wang SP, Eschenbach DA, Holmes KK, et al. Chlamydia trachomatis infection in Fitz-Hugh-Curtis syndrome. Am J Obstet Gynecol 1980; 138:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/21\">",
"      Paavonen J, Saikku P, von Knorring J, et al. Association of infection with Chlamydia trachomatis with Fitz-Hugh-Curtis syndrome. J Infect Dis 1981; 144:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/22\">",
"      Piton S, Marie E, Parmentier JL. [Chlamydia trachomatis perihepatitis (Fitz Hugh-Curtis syndrome). Apropos of 20 cases]. J Gynecol Obstet Biol Reprod (Paris) 1990; 19:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/23\">",
"      McCormack WM. Pelvic inflammatory disease. N Engl J Med 1994; 330:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/24\">",
"      Semchyshyn S. Fitz-Hugh and Curtis syndrome. J Reprod Med 1979; 22:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/25\">",
"      Litt IF, Cohen MI. Perihepatitis associated with salpingitis in adolescents. JAMA 1978; 240:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/26\">",
"      Livengood CH 3rd, Hill GB, Addison WA. Pelvic inflammatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease. Am J Obstet Gynecol 1992; 166:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/27\">",
"      Paavonen J, Teisala K, Heinonen PK, et al. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987; 94:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/28\">",
"      Soper DE, Brockwell NJ, Dalton HP, Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994; 170:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/29\">",
"      Sellors J, Mahony J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol 1991; 164:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/30\">",
"      Korn AP, Hessol N, Padian N, et al. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis 1995; 22:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/31\">",
"      Hadgu A, Westrom L, Brooks CA, et al. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol 1986; 155:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/32\">",
"      Peipert JF, Boardman LA, Sung CJ. Performance of clinical and laparoscopic criteria for the diagnosis of upper genital tract infection. Infect Dis Obstet Gynecol 1997; 5:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/33\">",
"      Peipert JF, Boardman L, Hogan JW, et al. Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 1996; 87:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/34\">",
"      Eschenbach DA, Buchanan TM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975; 293:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/35\">",
"      Kahn JG, Walker CK, Washington AE, et al. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA 1991; 266:2594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/36\">",
"      Moley KH, Massad LS, Mutch DG. Pelvic inflammatory disease. Correlation of severity with CA-125 levels. J Reprod Med 1996; 41:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/37\">",
"      Bulas DI, Ahlstrom PA, Sivit CJ, et al. Pelvic inflammatory disease in the adolescent: comparison of transabdominal and transvaginal sonographic evaluation. Radiology 1992; 183:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/38\">",
"      Cacciatore B, Leminen A, Ingman-Friberg S, et al. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992; 80:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/39\">",
"      Boardman LA, Peipert JF, Brody JM, et al. Endovaginal sonography for the diagnosis of upper genital tract infection. Obstet Gynecol 1997; 90:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1032/abstract/40\">",
"      Golden N, Cohen H, Gennari G, Neuhoff S. The use of pelvic ultrasonography in the evaluation of adolescents with pelvic inflammatory disease. Am J Dis Child 1987; 141:1235.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7581 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-99C72D4C66-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1032=[""].join("\n");
var outline_f1_0_1032=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H155838\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Subclinical PID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Perihepatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSTIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Plasma cell endometritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Diagnostic criteria and guidelines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Imaging techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H155838\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/7581\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/7581|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/33/4636\" title=\"table 1\">",
"      Differential diagnosis of PID",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38452?source=related_link\">",
"      Abdominal actinomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24601?source=related_link\">",
"      Approach to the patient with an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=related_link\">",
"      Differential diagnosis of the adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36823?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11992?source=related_link\">",
"      Pathogenesis of and risk factors for pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/14/24802?source=related_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/14/26850?source=related_link\">",
"      Patient information: Pelvic inflammatory disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=related_link\">",
"      Treatment of pelvic inflammatory disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_0_1033="Approach to upper gastrointestinal bleeding in children";
var content_f1_0_1033=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to upper gastrointestinal bleeding in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1033/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1033/contributors\">",
"     Xavier Villa, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1033/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1033/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1033/contributors\">",
"     Stephen J Teach, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1033/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1033/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/0/1033/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper gastrointestinal (UGI) bleeding (arising proximal to the ligament of Treitz in the distal duodenum) commonly presents with hematemesis (vomiting of blood or coffee ground-like material)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    melena (black, tarry stools). In comparison, hematochezia (bright red or maroon-colored blood or fresh clots per rectum) is usually a sign of a lower gastrointestinal (LGI) source (defined as distal to the ligament of Treitz).",
"   </p>",
"   <p>",
"    The initial approach to a child with suspected UGI bleeding is discussed in this topic review. The approach to lower GI bleeding in children, or to UGI bleeding in adults, is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29513?source=see_link\">",
"     \"Diagnostic approach to lower gastrointestinal bleeding in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28538?source=see_link\">",
"     \"Approach to acute upper gastrointestinal bleeding in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of UGI bleeding is not well established in children. An UGI source represents as much as 20 percent of all episodes of gastrointestinal bleeding in children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most detailed studies have been in the critical care setting [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. In one of the largest prospective studies, UGI bleeding (defined as hematemesis or any amount of blood from the nasogastric tube) was observed in 63 of 984 (6.4 percent) pediatric ICU admissions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/3\">",
"     3",
"    </a>",
"    ]. Independent risk factors for bleeding included a high Pediatric Risk Mortality score, coagulopathy, pneumonia, and multiple trauma. Higher rates of bleeding (up to 25 percent) were observed in two other series of critically ill pediatric patients who were not receiving prophylactic therapy to prevent UGI bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of UGI bleeding in children vary depending upon age and the geographic setting. In Western countries, the most common causes are gastric and duodenal ulcers, esophagitis, gastritis, and varices, whereas in India and some other parts of the world, variceal bleeding predominates [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. These observations may reflect regional differences in indications for endoscopy, in addition to differences in predisposing conditions. Conditions associated with structural abnormalities of blood vessels (such as hereditary hemorrhagic telangiectasia and Ehlers-Danlos syndrome) and congenital or acquired coagulopathies can produce bleeding at any time of life [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;UGI bleeding is rare in the first month of life, but may occur for a variety of reasons (",
"    <a class=\"graphic graphic_table graphicRef68243 \" href=\"UTD.htm?35/59/36796\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/11-26\">",
"     11-26",
"    </a>",
"    ]: &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      True UGI bleeding in a neonate must be distinguished from swallowed maternal blood. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Vitamin K deficient bleeding (hemorrhagic disease of the newborn) should be considered in neonates who were not given vitamin K prophylaxis at birth. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/37/15960?source=see_link&amp;anchor=H13#H13\">",
"       \"Overview of vitamin K\", section on 'Vitamin K deficient bleeding in the newborn'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Stress gastritis or ulcers are associated with critical illness.",
"     </li>",
"     <li>",
"      Congenital anomalies including intestinal duplications or vascular anomalies may present with gastrointestinal hemorrhage.",
"     </li>",
"     <li>",
"      Coagulopathy in a neonate may also be caused by infection, liver failure, or a congenital coagulation factor deficiency.",
"     </li>",
"     <li>",
"      Milk protein intolerance may present with UGI bleeding, although LGI bleeding is much more common. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"       \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Infants and toddlers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of causes of UGI bleeding in infants and toddlers is similar to that described for neonates (",
"    <a class=\"graphic graphic_table graphicRef68243 \" href=\"UTD.htm?35/59/36796\">",
"     table 1",
"    </a>",
"    ). In addition, infants and toddlers are susceptible to ingestion of a foreign body. The history often suggests a likely cause of the bleeding:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children who have been vomiting may develop a Mallory-Weiss tear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43317?source=see_link\">",
"       \"Mallory-Weiss syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ulcers and gastritis are more likely in the setting of critical illness or use of nonsteroidal anti-inflammatory drugs (NSAIDs), and are often associated with recurrent emesis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=see_link&amp;anchor=H11#H11\">",
"       \"Causes of acute abdominal pain in children and adolescents\", section on 'Peptic ulcer disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Esophagitis is more likely in children with gastroesophageal reflux disease, recurrent emesis, or caustic ingestion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41625?source=see_link\">",
"       \"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4473?source=see_link\">",
"       \"Caustic esophageal injury in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Variceal bleeding is more likely in children with portal hypertension (eg, from portal vein thrombosis or cirrhosis).",
"     </li>",
"     <li>",
"      An esophageal or gastrointestinal foreign body is suggested by a history of a choking episode, even if it was transient or occurred days or even weeks before the bleeding episode. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=see_link\">",
"       \"Foreign bodies of the esophagus and gastrointestinal tract in children\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unusual causes of UGI bleeding have been described in case reports, including hemangiomas, Dieulafoy's lesions (a lesion of an end arteriole), aortoesophageal fistulas, hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), Kasabach-Merritt syndrome, duplication cysts, parasites, vasculitis, gastric polyps, and systemic mastocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/11,27-38\">",
"     11,27-38",
"    </a>",
"    ]. Helicobacter pylori also has been reported as a cause of GI bleeding in children with hemophilia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Older children and adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of UGI bleeding in older children and adolescents are similar to those seen in adults. The most common considerations are Mallory-Weiss tears, peptic ulcers, gastritis, varices, and pill esophagitis, although miscellaneous other lesions have been described (",
"    <a class=\"graphic graphic_table graphicRef68243 \" href=\"UTD.htm?35/59/36796\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71768 \" href=\"UTD.htm?38/23/39293\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/11,33,40-48\">",
"     11,33,40-48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12664?source=see_link\">",
"     \"Major causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As in toddlers, a history of vomiting followed by low-grade hematemesis (eg, blood streaks in the vomitus) is characteristic of a Mallory-Weiss tear, esophagitis, or gastritis.",
"   </p>",
"   <p>",
"    Severe acute UGI bleeding is more likely to be caused by a vascular bleed, either arterial or venous. Variceal rupture is the most common cause of severe UGI bleeding in children; this may be the presenting symptom of a disorder that causes portal hypertension, such as cirrhosis. Cirrhosis should be suspected in any patient with UGI bleeding and a history of chronic biliary disease, such as biliary atresia, cystic fibrosis, or parenteral nutrition-induced liver disease. Less frequently, portal hypertension may be caused by portal vein thrombosis or hepatic vein obstruction (Budd-Chiari syndrome). Splenomegaly",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thrombocytopenia support the possibility of portal hypertension, even in a patient without a history of liver disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39929?source=see_link\">",
"     \"Biliary atresia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H23#H23\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Hepatobiliary disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3434?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome\"",
"    </a>",
"    .) Arterial bleeds are frequently associated with an overlying ulcer, or even a Dieulafoy lesion. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vomited blood may originate from structures or organs other than the gastrointestinal tract. As an example, neonates and infants may swallow maternal blood during delivery or while nursing [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/49\">",
"     49",
"    </a>",
"    ]. One method with which to distinguish maternal blood is the Apt-Downey test. Fetal hemoglobin is resistant to denaturation in an alkaline solution and remains red or pink, while adult hemoglobin discolors to a brownish-yellow. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=see_link\">",
"     \"Fetal blood sampling\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=see_link&amp;anchor=H17#H17\">",
"     \"Fetal blood sampling\", section on 'Confirmation of fetal blood'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Red food colorings and dyes (eg, soda or liquid medications) also may be confused with blood, particularly after vomiting. While this can frequently be suspected from this history, bedside tests for occult blood also can be helpful. These tests rely on color changes to detect the presence of hemoglobin. However, some of the commercial tests (such as Hemoccult&reg;) may produce false-negative results in the presence of acid. Gastroccult&reg; kits, which incorporate additional alkali to neutralize the gastric acid present in emesis, are preferred [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Swallowed blood from the patient's nasopharynx or respiratory tract may be very difficult to distinguish from UGI bleeding. Physical examination should include inspection of the nares for evidence of venous injury of the anterior medial septum. Some patients may require endoscopic evaluation to adequately assess for lesions in the nasopharynx, larynx, or respiratory tract. Munchausen syndrome by proxy also should be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18086?source=see_link\">",
"     \"Evaluation of epistaxis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36104?source=see_link\">",
"     \"Munchausen syndrome by proxy (medical child abuse)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of the patient with UGI bleeding should always start with an assessment of hemodynamic stability and resuscitation if indicated. Diagnostic studies (usually endoscopy) follow, with the goal of diagnosing the cause of the bleed; in some cases the source of the bleeding can be treated through the endoscopic procedure. Both a gastroenterologist and a surgeon should be notified promptly of all patients with severe acute UGI bleeding. Endoscopic evaluation and treatment should generally be performed within 24 to 48 hours of presentation of the GI bleed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13582162\">",
"    <span class=\"h2\">",
"     Initial assessment and resuscitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vital signs, including the heart rate, blood pressure, presence of orthostatic changes, and capillary refill, are used to assess and monitor the hemodynamic state of the patient. Rapid assessment and early resuscitation are particularly important in children.",
"   </p>",
"   <p>",
"    The principles involved in resuscitation of children with hemorrhagic shock including UGI bleeding are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=see_link&amp;anchor=H13#H13\">",
"     \"Hypovolemic shock in children: Initial evaluation and management\", section on 'Fluid resuscitation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Obtaining intravenous access can be difficult, especially in severely volume-depleted patients. Intraosseous fluids or central venous access may be required in this setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=see_link\">",
"     \"Intraosseous infusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical history should include information concerning the time course of the bleeding episode, estimated blood loss, and any associated symptoms. Particular attention should be given to gastrointestinal symptoms including dyspepsia, heartburn, abdominal pain, dysphagia, and weight loss. In infants, these features may be reflected in poor feeding and irritability. &nbsp;",
"   </p>",
"   <p>",
"    UGI bleeding tends to be associated with melena (dark red or black and sticky), while LGI bleeding tends to be associated with hematochezia (bright red in color). However, these distinctions in stool color are not absolute, because melena can be seen with proximal LGI bleeding, and hematochezia can be seen with massive UGI bleeding. Because of short intestinal transit time, neonates and infants with UGI bleeding are more likely than adults to present with hematochezia. &nbsp;",
"   </p>",
"   <p>",
"    The history should also include information about the following symptoms or signs which may provide clues to an underlying disorder:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recent onset of jaundice, easy bruising or change in stool color, which may suggest underlying liver disease",
"     </li>",
"     <li>",
"      Recent or recurrent epistaxis, to investigate the possibility of a nasopharyngeal source of bleeding",
"     </li>",
"     <li>",
"      History of easy bruising or bleeding, which suggests a disorder of coagulation, platelet dysfunction, or thrombocytopenia",
"     </li>",
"     <li>",
"      Personal or family history or liver, kidney or heart disease, or coagulation disorders &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A drug history is important to assess potential contributions from medications that may induce ulceration (such as NSAIDs and corticosteroids); even short-term use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    can cause gastric ulcers and hematemesis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/52\">",
"     52",
"    </a>",
"    ]. Tetracyclines, which are commonly used to treat acne, may cause a pill esophagitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37078?source=see_link\">",
"     \"Medication-induced esophagitis\"",
"    </a>",
"    .) Some medications, such as NSAIDs, can also affect coagulation, and cause worse and prolonged bleeding from any lesion.",
"   </p>",
"   <p>",
"    In addition, it is important to know if the patient has been taking drugs or has a cardiac condition that affects homeostatic responses (such as beta-adrenergic antagonists), because these may mask tachycardia associated with life-threatening hypovolemia and shock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13582270\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include the following elements, which suggest possible sources for the bleeding:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Examination of the skin for cutaneous signs of generalized vascular",
"      <span class=\"nowrap\">",
"       malformations/disorders.",
"      </span>",
"      Visceral involvement may be more likely if the infant has five or more cutaneous hemangiomas. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) is characterized by mucocutaneous telangiectasia (",
"      <a class=\"graphic graphic_picture graphicRef52483 \" href=\"UTD.htm?36/32/37376\">",
"       picture 1",
"      </a>",
"      ) and commonly presents with recurrent epistaxis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      gastrointestinal bleeding. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44665?source=see_link\">",
"       \"Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link\">",
"       \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evidence of portal hypertension, such as the presence of splenomegaly or prominent abdominal and hemorrhoidal vessels and a protruding abdomen. Portal hypertension often leads to esophageal varices which may hemorrhage. &nbsp;",
"     </li>",
"     <li>",
"      Inspection of the nasopharynx for evidence of disrupted mucosa or inflamed tonsils suggesting swallowed blood, and inspection of the anterior nares for evidence of venous injury of the anterior medial septum. If present, these findings suggest the possibility of a nasopharyngeal rather than UGI bleed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18086?source=see_link\">",
"       \"Evaluation of epistaxis in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13582277\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending on the clinical scenario and magnitude of the blood loss, the laboratory assessment should include a complete blood count, coagulation studies, test evaluating liver function, blood urea nitrogen, and serum creatinine. For patients with clinically significant bleeding or known varices, a specimen should be drawn to type and cross-match blood in case transfusion is required. Less extensive laboratory evaluation may be appropriate for patients with small amounts of blood in the vomitus and a likely explanation. &nbsp;",
"   </p>",
"   <p>",
"    Assessment of blood urea nitrogen can be helpful for confirming the source of bleeding. An increase in blood urea nitrogen in the absence of renal disease is consistent with an UGI (rather than a LGI) source of blood loss, because blood in the proximal GI tract has relatively more time to be absorbed, leading to an increase in the blood urea nitrogen. However, a normal or low BUN does not rule out an upper GI bleed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Nasogastric tube",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients presenting with unexplained gastrointestinal bleeding that is clinically significant (eg, more than a teaspoon estimated blood loss), nasogastric or orogastric tube lavage is sometimes used to confirm the diagnosis and determine if the bleeding is ongoing. This approach is particularly helpful if the bleeding is suspected to be a vascular bleed (eg, variceal). The lavage will also remove particulate matter, fresh blood, and clots to facilitate endoscopy and decrease the risk of aspiration. Ice water lavage (an older practice) does not slow bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/53\">",
"     53",
"    </a>",
"    ] and may induce iatrogenic hypothermia, particularly in infants and small children, and is",
"    <strong>",
"     not",
"    </strong>",
"    recommended.",
"   </p>",
"   <p>",
"    If the lavage returns fresh blood or blood with the appearance of coffee grounds, this helps to confirm an UGI (or nasopharyngeal) source of bleeding. However, lavage may not be positive if the bleeding has ceased or arises beyond a closed pylorus. The presence of bilious fluid suggests that the pylorus is open and, if lavage is negative, that there is no active UGI bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13582296\">",
"    <span class=\"h2\">",
"     Pharmacologic options",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Acid suppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acid suppression is recommended in children with UGI bleeding, although studies to establish a benefit in this age group have not been performed.",
"   </p>",
"   <p>",
"    The studies in adults have examined the effect of acid suppression given before or after endoscopy (with or without therapeutic intervention). In the setting of active UGI bleeding due to peptic ulcers, high-dose anti-secretory therapy with an intravenous infusion of proton pump inhibitor (PPI) significantly reduced the rate of rebleeding compared with standard treatment in patients with bleeding ulcers. Oral and intravenous PPI therapy also decreases the hospital stay, rebleeding rate, and the need for blood transfusion in adult patients with high-risk ulcers treated with endoscopic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28538?source=see_link&amp;anchor=H5079756#H5079756\">",
"     \"Approach to acute upper gastrointestinal bleeding in adults\", section on 'Acid suppression'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Somatostatin and octreotide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Somatostatin or its analog,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    , reduces portal venous inflow and intravariceal pressure; these medications reduce the risk of rebleeding in adult patients with variceal hemorrhage. In addition, these medications may reduce the risk of bleeding due to nonvariceal causes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    may help in reducing or temporizing GI bleeding in selected cases of variceal bleeding that is difficult to control, as adjunctive therapy to help control bleeding before endoscopy, or when endoscopy is unsuccessful, contraindicated, or unavailable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Guidelines for the use of octreotide in the pediatric age group have not been developed, but octreotide is commonly administered as an initial bolus of 1",
"    <span class=\"nowrap\">",
"     microgram/kg",
"    </span>",
"    body weight (maximum 100 micrograms), followed by 1",
"    <span class=\"nowrap\">",
"     microgram/kg/hour",
"    </span>",
"    as a continuous IV infusion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/11\">",
"     11",
"    </a>",
"    ]. The optimal duration of therapy is unclear. Discovering and treating the cause of the GI bleed should remain the principle goal. &nbsp;",
"   </p>",
"   <p>",
"    Experience with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    in children is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/55\">",
"     55",
"    </a>",
"    ]. In selected cases of variceal bleeding that is difficult to control, as adjunctive therapy to help control bleeding before endoscopy, or when endoscopy is unsuccessful, contraindicated, or unavailable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24826?source=see_link\">",
"     \"Overview of the treatment of bleeding peptic ulcers\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"     \"Treatment of active variceal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     ENDOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper endoscopy is the diagnostic modality of choice for UGI bleeding. It permits identification of the bleeding source, allows for risk stratification regarding the likelihood of continued bleeding, and permits therapeutic intervention. Multiple reports have attested to the safety of upper endoscopy in children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/8,9,57-59\">",
"     8,9,57-59",
"    </a>",
"    ]. Elective endotracheal intubation in patients with ongoing hematemesis or altered respiratory or mental status may facilitate endoscopy and decrease the risk of aspiration. &nbsp;",
"   </p>",
"   <p>",
"    We suggest that endoscopy be performed within 24 to 48 hours for infants and children presenting with UGI bleeding that is acute and severe, particularly if transfusions are required and in children with low-grade bleeding that is unexplained and persistent or recurrent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/11\">",
"     11",
"    </a>",
"    ]. Hemodynamically unstable patients should be stabilized prior to endoscopy, including transfusion and correction of coagulopathy if present. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    The techniques involved in performing an endoscopy and therapeutic intervention are similar in children and adults (see appropriate topic reviews). However, there are several considerations pertinent to children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children often require deep sedation or general anesthesia for upper endoscopy. In some series, use of general anesthesia, administered by a dedicated anesthesiologist, was associated with a lower rate of complications than use of deep sedation [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/60,61\">",
"       60,61",
"      </a>",
"      ]. Children undergoing endoscopy for a GI bleed should be carefully monitored during the procedure; sedation in these cases should be guided by a clinician experienced in anesthesiology or intensive care. &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Smaller caliber endoscopes limit the size of catheters that can be passed through the working channel.",
"     </li>",
"     <li>",
"      Band ligation of esophageal varices is often possible, but use of this technique in small children is limited by the small diameter of the esophagus [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/62-65\">",
"       62-65",
"      </a>",
"      ]. In small children, an overtube should probably not be used [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1033/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35689?source=see_link\">",
"       \"Endoscopic variceal ligation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Endoscopy is generally successful in treating active bleeding. Surgery or angiography is reserved for the uncommon patients in whom endoscopy fails to control bleeding or in whom an anatomic abnormality exists that requires surgery, and if the patient cannot be fully stabilized despite resuscitative measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     OTHER DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other imaging tests can be helpful in specific clinical settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain radiographs may be helpful to identify a foreign body if this is suspected by the clinical history; abdominal radiographs may identify bowel obstruction or perforation.",
"     </li>",
"     <li>",
"      Abdominal ultrasound can be used to confirm splenomegaly and portal hypertension.",
"     </li>",
"     <li>",
"      UGI",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      studies should NOT be performed in the setting of UGI bleeding, because the contrast will interfere with subsequent endoscopy, angiography, or surgery.",
"     </li>",
"     <li>",
"      In patients with rapid bleeding in whom endoscopy is unsuccessful, angiography may be used to identify the source. Angiography also permits therapeutic intervention for some patients with vascular anomalies, hemobilia, or some ulcers that are not amenable to other types of treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/2/24616?source=see_link\">",
"       \"Angiographic control of nonvariceal gastrointestinal bleeding in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radionucleotide imaging (a tagged red blood cell scan) also can be used to detect an obscure bleeding source for patients with very brisk bleeding. However, this is rarely helpful in patients with UGI bleeding because endoscopy is far more sensitive for detecting bleeding above the ligament of Treitz. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11336?source=see_link\">",
"       \"Evaluation of occult gastrointestinal bleeding\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Upper gastrointestinal (UGI) bleeding can present with hematemesis (vomiting of blood or coffee ground-like material)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      melena (black, tarry stools). The appearance of the stool is not a reliable indicator of the source of the bleeding. Although melena suggests UGI bleeding, it may also occur in patients with a proximal LGI source. Conversely, patients with brisk UGI bleeding and rapid intestinal transit time may present with hematochezia, particularly if they are infants or toddlers. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Swallowed blood from the nasopharynx may also present with hematemesis or melena, and may be difficult to distinguish from UGI bleeding. The clinician should evaluate this possibility by inquiring about a history of recent epistaxis and inspecting the nose and oropharynx carefully. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13582270\">",
"       'Physical examination'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      The most common causes of UGI bleeding in children vary depending upon age and the geographic setting. In Western countries, the most common causes are Mallory-Weiss tears, gastric and duodenal ulcers, esophagitis, gastritis, and varices (",
"      <a class=\"graphic graphic_table graphicRef68243 \" href=\"UTD.htm?35/59/36796\">",
"       table 1",
"      </a>",
"      ). Very rapid UGI bleeding is characteristic of variceal hemorrhage and may be the presenting symptom of portal hypertension. Foreign body ingestion should be considered in a patient with a history of a choking episode, even if transient. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial evaluation of the patient with UGI bleeding involves an assessment of hemodynamic stability and resuscitation if necessary. (See",
"      <a class=\"local\" href=\"#H13582162\">",
"       'Initial assessment and resuscitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nasogastric or orogastric lavage may be performed in patients with clinically significant UGI bleeding to confirm the diagnosis and to remove fresh blood or particulate matter to facilitate endoscopy. Lavage using ice water is NOT recommended, and frequent lavage can lead to electrolyte imbalances. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Nasogastric tube'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Upper endoscopy should be performed in patients with acute severe hemorrhage, or low-grade persistent or recurrent hemorrhage. Endoscopy usually permits identification of the bleeding source, allows for risk stratification regarding the likelihood of continued bleeding, and in some cases permits therapeutic intervention. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Endoscopy'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/1\">",
"      Rodgers BM. Upper gastrointestinal hemorrhage. Pediatr Rev 1999; 20:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/2\">",
"      Cochran EB, Phelps SJ, Tolley EA, Stidham GL. Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med 1992; 20:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/3\">",
"      Lacroix J, Nadeau D, Laberge S, et al. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med 1992; 20:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/4\">",
"      L&oacute;pez-Herce J, Dorao P, Elola P, et al. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. The Gastrointestinal Hemorrhage Study Group. Crit Care Med 1992; 20:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/5\">",
"      Cox K, Ament ME. Upper gastrointestinal bleeding in children and adolescents. Pediatrics 1979; 63:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/6\">",
"      Yachha SK, Khanduri A, Sharma BC, Kumar M. Gastrointestinal bleeding in children. J Gastroenterol Hepatol 1996; 11:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/7\">",
"      Mittal SK, Kalra KK, Aggarwal V. Diagnostic upper GI endoscopy for hemetemesis in children: experience from a pediatric gastroenterology centre in north India. Indian J Pediatr 1994; 61:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/8\">",
"      Kato S, Nakagawa H, Harada Y, et al. A clinical study of upper gastrointestinal endoscopy in Japanese children. Acta Paediatr Jpn 1991; 33:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/9\">",
"      Zahavi I, Arnon R, Ovadia B, et al. Upper gastrointestinal endoscopy in the pediatric patient. Isr J Med Sci 1994; 30:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/10\">",
"      Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg 1998; 33:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/11\">",
"      Fox VL. Gastrointestinal bleeding in infancy and childhood. Gastroenterol Clin North Am 2000; 29:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/12\">",
"      Borowitz SM. Ulcerative esophagitis. A rare source of upper gastrointestinal bleeding in a neonate. Use of fiberoptic endoscopy for diagnosis. Clin Pediatr (Phila) 1989; 28:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/13\">",
"      O'Neil EA, Chwals WJ, O'Shea MD, Turner CS. Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child 1992; 67:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/14\">",
"      Wilcox DT, Jacobson A, Bruce J. Haemorrhage from a duodenal ulcer in a neonate. Pediatr Surg Int 1997; 12:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/15\">",
"      Goyal A, Treem WR, Hyams JS. Severe upper gastrointestinal bleeding in healthy full-term neonates. Am J Gastroenterol 1994; 89:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/16\">",
"      Madan A, Lavine JE, Heyman MB, Townsend SF. Acute hemorrhagic gastritis in the newborn infant. J Perinatol 1992; 12:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/17\">",
"      Telsey AM, Merrit TA, Dixon SD. Cocaine exposure in a term neonate. Necrotizing enterocolitis as a complication. Clin Pediatr (Phila) 1988; 27:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/18\">",
"      Dillard RG. Fatal gastrointestinal hemorrhage in a neonate treated with tolazoline. Clin Pediatr (Phila) 1982; 21:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/19\">",
"      Ng PC, So KW, Fok TF, et al. Fatal haemorrhagic gastritis associated with oral sulindac treatment for patent ductus arteriosus. Acta Paediatr 1996; 85:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/20\">",
"      Peiper M, Lambrecht W, Kluth D, H&uuml;neke B. Bleeding esophageal duplication detected in utero. Ann Thorac Surg 1995; 60:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/21\">",
"      Bedu A, Faure C, Sibony O, et al. Prenatal gastrointestinal bleeding caused by esophagitis and gastritis. J Pediatr 1994; 125:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/22\">",
"      Cairo MS, Grosfeld JL, Weetman RM. Gastric teratoma: unusual cause for bleeding of the upper gastrointestinal tract in the newborn. Pediatrics 1981; 67:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/23\">",
"      Ganopadhyay AN, Pandit SK, Gopal CS. Gastric teratoma revealed by gastrointestinal hemorrhage. Indian Pediatr 1992; 29:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/24\">",
"      Haley T, Dimler M, Hollier P. Gastric teratoma with gastrointestinal bleeding. J Pediatr Surg 1986; 21:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/25\">",
"      Nagaya M, Kato J, Niimi N, et al. Isolated cavernous hemangioma of the stomach in a neonate. J Pediatr Surg 1998; 33:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/26\">",
"      Stillman AE, Hansen RC, Hallinan V, Strobel C. Diffuse neonatal hemangiomatosis with severe gastrointestinal involvement. Favorable response to steroid therapy. Clin Pediatr (Phila) 1983; 22:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/27\">",
"      Grosfeld JL, Eng K. Right iliac artery-duodenal fistula in infancy: massive hemorrhage due to \"whisk-broom\" bristle perforation. Ann Surg 1972; 176:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/28\">",
"      Spitz L, Batcup G. Haematemesis in infantile hypertrophic pyloric stenosis: the source of the bleeding. Br J Surg 1979; 66:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/29\">",
"      Takeuchi S, Tamate S, Nakahira M, Kadowaki H. Esophagitis in infants with hypertrophic pyloric stenosis: a source of hematemesis. J Pediatr Surg 1993; 28:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/30\">",
"      Murty TV, Bhargava RK, Rakas FS. Gastroduodenal duplication. J Pediatr Surg 1992; 27:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/31\">",
"      Nagpal R, Schnaufer L, Altschuler SM. Duodenal web presenting with gastrointestinal bleeding in a seven-month-old infant. J Pediatr Gastroenterol Nutr 1993; 16:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/32\">",
"      Beluffi G, Luraschi D, De Giacomo C, et al. Antral web--a rare cause of vomiting and haematemesis in childhood. Australas Radiol 1985; 29:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/33\">",
"      Stephen TC, Bendon RW, Nagaraj HS, Sachdeva R. Antral duplication cyst: a cause of hypergastrinemia, recurrent peptic ulceration, and hemorrhage. J Pediatr Gastroenterol Nutr 1998; 26:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/34\">",
"      Adeyemi SD, Ein SH, Simpson JS. Perforated stress ulcer in infants: a silent threat. Ann Surg 1979; 190:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/35\">",
"      Glasow PF, Murphy DJ Jr, Bloss RS, et al. Massive upper gastrointestinal hemorrhage in an infant following cardiac surgery. J Pediatr Surg 1987; 22:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/36\">",
"      Bowles LJ, Kostopoulos-Farri E, Papageorgiou AN. Perinatal hemorrhage associated with the Kassabach-Merritt syndrome. Clin Pediatr (Phila) 1981; 20:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/37\">",
"      Mestre JR, Andres JM. Hereditary hemorrhagic telangiectasia causing hematemesis in an infant. J Pediatr 1982; 101:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/38\">",
"      Sigalet DL, Laberge JM, DiLorenzo M, et al. Aortoesophageal fistula: congenital and acquired causes. J Pediatr Surg 1994; 29:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/39\">",
"      Choe BH, Kim JY, Lee JH, et al. Upper gastrointestinal bleeding in children with haemophilia: a clinical significance of Helicobacter pylori infection. Haemophilia 2010; 16:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/40\">",
"      Annunziata GM, Gunasekaran TS, Berman JH, Kraut JR. Cough-induced Mallory-Weiss tear in a child. Clin Pediatr (Phila) 1996; 35:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/41\">",
"      Cannon RA, Lee G, Cox KL. Gastrointestinal hemorrhage due to Mallory-Weiss syndrome in an infant. J Pediatr Gastroenterol Nutr 1985; 4:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/42\">",
"      Kato S, Kobayashi M, Sato H, et al. Doxycycline-induced hemorrhagic esophagitis: a pediatric case. J Pediatr Gastroenterol Nutr 1988; 7:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/43\">",
"      Armstrong KL, Fraser DK, Faoagali JL. Gastrointestinal bleeding with influenza virus. Med J Aust 1991; 154:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/44\">",
"      Murray KF, Jennings RW, Fox VL. Endoscopic band ligation of a Dieulafoy lesion in the small intestine of a child. Gastrointest Endosc 1996; 44:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/45\">",
"      Sarles HE Jr, Schenkein JP, Hecht RM, et al. Dielafoy's ulcer: a rare cause of massive gastric hemorrhage in an 11-year-old girl: case report and literature review. Am J Gastroenterol 1984; 79:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/46\">",
"      Clark JH, Fitzgerald JF. Hemorrhagic complications of Henoch-Sch&ouml;nlein syndrome. J Pediatr Gastroenterol Nutr 1985; 4:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/47\">",
"      Smith TF, Welch TR, Allen JB, Sondheimer JM. Cutaneous mastocytosis with bleeding: probable heparin effect. Cutis 1987; 39:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/48\">",
"      Itani M, Alsaied T, Charafeddine L, Yazbeck N. Dieulafoy's lesion in children. J Pediatr Gastroenterol Nutr 2010; 51:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/49\">",
"      Bulstrode NW, Cuckow PM, Spitz LS. Neonatal gastrointestinal pseudohaemorrhage. J R Coll Surg Edinb 1998; 43:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/50\">",
"      Rosenthal P, Thompson J, Singh M. Detection of occult blood in gastric juice. J Clin Gastroenterol 1984; 6:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/51\">",
"      Mills RW, Burke S. Gastrointestinal bleeding in a 15 month old male. A presentation of Munchausen's syndrome by proxy. Clin Pediatr (Phila) 1990; 29:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/52\">",
"      Berezin SH, Bostwick HE, Halata MS, et al. Gastrointestinal bleeding in children following ingestion of low-dose ibuprofen. J Pediatr Gastroenterol Nutr 2007; 44:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/53\">",
"      Gilbert DA, Saunders DR. Iced saline lavage does not slow bleeding from experimental canine gastric ulcers. Dig Dis Sci 1981; 26:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/54\">",
"      Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Ann Intern Med 1997; 127:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/55\">",
"      Lam JC, Aters S, Tobias JD. Initial experience with octreotide in the pediatric population. Am J Ther 2001; 8:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/56\">",
"      Eroglu Y, Emerick KM, Whitingon PF, Alonso EM. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2004; 38:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/57\">",
"      Goenka AS, Dasilva MS, Cleghorn GJ, et al. Therapeutic upper gastrointestinal endoscopy in children: an audit of 443 procedures and literature review. J Gastroenterol Hepatol 1993; 8:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/58\">",
"      Balsells F, Wyllie R, Kay M, Steffen R. Use of conscious sedation for lower and upper gastrointestinal endoscopic examinations in children, adolescents, and young adults: a twelve-year review. Gastrointest Endosc 1997; 45:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/59\">",
"      Chang MH, Wang TH, Hsu JY, et al. Endoscopic examination of the upper gastrointestinal tract in infancy. Gastrointest Endosc 1983; 29:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/60\">",
"      Thakkar K, El-Serag HB, Mattek N, Gilger MA. Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc 2007; 65:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/61\">",
"      Mahoney LB, Lightdale JR. Sedation of the pediatric and adolescent patient for GI procedures. Curr Treat Options Gastroenterol 2007; 10:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/62\">",
"      Cano I, Urruzuno P, Medina E, et al. Treatment of esophageal varices by endoscopic ligation in children. Eur J Pediatr Surg 1995; 5:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/63\">",
"      Fox VL, Carr-Locke DL, Connors PJ, Leichtner AM. Endoscopic ligation of esophageal varices in children. J Pediatr Gastroenterol Nutr 1995; 20:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/64\">",
"      Price MR, Sartorelli KH, Karrer FM, et al. Management of esophageal varices in children by endoscopic variceal ligation. J Pediatr Surg 1996; 31:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1033/abstract/65\">",
"      Sasaki T, Hasegawa T, Nakajima K, et al. Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia. J Pediatr Surg 1998; 33:1628.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5857 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-F6FDDAB425-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1033=[""].join("\n");
var outline_f1_0_1033=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Neonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Infants and toddlers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Older children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13582162\">",
"      Initial assessment and resuscitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13582270\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13582277\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Nasogastric tube",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13582296\">",
"      Pharmacologic options",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Acid suppression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Somatostatin and octreotide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ENDOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      OTHER DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5857\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5857|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/32/37376\" title=\"picture 1\">",
"      Osler Weber Rendu",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5857|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/59/36796\" title=\"table 1\">",
"      Causes of UGI bleeding in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/23/39293\" title=\"table 2\">",
"      Etiology acute UGI bleeding in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/2/24616?source=related_link\">",
"      Angiographic control of nonvariceal gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28538?source=related_link\">",
"      Approach to acute upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39929?source=related_link\">",
"      Biliary atresia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/20/11593?source=related_link\">",
"      Causes of acute abdominal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/23/4473?source=related_link\">",
"      Caustic esophageal injury in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/41/41625?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3434?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of the Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=related_link\">",
"      Cystic fibrosis: Overview of gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/52/29513?source=related_link\">",
"      Diagnostic approach to lower gastrointestinal bleeding in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35689?source=related_link\">",
"      Endoscopic variceal ligation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44665?source=related_link\">",
"      Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18086?source=related_link\">",
"      Evaluation of epistaxis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11336?source=related_link\">",
"      Evaluation of occult gastrointestinal bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=related_link\">",
"      Fetal blood sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=related_link\">",
"      Foreign bodies of the esophagus and gastrointestinal tract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=related_link\">",
"      Hypovolemic shock in children: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=related_link\">",
"      Intraosseous infusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12664?source=related_link\">",
"      Major causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43317?source=related_link\">",
"      Mallory-Weiss syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/13/37078?source=related_link\">",
"      Medication-induced esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36104?source=related_link\">",
"      Munchausen syndrome by proxy (medical child abuse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/15/24826?source=related_link\">",
"      Overview of the treatment of bleeding peptic ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/37/15960?source=related_link\">",
"      Overview of vitamin K",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=related_link\">",
"      Treatment of active variceal hemorrhage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_0_1034="Pendular nystagmus";
var content_f1_0_1034=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pendular nystagmus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1034/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1034/contributors\">",
"     Jason JS Barton, MD, PhD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1034/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1034/contributors\">",
"     Paul W Brazis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/0/1034/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/0/1034/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/0/1034/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pendular nystagmus is a sinusoidal oscillation. The waveform of pendular nystagmus may occur in any direction; it can be torsional, horizontal, vertical, or a combination of these, resulting in circular, oblique, or elliptical trajectories. It may be different in the two eyes, sometimes even monocular. Diagnosis is an exercise in pattern recognition since pendular nystagmus is subdivided into a number of types, some characterized by specific trajectories:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acquired pendular nystagmus",
"     </li>",
"     <li>",
"      Pendular nystagmus from visual loss",
"     </li>",
"     <li>",
"      Specific variants: spasmus nutans; oculopalatal myoclonus; see-saw nystagmus; oculomasticatory myorhythmia (Whipple's)",
"     </li>",
"     <li>",
"      Congenital nystagmus",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACQUIRED PENDULAR NYSTAGMUS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5901046\">",
"    <span class=\"h2\">",
"     Causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with acquired pendular nystagmus have multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]; the incidence of pendular nystagmus in this population is about 2 to 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Less commonly it follows strokes, encephalitis, or vascular malformations in the brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. Rare causes include chronic toluene encephalopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/6\">",
"     6",
"    </a>",
"    ], Pelizaeus-Merzbacher leukodystrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/7\">",
"     7",
"    </a>",
"    ], unusual familial syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/8\">",
"     8",
"    </a>",
"    ], and orbital myositis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/9\">",
"     9",
"    </a>",
"    ]. One unique case with monocular nystagmus had a chiasmal glioma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/10\">",
"     10",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of acquired pendular nystagmus is unclear. It is associated with cerebellar signs, so it may be a \"cerebellar tremor\" [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/3\">",
"     3",
"    </a>",
"    ]. The association with internuclear ophthalmoplegia suggests a brainstem site [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1\">",
"     1",
"    </a>",
"    ]; dysfunction of the vergence system is a possibility in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pendular nystagmus can be asymmetric or even monocular. How this arises is an interesting problem. It may reflect asymmetric brainstem disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1\">",
"     1",
"    </a>",
"    ]; however, asymmetries in nystagmus do not correlate with asymmetries in other brainstem signs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/4,12\">",
"     4,12",
"    </a>",
"    ]. It may be related to optic nerve function since larger oscillations correlate with greater optic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/4\">",
"     4",
"    </a>",
"    ]. Taking all this together, pendular nystagmus is most likely caused by abnormal brainstem feedback circuits for eye position [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/13\">",
"     13",
"    </a>",
"    ], which are calibrated by visual factors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Imaging points to lesions in the pontine tegmentum [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/4,12\">",
"     4,12",
"    </a>",
"    ]. A requirement for multiple lesions in visual and cerebellar systems may explain why it tends to be a less common, late, and unremitting sign in multiple sclerosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients complain of constant oscillopsia that interferes with tasks such as reading, although patients with poor vision may not notice oscillopsia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Poor vision is due partly to blurring from constant eye motion, but many patients with multiple sclerosis also have optic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acquired pendular nystagmus is usually present in primary position and seldom varies with gaze direction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/16\">",
"     16",
"    </a>",
"    ], with exceptions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/17\">",
"     17",
"    </a>",
"    ]. The nystagmus often differs in size and direction between the two eyes, and can even be monocular [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/3,4,16,18,19\">",
"     3,4,16,18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients also have jerk nystagmus, including gaze-evoked, rebound, and upbeat nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/4\">",
"     4",
"    </a>",
"    ]. Most have cerebellar dysfunction of gait, limb coordination, or speech, and tremor or head titubation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Some have internuclear ophthalmoplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20246?source=see_link\">",
"     \"Internuclear ophthalmoplegia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A video example of acquired pendular nystagmus in the setting of multiple sclerosis is available at:",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case19/case19.html\">",
"     file://www.neuroophthalmology.ca/cases/case19/case19.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The direction of nystagmus should be observed to see if it fits a specific variant, such as see-saw nystagmus, oculomasticatory myorhythmia, and spasmus nutans in children. These require different evaluations (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Specific variants'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Otherwise, the investigation of choice is MRI with focus on the cerebellum and brainstem, and sequences designed to detect demyelination. Other investigations for multiple sclerosis can include CSF studies and brainstem, somatosensory, and visual evoked potentials; these are unnecessary if the MRI, history, and examination point strongly to multiple sclerosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prognosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;As previously mentioned, pendular nystagmus is seldom a presenting sign of multiple sclerosis. It tends to develop later in the course and persists indefinitely, resolving in only 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Controlled trials show transient benefit with intravenous anticholinergic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/20\">",
"     20",
"    </a>",
"    ]; oral or transcutaneous forms are not helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     Memantine",
"    </a>",
"    , a glutamate antagonist [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/22\">",
"     22",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    , 300 mg three times daily [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/23\">",
"     23",
"    </a>",
"    ], may be effective. Two small crossover trials have compared gabapentin and memantine in patients with acquired pendular nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Both drugs appeared to have efficacy in regard to measures of reduced median eye speed and amplitude as well as improved visual acuity. There also are anecdotal reports of benefit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/27\">",
"     27",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/28\">",
"     28",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are ongoing investigations of devices that have electronically servo-controlled prisms, much like the gaze stabilization features in modern cameras. These use a sensor that detects eye movements to adjust prisms to shift the image in the direction opposite to the eye oscillation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. Other devices use eye movement sensors to trigger a filter that gates vision, eliminating periods with excessive motion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/32\">",
"     32",
"    </a>",
"    ]. Experiments with surgery and botulinum toxin injections to weaken extraocular muscles have been somewhat disappointing [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/33,34\">",
"     33,34",
"    </a>",
"    ], although some successes have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PENDULAR NYSTAGMUS FROM VISUAL LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monocular pendular nystagmus occurs in children with congenital optic atrophy, strabismic amblyopia, and acquired visual loss, including chiasmal glioma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1,36,37\">",
"     1,36,37",
"    </a>",
"    ]. Bilateral visual impairment in infants with optic nerve hypoplasia or optic atrophy can cause intermittent vertical pendular nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/38\">",
"     38",
"    </a>",
"    ]. Infantile esotropia is not uncommonly associated with a fine torsional pendular nystagmus that may be seen only with fundoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/39\">",
"     39",
"    </a>",
"    ]; it occurs alone or with latent nystagmus.",
"   </p>",
"   <p>",
"    Adults may develop vertical pendular oscillations years after visual loss [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The nystagmus is usually, but not always, small and slow [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. The nystagmus can resolve if the visual loss is correctable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A video example of pendular nystagmus with visual loss in the setting of an optic nerve meningioma is available at:",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case84/case84.html\">",
"     file://www.neuroophthalmology.ca/cases/case84/case84.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SPECIFIC VARIANTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Spasmus nutans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spasmus nutans is a pediatric disorder that consists of the triad of ocular oscillations, head nodding, and head turning (torticollis). All three are not required for the diagnosis; head nodding and nystagmus are most common, with head turn in only 30 percent. The age at onset is usually 6 to 12 months, but can be up to several years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spasmus nutans was more common at the turn of the century [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/44\">",
"     44",
"    </a>",
"    ]; it was attributed to poor socioeconomic conditions, inadequate diet, and light deprivation since it seemed to occur in winter and resolve in the spring [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/45\">",
"     45",
"    </a>",
"    ]. A case-control study in 2002 found that spasmus nutans was associated with Hispanic and African-American ethnicity, lower gestational age at birth, lower household income, and higher incidence of psychiatric and substance abuse problems in parents, compared with a control group of congenital nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/46\">",
"     46",
"    </a>",
"    ]. A hereditary component is suggested by its occurrence in monozygotic twins [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Delayed maturation of eye movement circuits with prolonged time delays are hypothesized to underlie this disorder, possibly involving the saccadic system [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/45\">",
"     45",
"    </a>",
"    ]. However, saccades are normal in most [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nystagmus is a small, fast oscillation, usually horizontal, sometimes oblique [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/4\">",
"     4",
"    </a>",
"    ]. A key feature is dysconjugacy: spasmus nutans can be unilateral or bilateral with asymmetric size, and when bilateral it is not synchronized between the two eyes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/45,48\">",
"     45,48",
"    </a>",
"    ]. The nystagmus can even change within a session [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/45\">",
"     45",
"    </a>",
"    ]. It is often intermittent, with bursts of 5 to 30 seconds. A video example of spasmus nutans is available at:",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/textbook/video/spasmusnutans.html\">",
"     file://www.neuroophthalmology.ca/textbook/video/spasmusnutans.html",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The head motion is often oblique, with both nodding and shaking [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/18\">",
"     18",
"    </a>",
"    ]. It is slower and larger than nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Head nodding is a compensatory act that suppresses nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Strabismus and amblyopia are seen in 60 percent of children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/43,48,52\">",
"     43,48,52",
"    </a>",
"    ]. These in turn can be associated with latent nystagmus and dissociated vertical divergence [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/52\">",
"     52",
"    </a>",
"    ]. Refractive errors such as anisometropia and astigmatism are more frequent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/61/8153?source=see_link\">",
"     \"Overview of amblyopia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Criteria for distinguishing spasmus nutans from congenital nystagmus have been derived (",
"    <a class=\"graphic graphic_table graphicRef76335 \" href=\"UTD.htm?11/3/11324\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/48,53\">",
"     48,53",
"    </a>",
"    ]. Head nodding is not specific for spasmus nutans since it occurs in about 10 percent of children with congenital nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some cases are associated with underlying retinal or neurologic problems. The features of nystagmus do not differentiate more benign spasmus nutans from that with these other problems [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/48,54,55\">",
"     48,54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Retinal conditions include achromatopsia [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/54\">",
"       54",
"      </a>",
"      ], congenital stationary night blindness [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/55,56\">",
"       55,56",
"      </a>",
"      ], and cone or",
"      <span class=\"nowrap\">",
"       rod/cone",
"      </span>",
"      dystrophies [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neurologic problems consist of underlying tumors in about 1 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/57\">",
"       57",
"      </a>",
"      ]. These are usually gliomas of the intracranial visual system [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/58-61\">",
"       58-61",
"      </a>",
"      ], but sometimes can be ependymomas of the fourth ventricle [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/18\">",
"       18",
"      </a>",
"      ] and posterior thalamic tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/62\">",
"       62",
"      </a>",
"      ]. A vertical or see-saw nystagmus should raise the suspicion of tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/57\">",
"       57",
"      </a>",
"      ]. Other rarely reported neurologic associations include Leigh's encephalopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/63\">",
"       63",
"      </a>",
"      ], arachnoid cysts, and porencephalic cysts [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/49,64\">",
"       49,64",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinical features distinguish spasmus nutans from congenital nystagmus. A positive family history and infantile myopia are clues to congenital stationary night blindness; the diagnosis is made with electroretinogram (ERG) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/56\">",
"     56",
"    </a>",
"    ]. Associated signs that suggest tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/57,64\">",
"     57,64",
"    </a>",
"    ] include optic atrophy, visual loss, failure to thrive [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/59,65\">",
"     59,65",
"    </a>",
"    ], and hydrocephalus. MRI of the brain or orbits is required if such features are present.",
"   </p>",
"   <p>",
"    Unlike congenital nystagmus, spasmus nutans is considered transient, lasting a few months to years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/43,45\">",
"     43,45",
"    </a>",
"    ]. However, clinical resolution does not always occur; even when it does, residual oscillations are seen on eye movement recordings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the long term, visual acuity is good,",
"    <span class=\"nowrap\">",
"     20/50",
"    </span>",
"    or better in most [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/52\">",
"     52",
"    </a>",
"    ]. Slight reductions in acuity may reflect strabismic amblyopia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/52\">",
"     52",
"    </a>",
"    ] and are not correlated with the nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/43\">",
"     43",
"    </a>",
"    ]. Developmental delay is seen in a few children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/43,48\">",
"     43,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Oculopalatal myoclonus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two variants of palatal myoclonus or tremor have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/66\">",
"     66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Essential palatal tremor presents with symptoms of ear clicking from motion of the tensor veli palatini; no other muscles are involved and there is no nystagmus. It is idiopathic, and neuroimaging is normal.",
"     </li>",
"     <li>",
"      Symptomatic palatal tremor follows brainstem infarction or cerebellar degeneration and the palatal motion results from contraction of the levator veli palatini [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/66\">",
"       66",
"      </a>",
"      ]. Other muscle groups also are frequently involved, such as the tongue and pharynx; oscillations can be shown in the limbs on electromyography (EMG) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/67\">",
"       67",
"      </a>",
"      ]. This group frequently has nystagmus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In most cases of symptomatic palatal tremor, the abnormal movements develop months to years after a brainstem infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/14,68,69\">",
"     14,68,69",
"    </a>",
"    ]. On occasion it has been described in multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Palatal tremor has also been described in adult-onset Alexander disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/71,72\">",
"     71,72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The damage affects components of the dentato-rubro-olivary circuit, \"Mollaret's triangle.\" This denervates the inferior olive, which subsequently hypertrophies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/73\">",
"     73",
"    </a>",
"    ]. The mechanism by which this leads to nystagmus is unclear; one hypothesis is that cerebellar control of the vestibuloocular reflex is impaired due to failure of visuo-vestibular adaptive mechanisms mediated by the inferior olive [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/14\">",
"     14",
"    </a>",
"    ]. One model proposes that the hypertrophied inferior olive develops increased conductance through gap junctions, causing it to become a generator of synchronized spike trains, which are passed on to the cerebellum; cerebellar learning processes for timing adjustments then transform into outputs that cause ocular oscillations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oscillopsia is a frequent complaint. Patients may or may not be aware of the noise from the palatal motion. Other oscillations are not often a problem.",
"   </p>",
"   <p>",
"    The ocular oscillations are a distinct subset of acquired pendular nystagmus. The trajectory is stereotyped, with one of two forms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A vertical-torsional form which is conjugate, except that the vertical component is much larger in one eye. In these cases the palatal myoclonus is unilateral, involving the side with the eye that has the larger vertical nystagmus.",
"     </li>",
"     <li>",
"      A pure symmetric vertical pendular oscillation, associated with bilateral palatal myoclonus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The nystagmus is slow (about 2 to 3 Hz), regular, and synchronous with the palatal motion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/2,68,69\">",
"     2,68,69",
"    </a>",
"    ]. It is larger in amplitude, slower, and more irregular than acquired pendular nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/2\">",
"     2",
"    </a>",
"    ]. Like the palatal movements, pendular nystagmus persists in a more irregular form during sleep.",
"   </p>",
"   <p>",
"    A video example of oculopalatal myoclonus is available at:",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/cases/case68/case68.html\">",
"     file://www.neuroophthalmology.ca/cases/case68/case68.html",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Associated signs of brainstem damage are common, including horizontal gaze paresis, palsies of cranial nerves V to XII, cerebellar dysarthria and ataxia, and damage to spinothalamic and pyramidal tracts [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/66,68,69\">",
"     66,68,69",
"    </a>",
"    ]. In some patients with pontine strokes, similar nystagmus results without the palatal tremor, although rhythmic motions may be seen in other muscles such as the tongue, mentalis, or arm [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1\">",
"     1",
"    </a>",
"    ]. Most of this latter group have severe lesions, causing coma or the locked-in state, and have horizontal gaze palsies.",
"   </p>",
"   <p>",
"    MRI shows increased signal and size of the inferior olive in the lateral medulla [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/66,75\">",
"     66,75",
"    </a>",
"    ]. This pseudohypertrophy is considered essential to the genesis of oculopalatal myoclonus. With the lateralized or dissociated form, there is cerebellar atrophy on the side with larger nystagmus and olivary hyperintensity on that side [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/14,66,76\">",
"     14,66,76",
"    </a>",
"    ]. The symmetric form of nystagmus can be seen with unilateral or bilateral signal change in the inferior olivary nucleus.",
"   </p>",
"   <p>",
"    There is no proven therapy. There are small reports of benefit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/29\">",
"     29",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/1/6165?source=see_link\">",
"     trihexyphenidyl",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/77\">",
"     77",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     Gabapentin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    may reduce the amplitude and frequency variability of the oscillation and improve symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/24,26\">",
"     24,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     See-saw nystagmus",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is a combination of a conjugate torsional motion and a dysconjugate but synchronized vertical component: as one eye goes up, the other descends; the elevating eye intorts while the descending eye extorts. Both components are pendular.",
"   </p>",
"   <p>",
"    The most frequent cause of see-saw nystagmus is a parasellar mass, usually a craniopharyngioma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/78-80\">",
"     78-80",
"    </a>",
"    ] or pituitary adenoma (",
"    <a class=\"graphic graphic_figure graphicRef56649 \" href=\"UTD.htm?17/49/18206\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Vascular disease such as lateral medullary infarcts, meso-diencephalic infarcts, or hemorrhages [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/83\">",
"     83",
"    </a>",
"    ] can cause jerk-type see-saw nystagmus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39273?source=see_link&amp;anchor=H8#H8\">",
"     \"Posterior circulation cerebrovascular syndromes\", section on 'Lateral medullary infarction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Head trauma can also cause see-saw nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/15,84,85\">",
"     15,84,85",
"    </a>",
"    ]. In rare cases, see-saw nystagmus is described in Arnold Chiari malformation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/86\">",
"     86",
"    </a>",
"    ], multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/87\">",
"     87",
"    </a>",
"    ], and spinocerebellar ataxia type 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    See-saw nystagmus is also associated with visual disorders, including cone-rod dystrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/89\">",
"     89",
"    </a>",
"    ], retinitis pigmentosa [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/90\">",
"     90",
"    </a>",
"    ], septo-optic dysplasia, and toxoplasma chorioretinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/91\">",
"     91",
"    </a>",
"    ]. Congenital forms exist [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/79,92,93\">",
"     79,92,93",
"    </a>",
"    ], including patients born without an optic chiasm (the \"non-decussating retinal-fugal fiber syndrome\") [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathophysiology of see-saw nystagmus is controversial. Large masses that compress the optic chiasm could also damage midbrain structures that control vertical and torsional eye movements [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/81,96\">",
"     81,96",
"    </a>",
"    ]. This \"midbrain theory\" is supported by cases with midbrain lesions and no bitemporal hemianopia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/81,97\">",
"     81,97",
"    </a>",
"    ], and cases in which see-saw nystagmus resolved but bitemporal hemianopia remained [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/78,80\">",
"     78,80",
"    </a>",
"    ]. This is the likely mechanism in cases of see-saw nystagmus from medullary or midbrain infarction, particularly jerk forms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/83\">",
"     83",
"    </a>",
"    ]. The experimental evidence from monkeys is mixed: using muscimol to inactivate neurons, one group failed to find an effect of injection into the interstitial nucleus of Cajal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/98\">",
"     98",
"    </a>",
"    ], whereas another group produced hemi-seesaw nystagmus with injections just caudal to this midbrain nucleus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there are cases with visual loss and no midbrain damage [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. Suggestions that bitemporal hemianopia may cause see-saw nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/78,81\">",
"     78,81",
"    </a>",
"    ] have received support from reports of nystagmus in humans and sheepdogs with congenital absence of the optic chiasm [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/94\">",
"     94",
"    </a>",
"    ]. The optic chiasm may contain visual fibers that send a corrective visual signal for the vestibular system to the brainstem [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acquired see-saw nystagmus causes oscillopsia; patients with the congenital version do not have this symptom. See-saw nystagmus is usually present in all positions of gaze, although maximal in downgaze [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/81,92,96\">",
"     81,92,96",
"    </a>",
"    ]. It is usually constant, and rarely intermittent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/18\">",
"     18",
"    </a>",
"    ]. The frequency varies from 2 to 5 Hz [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/78,79,100\">",
"     78,79,100",
"    </a>",
"    ]. A jerk type of see-saw nystagmus occurs with unilateral midbrain or medullary lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/83,101\">",
"     83,101",
"    </a>",
"    ]. A video example of sew-saw nystagmus is available at:",
"    <a class=\"external\" href=\"file://www.neuroophthalmology.ca/textbook/video/nystagmusseesaaw.html\">",
"     file://www.neuroophthalmology.ca/textbook/video/nystagmusseesaaw.html",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Bitemporal hemianopia is frequent with sellar masses or head trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/15,84,85\">",
"     15,84,85",
"    </a>",
"    ]. Among cases without bitemporal hemianopia, mainly from brainstem infarction, there is often internuclear ophthalmoplegia, exotropia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/79-81,97\">",
"     79-81,97",
"    </a>",
"    ], and skew deviation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/13,16\">",
"     13,16",
"    </a>",
"    ]. Congenital see-saw nystagmus is mixed with other more typical features of horizontal congenital nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/79,92,94\">",
"     79,92,94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A fundus examination and possibly ERG are indicated if there is suspicion of visual loss that does not fit with bitemporal hemianopia. If bitemporal hemianopia is present, MRI of the sella with contrast is required. Without hemianopia, MRI should be directed at the brainstem.",
"   </p>",
"   <p>",
"    The prognosis of see-saw nystagmus is variable. Cases with brainstem infarction may resolve [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/81,97\">",
"     81,97",
"    </a>",
"    ]. With sellar masses, see-saw may resolve postoperatively as visual loss improves, but it may also resolve even if bitemporal hemianopia does not [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/78,80\">",
"     78,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no agreed-upon treatment. Some patients benefit from contact lenses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/92\">",
"     92",
"    </a>",
"    ] or ethanol [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/85,90\">",
"     85,90",
"    </a>",
"    ]. One patient is said to have improved with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Oculomasticatory myorhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whipple's disease is a rare systemic infection, affecting the central nervous system (CNS) in 4 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/102\">",
"     102",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/35/11833?source=see_link\">",
"     \"Whipple's disease\"",
"    </a>",
"    .) While cognitive dysfunction is the most common abnormality among those with CNS disease, the finding of oculomasticatory or oculo-facial-skeletal myorhythmia (continuous rhythmic movements of eye convergence with concurrent contractions of the masticatory or other muscles), present in about 20 percent of such patients, is considered pathognomonic of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CNS Whipple's disease can be associated with other systemic or ocular features [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/103-105\">",
"     103-105",
"    </a>",
"    ]. It can also occur without them as an initial presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/106\">",
"     106",
"    </a>",
"    ], or with relapse of previously systemic disease, sometimes many years later [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/107,108\">",
"     107,108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of oculomasticatory myorhythmia is unknown. It may derive from dysfunction in control of the vergence system, but it is difficult to speculate how that would lead to synchronized oscillation with other muscles.",
"   </p>",
"   <p>",
"    The nystagmus is usually asymptomatic, although others may note the abnormal movements. Patients with CNS disease usually present with other complaints, especially dementia and arousal disturbances.",
"   </p>",
"   <p>",
"    Ocular myorhythmia is a slow convergent-divergent nystagmus, in that the eyes oscillate horizontally towards and away from each other [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/109\">",
"     109",
"    </a>",
"    ]. The nystagmus is synchronous with diffuse muscle contractions elsewhere, particularly the masticatory and facial muscles, including lids, mouth, tongue, and neck [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/105,109-111\">",
"     105,109-111",
"    </a>",
"    ], and sometimes the palate, arms, and legs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/105,108,112\">",
"     105,108,112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is almost always an associated supranuclear gaze palsy affecting vertical then horizontal eye movements, with eventual loss of all eye movements [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/103-105,107,109,113\">",
"     103-105,107,109,113",
"    </a>",
"    ]. Bilateral ptosis can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI is normal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/105,112,113\">",
"     105,112,113",
"    </a>",
"    ] or shows multifocal enhancing lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/102,104\">",
"     102,104",
"    </a>",
"    ]. CSF can be normal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/104,105,112\">",
"     104,105,112",
"    </a>",
"    ] or contain PAS-positive cells [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/102\">",
"     102",
"    </a>",
"    ]. A mild lymphocytosis and elevated protein is seen in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intestinal biopsy shows PAS-positive cells and bacilli on electron microscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/112,113\">",
"     112,113",
"    </a>",
"    ], but may be normal in patients with isolated CNS disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/109\">",
"     109",
"    </a>",
"    ]. PAS-positive cells also can be found in brain tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/102,111\">",
"     102,111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A polymerase chain reaction assay for the 16s ribosomal RNA sequence can diagnose active Whipple's disease in intestinal biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/114\">",
"     114",
"    </a>",
"    ]. However, the value of the intestinal test in CNS Whipple's is uncertain: it has been positive in two cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/115\">",
"     115",
"    </a>",
"    ] but negative in three who developed CNS relapses after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/114\">",
"     114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best treatment of CNS Whipple's disease is not certain. It can develop after treatment and resolution of systemic features. This sometimes reflects poor drug penetration of the blood-brain barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/116\">",
"     116",
"    </a>",
"    ], but in other cases may reflect transport of macrophages containing intracellular bacilli to periventricular locations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/113\">",
"     113",
"    </a>",
"    ]. There are reports of CNS benefit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/109\">",
"     109",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/104,105\">",
"     104,105",
"    </a>",
"    ], and pefloxacine [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The myorhythmia may symptomatically respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/105\">",
"     105",
"    </a>",
"    ], although the effect can fade after a few months [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/108\">",
"     108",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     Clonazepam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/31/36342?source=see_link\">",
"     baclofen",
"    </a>",
"    are ineffective [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pendular nystagmus mimics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pendular pseudonystagmus is seen in patients with two unrelated conditions: essential head tremor and bilateral vestibular loss [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. Fundoscopy reveals a fine pendular motion of the eyes which is reduced by firm support of the head. The oscillopsia from vestibular insufficiency improves if the head tremor is treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CONGENITAL NYSTAGMUS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients are not aware of oscillopsia. Decreased visual acuity is the rule. In part, this is caused by degradation of the visual image by continual eye motion, but it may also reflect associated visual abnormalities, which are frequent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most congenital nystagmus is horizontal and conjugate, with rare vertical hereditary variants [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/119,120\">",
"     119,120",
"    </a>",
"    ]. A small torsional component is apparent in many [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/121\">",
"     121",
"    </a>",
"    ]. Initially, congenital nystagmus was divided into two broad types, jerk and pendular [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/122\">",
"     122",
"    </a>",
"    ], but detailed analyses show a wide variety of patterns of oscillation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/123,124\">",
"     123,124",
"    </a>",
"    ]. Most patients have a mix of jerk and pendular waveforms, varying from moment to moment with direction of gaze, and with age [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/124-126\">",
"     124-126",
"    </a>",
"    ]. With jerk forms, there is often a gaze position to the side where nystagmus is minimal (the null point), and beyond which the nystagmus reverses direction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Associated signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head turn may be present to place the eyes at the null point when looking straight ahead. Other signs are generally related to the associated visual problems (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Etiology/differential diagnosis'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The origins of congenital nystagmus remain obscure. Initially it was hypothesized that jerk waveforms reflected a \"motor\" dysfunction and pendular waveforms a \"sensory\" dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/122\">",
"     122",
"    </a>",
"    ]. It now appears that most cases of congenital nystagmus have underlying visual abnormalities. The actual waveform does not correlate with any specific condition [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/125\">",
"     125",
"    </a>",
"    ]. Abnormal feedback to eye movement control systems are probably responsible [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/127\">",
"     127",
"    </a>",
"    ]. Failure in sensorimotor integration, perhaps secondary to reduced contrast sensitivity at high spatial frequencies, may explain the association of congenital nystagmus with conditions like foveal hypoplasia or congenital cataracts [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/128\">",
"     128",
"    </a>",
"    ]. Monkeys raised in a strobe-lit environment also develop a pendular nystagmus, suggesting that impaired motion processing in early life may also lead to congenital nystagmus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/129\">",
"     129",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Etiology/differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among children, the main differential is spasmus nutans. Differentiation from spasmus nutans can be made by close attention to the features of nystagmus (",
"    <a class=\"graphic graphic_table graphicRef76335 \" href=\"UTD.htm?11/3/11324\">",
"     table 1",
"    </a>",
"    ). Most adults with congenital nystagmus have known about their problem since childhood. Rarely, cases with purported congenital nystagmus have been reported to have onset in adulthood, with symptomatic oscillopsia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The visual disorders associated with congenital nystagmus encompass a wide range of conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Structural ocular lesions such as corneal scars, cataracts, and vitreous hemorrhages",
"     </li>",
"     <li>",
"      Retinal dystrophies such as Leber's congenital amaurosis, achromatopsia, congenital stationary night blindness [",
"      <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/131\">",
"       131",
"      </a>",
"      ], cone-rod dystrophies, albinism",
"     </li>",
"     <li>",
"      Optic neuropathy and optic nerve hypoplasia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Diagnostic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases the diagnosis is straightforward. Ophthalmologic examination is required. Electroretinogram is useful if a retinal dystrophy is suspected. With optic nerve disease, visual evoked potentials or MRI of orbits and sella are sometimes helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Prognosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital nystagmus is a lifelong condition. Symptomatic treatment is attempted occasionally to reduce head turn or improve motion-degraded visual acuity. Soft contact lenses can dampen the oscillations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/132\">",
"     132",
"    </a>",
"    ]. Some suggest that this benefit can be predicted in those who show dampening of nystagmus with stimulation of the first branch of the trigeminal nerve, as with forehead vibration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/133\">",
"     133",
"    </a>",
"    ]. Prisms or surgery can be used to shift the null point to coincide with gaze straight ahead, as well as to increase convergent tone in far gaze, in those patients whose nystagmus decreases in near gaze [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/133\">",
"     133",
"    </a>",
"    ]. Four-muscle tenotomy has also been advocated as a treatment, but more studies are required [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/133\">",
"     133",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with acquired pendular nystagmus, medical treatment may be helpful in managing symptoms. In a clinical trial, 48 patients with congenital nystagmus were randomly assigned to treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    (20 to 40 mg daily),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    (1200 to 2400 mg daily), or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/0/1034/abstract/134\">",
"     134",
"    </a>",
"    ]. Both treatments were associated with improved visual acuity and reduced intensity of nystagmus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7763686\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pendular nystagmus consists of slow, sinusoidal, \"pendular\" oscillations to and fro subdivided into a number of types recognized mainly by very specific trajectories.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acquired pendular nystagmus is most often seen in the setting of multiple sclerosis. Patients complain of oscillopsia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      blurred vision. Nystagmus is present in the primary position and does not change with gaze direction, it may affect either eye asymmetrically. Other forms of nystagmus may co-occur along with other findings of cerebellar or brainstem dysfunction. Medication trials may provide symptomatic benefit. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Acquired pendular nystagmus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pendular nystagmus, often vertical, can occur after vision loss from a variety of causes. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pendular nystagmus from visual loss'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Spasmus nutans is pediatric disorder that consists of the triad of nystagmus, head nodding, and torticollis. The nystagmus is a small, fast oscillation, usually horizontal, sometimes oblique. The age at onset is usually 6 to 12 months, but can be up to several years. The condition is generally benign and self-limited; some cases are associated with retinal or neurologic problems. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Spasmus nutans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An acquired pendular nystagmus can occur along with symptomatic palatal tremor that usually results from brainstem infarction. The oscillations can be vertical-torsional and asymmetric or purely vertical and symmetric. Associated brainstem signs are common (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Oculopalatal myoclonus'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      See-saw nystagmus is a combination of a conjugate torsional motion and a dysconjugate but synchronized vertical component: as one eye goes up, the other descends. There are many potential causes; the most frequent is a parasellar mass. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'See-saw nystagmus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oculomasticatory myorhythmia is characterized by continuous rhythmic movements of eye convergence with concurrent contractions of the masticatory or other muscles. It is present in about 20 percent of patients with Whipple's disease and is considered pathognomonic of the disease. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Oculomasticatory myorhythmia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Congenital pendular nystagmus is usually asymptomatic although patients frequently have impaired vision either as a consequence of the nystagmus or because of associated visual abnormalities. Most congenital nystagmus is horizontal and conjugate. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Congenital nystagmus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/1\">",
"      Gresty MA, Ell JJ, Findley LJ. Acquired pendular nystagmus: its characteristics, localising value and pathophysiology. J Neurol Neurosurg Psychiatry 1982; 45:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/2\">",
"      Tilikete C, Jasse L, Pelisson D, et al. Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology 2011; 76:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/3\">",
"      Aschoff JC, Conrad B, Kornhuber HH. Acquired pendular nystagmus with oscillopsia in multiple sclerosis: a sign of cerebellar nuclei disease. J Neurol Neurosurg Psychiatry 1974; 37:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/4\">",
"      Barton JJ, Cox TA. Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy. J Neurol Neurosurg Psychiatry 1993; 56:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/5\">",
"      Schievink WI, Piepgras DG, Earnest F 4th, Gordon H. Spontaneous carotid-cavernous fistulae in Ehlers-Danlos syndrome Type IV. Case report. J Neurosurg 1991; 74:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/6\">",
"      Maas EF, Ashe J, Spiegel P, et al. Acquired pendular nystagmus in toluene addiction. Neurology 1991; 41:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/7\">",
"      Trobe JD, Sharpe JA, Hirsh DK, Gebarski SS. Nystagmus of Pelizaeus-Merzbacher disease. A magnetic search-coil study. Arch Neurol 1991; 48:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/8\">",
"      Sharpe JA, Silversides JL, Blair RD. Familial paralysis of horizontal gaze. Associated with pendular nystagmus, progressive scoliosis, and facial contraction with myokymia. Neurology 1975; 25:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/9\">",
"      Goldberg RT. Vertical pendular nystagmus in chronic myositis of medial and lateral rectus. Ann Ophthalmol 1978; 10:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/10\">",
"      Jacob FD, Ramaswamy V, Goez HR. Acquired monocular nystagmus as the initial presenting sign of a chiasmal glioma. Can J Neurol Sci 2010; 37:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/11\">",
"      Averbuch-Heller L, Zivotofsky AZ, Remler BF, et al. Convergent-divergent pendular nystagmus: possible role of the vergence system. Neurology 1995; 45:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/12\">",
"      Lopez LI, Bronstein AM, Gresty MA, et al. Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain 1996; 119 ( Pt 2):465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/13\">",
"      Averbuch-Heller L, Zivotofsky AZ, Das VE, et al. Investigations of the pathogenesis of acquired pendular nystagmus. Brain 1995; 118 ( Pt 2):369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/14\">",
"      Nakada T, Kwee IL. Oculopalatal myoclonus. Brain 1986; 109 ( Pt 3):431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/15\">",
"      Nakada T, Kwee IL. Seesaw nystagmus. Role of visuovestibular interaction in its pathogenesis. J Clin Neuroophthalmol 1988; 8:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/16\">",
"      K&ouml;rner F. [Acquired and congenital monocular pendular nystagmus. A comparative electronystagmographic study of two cases (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975; 197:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/17\">",
"      Jasse L, Vighetto A, Vukusic S, et al. Unusual monocular pendular nystagmus in multiple sclerosis. J Neuroophthalmol 2011; 31:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/18\">",
"      Castaigne P, Chain F, Pierrot-Deseilligny C, Larmande P. [Monocular circumduction nystagmus (author's transl)]. Rev Neurol (Paris) 1979; 135:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/19\">",
"      el-Naggar M, Hawthorne M, Kumar U. Two bizarre cases of unilateral vertical pendular nystagmus. J Otolaryngol 1996; 25:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/20\">",
"      Barton JJ, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 1994; 35:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/21\">",
"      Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ. Effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology 1991; 41:1737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/22\">",
"      Starck M, Albrecht H, P&ouml;llmann W, et al. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 1997; 244:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/23\">",
"      Averbuch-Heller L, Tusa RJ, Fuhry L, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997; 41:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/24\">",
"      Thurtell MJ, Joshi AC, Leone AC, et al. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol 2010; 67:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/25\">",
"      Starck M, Albrecht H, P&ouml;llmann W, et al. Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol 2010; 257:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/26\">",
"      Shaikh AG, Thurtell MJ, Optican LM, Leigh RJ. Pharmacological tests of hypotheses for acquired pendular nystagmus. Ann N Y Acad Sci 2011; 1233:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/27\">",
"      Currie JN, Matsuo V. The use of clonazepam in the treatment of nystagmus-induced oscillopsia. Ophthalmology 1986; 93:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/28\">",
"      Traccis S, Rosati G, Monaco MF, et al. Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 1990; 40:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/29\">",
"      Lefkowitz D, Harpold G. Treatment of ocular myoclonus with valproic acid. Ann Neurol 1985; 17:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/30\">",
"      Stahl JS, Lehmkuhle M, Wu K, et al. Prospects for treating acquired pendular nystagmus with servo-controlled optics. Invest Ophthalmol Vis Sci 2000; 41:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/31\">",
"      Smith RM, Oommen BS, Stahl JS. Image-shifting optics for a nystagmus treatment device. J Rehabil Res Dev 2004; 41:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/32\">",
"      Smith RM, Oommen BS, Stahl JS. Application of adaptive filters to visual testing and treatment in acquired pendular nystagmus. J Rehabil Res Dev 2004; 41:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/33\">",
"      Spielmann A. Bilateral vertical retraction syndrome in horizontal bilateral Duane's syndrome. Graefes Arch Clin Exp Ophthalmol 1988; 226:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/34\">",
"      Leigh RJ, Tomsak RL, Grant MP, et al. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 1992; 32:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/35\">",
"      Spielmann AC. Large recession of the four vertical rectus muscles for acquired pendular vertical nystagmus and oscillopsia without a null zone. J AAPOS 2009; 13:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/36\">",
"      Stangler-Zuschrott E. [Disorders of eye movements in point fixation of the dominant eye in unilateral deprivation amblyopia, squint amblyopia and unilateral organ damage]. Klin Monbl Augenheilkd 1987; 191:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/37\">",
"      Schulman JA, Shults WT, Jones JM Jr. Monocular vertical nystagmus as an initial sign of chiasmal glioma. Am J Ophthalmol 1979; 87:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/38\">",
"      Johnsen SD, Deering WM. Intermittent vertical ocular oscillations in infancy. J Pediatr 1977; 90:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/39\">",
"      Dell'Osso LF, Schmidt D, Daroff RB. Latent, manifest latent, and congenital nystagmus. Arch Ophthalmol 1979; 97:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/40\">",
"      Smith JL, Flynn JT, Spiro HJ. Monocular vertical oscillations of amblyopia. The Heimann-Bielschowsky phenomenon. J Clin Neuroophthalmol 1982; 2:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/41\">",
"      Leigh RJ, Thurston SE, Tomsak RL, et al. Effect of monocular visual loss upon stability of gaze. Invest Ophthalmol Vis Sci 1989; 30:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/42\">",
"      Yee RD, Jelks GW, Baloh RW, Honrubia V. Uniocular nystagmus in monocular visual loss. Ophthalmology 1979; 86:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/43\">",
"      Young TL, Weis JR, Summers CG, Egbert JE. The association of strabismus, amblyopia, and refractive errors in spasmus nutans. Ophthalmology 1997; 104:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/44\">",
"      Jan JE, Groenveld M, Connolly MB. Head shaking by visually impaired children: a voluntary neurovisual adaptation which can be confused with spasmus nutans. Dev Med Child Neurol 1990; 32:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/45\">",
"      Weissman BM, Dell'Osso LF, Abel LA, Leigh RJ. Spasmus nutans. A quantitative prospective study. Arch Ophthalmol 1987; 105:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/46\">",
"      Wizov SS, Reinecke RD, Bocarnea M, et al. A comparative demographicand socioeconomic study of spasmus nutans and infantile nystagmus. Am J Ophthalmol 2002; 133:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/47\">",
"      Katzman B, Lu LW, Tiwari RP. Spasmus nutans in identical twins. Ann Ophthalmol 1981; 13:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/48\">",
"      Gottlob I, Zubcov A, Catalano RA, et al. Signs distinguishing spasmus nutans (with and without central nervous system lesions) from infantile nystagmus. Ophthalmology 1990; 97:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/49\">",
"      Gottlob I, Zubcov AA, Wizov SS, Reinecke RD. Head nodding is compensatory in spasmus nutans. Ophthalmology 1992; 99:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/50\">",
"      Gresty M, Leech J, Sanders M, Eggars H. A study of head and eye movement in spasmus nutans. Br J Ophthalmol 1976; 60:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/51\">",
"      Gresty MA, Ell JJ. Spasmus nutans or congenital nystagmus? Classification according to objective criteria. Br J Ophthalmol 1981; 65:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/52\">",
"      Gottlob I, Wizov SS, Reinecke RD. Spasmus nutans. A long-term follow-up. Invest Ophthalmol Vis Sci 1995; 36:2768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/53\">",
"      Kiblinger GD, Wallace BS, Hines M, Siatkowski RM. Spasmus nutans-like nystagmus is often associated with underlying ocular, intracranial, or systemic abnormalities. J Neuroophthalmol 2007; 27:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/54\">",
"      Gottlob I, Reinecke RD. Eye and head movements in patients with achromatopsia. Graefes Arch Clin Exp Ophthalmol 1994; 232:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/55\">",
"      Gottlob I, Wizov SS, Reinecke RD. Quantitative eye and head movement recordings of retinal disease mimicking spasmus nutans. Am J Ophthalmol 1995; 119:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/56\">",
"      Lambert SR, Newman NJ. Retinal disease masquerading as spasmus nutans. Neurology 1993; 43:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/57\">",
"      Arnoldi KA, Tychsen L. Prevalence of intracranial lesions in children initially diagnosed with disconjugate nystagmus (spasmus nutans). J Pediatr Ophthalmol Strabismus 1995; 32:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/58\">",
"      Kelly TW. Optic glioma presenting as spasmus nutans. Pediatrics 1970; 45:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/59\">",
"      Antony JH, Ouvrier RA, Wise G. Spasmus nutans: a mistaken identity. Arch Neurol 1980; 37:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/60\">",
"      Koenig SB, Naidich TP, Zaparackas Z. Optic glioma masquerading as spasmus nutans. J Pediatr Ophthalmol Strabismus 1982; 19:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/61\">",
"      Albright AL, Sclabassi RJ, Slamovits TL, Bergman I. Spasmus nutans associated with optic gliomas in infants. J Pediatr 1984; 105:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/62\">",
"      Baram TZ, Tang R. Atypical spasmus nutans as an initial sign of thalamic neoplasm. Pediatr Neurol 1986; 2:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/63\">",
"      Sedwick LA, Burde RM, Hodges FJ 3rd. Leigh's subacute necrotizing encephalomyelopathy manifesting as spasmus nutans. Arch Ophthalmol 1984; 102:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/64\">",
"      King RA, Nelson LB, Wagner RS. Spasmus nutans. A benign clinical entity? Arch Ophthalmol 1986; 104:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/65\">",
"      Garty BZ, Weitz R, Mimouni M, Bauman B. Spasmus nutans as a presenting sign of diencephalic syndrome. J Pediatr 1985; 107:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/66\">",
"      Deuschl G, Toro C, Valls-Sol&eacute; J, et al. Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 1994; 117 ( Pt 4):775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/67\">",
"      Nagaoka M, Narabayashi H. Palatal myoclonus--its remote influence. J Neurol Neurosurg Psychiatry 1984; 47:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/68\">",
"      Yap CB, Barron K, Mayo C. \"Ocular bobbing\" in palatal myoclonus. Arch Neurol 1968; 18:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/69\">",
"      Chokroverty S, Barron KD. Palatal myoclonus and rhythmic ocular movements: a polygraphic study. Neurology 1969; 19:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/70\">",
"      Revol A, Vighetto A, Confavreux C, et al. [Oculo-palatal myoclonus and multiple sclerosis]. Rev Neurol (Paris) 1990; 146:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/71\">",
"      Pareyson D, Fancellu R, Mariotti C, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 2008; 131:2321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/72\">",
"      Farina L, Pareyson D, Minati L, et al. Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol 2008; 29:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/73\">",
"      Koeppen AH, Barron KD, Dentinger MP. Olivary hypertrophy: histochemical demonstration of hydrolytic enzymes. Neurology 1980; 30:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/74\">",
"      Hong S, Leigh RJ, Zee DS, Optican LM. Inferior olive hypertrophy and cerebellar learning are both needed to explain ocular oscillations in oculopalatal tremor. Prog Brain Res 2008; 171:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/75\">",
"      Massry GG, Chung SM. Magnetic resonance imaging findings in oculopalatal myoclonus. Am J Ophthalmol 1994; 117:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/76\">",
"      Kim JS, Moon SY, Choi KD, et al. Patterns of ocular oscillation in oculopalatal tremor: imaging correlations. Neurology 2007; 68:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/77\">",
"      Jabbari B, Rosenberg M, Scherokman B, et al. Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 1987; 2:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/78\">",
"      Arnott EJ. Vertical see-saw nystagmus. Trans Ophthalmol Soc U K 1964; 84:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/79\">",
"      Druckman R, Ellis P, Kleinfeld J, Waldman M. Seesaw nystagmus. Arch Ophthalmol 1966; 76:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/80\">",
"      KINDER RS, HOWARD GM. SEE-SAW NYSTAGMUS. AN UNUSUAL SIGN OF LESIONS NEAR THE THIRD VENTRICLE. Am J Dis Child 1963; 106:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/81\">",
"      DAROFF RB. SEE-SAW NYSTAGMUS. Neurology 1965; 15:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/82\">",
"      Drachman DA. See-saw nystagmus. J Neurol Neurosurg Psychiatry 1966; 29:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/83\">",
"      Halmagyi GM, Aw ST, Dehaene I, et al. Jerk-waveform see-saw nystagmus due to unilateral meso-diencephalic lesion. Brain 1994; 117 ( Pt 4):789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/84\">",
"      Schmidt D, Kommerell G. [Seesaw nystagmus with bitemporal hemianopia following head traumas]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1969; 178:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/85\">",
"      Fris&eacute;n L, Wikkels&oslash; C. Posttraumatic seesaw nystagmus abolished by ethanol ingestion. Neurology 1986; 36:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/86\">",
"      Zimmerman CF, Roach ES, Troost BT. See-saw nystagmus associated with Chiari malformation. Arch Neurol 1986; 43:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/87\">",
"      Sandramouli S, Benamer HT, Mantle M, Chavan R. See-saw nystagmus as the presenting sign in multiple sclerosis. J Neuroophthalmol 2005; 25:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/88\">",
"      Manto MU. Episodic see-saw nystagmus in spino-cerebellar ataxia type 2 (SCA-2). Cerebellum 2002; 1:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/89\">",
"      May EF, Truxal AR. Loss of vision alone may result in seesaw nystagmus. J Neuroophthalmol 1997; 17:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/90\">",
"      Lepore FE. Ethanol-induced resolution of pathologic nystagmus. Neurology 1987; 37:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/91\">",
"      Rucker, CW. See-saw nystagmus associated with choroiditis and positive neutralization test for toxoplasma. Arch Ophthalmol 1946; 35:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/92\">",
"      SLATT B, NYKIEL F. SEE-SAW NYSTAGMUS. Am J Ophthalmol 1964; 58:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/93\">",
"      Schmidt D, Kommerell G. [Congenital seewaw nystagmus (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1974; 191:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/94\">",
"      Dell'Osso LF. See-saw nystagmus in dogs and humans: an international, across-discipline, serendipitous collaboration. Neurology 1996; 47:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/95\">",
"      Apkarian P, Bour LJ. See-saw nystagmus and congenital nystagmus identified in the non-decussating retinal-fugal fiber syndrome. Strabismus 2001; 9:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/96\">",
"      SMITH JL, MARK VH. See-saw nystagmus with suprasellar epidermoid tumor. AMA Arch Ophthalmol 1959; 62:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/97\">",
"      JENSEN OA. Seesaw nystagmus. Br J Ophthalmol 1959; 43:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/98\">",
"      Rambold H, Helmchen C, B&uuml;ttner U. Unilateral muscimol inactivations of the interstitial nucleus of Cajal in the alert rhesus monkey do not elicit seesaw nystagmus. Neurosci Lett 1999; 272:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/99\">",
"      Das VE, Leigh RJ, Swann M, Thurtell MJ. Muscimol inactivation caudal to the interstitial nucleus of Cajal induces hemi-seesaw nystagmus. Exp Brain Res 2010; 205:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/100\">",
"      Maddox, EE. See-saw nystagmus with bitemporal hemianopia. Proc Roy Soc Med 1914; 7:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/101\">",
"      Halmagyi GM, Hoyt WF. See-saw nystagmus due to unilateral mesodiencephalic lesion. J Clin Neuroophthalmol 1991; 11:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/102\">",
"      Durand DV, Lecomte C, Cath&eacute;bras P, et al. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Soci&eacute;t&eacute; Nationale Fran&ccedil;aise de M&eacute;decine Interne. Medicine (Baltimore) 1997; 76:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/103\">",
"      Knox DL, Bayless TM, Pittman FE. Neurologic disease in patients with treated Whipple's disease. Medicine (Baltimore) 1976; 55:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/104\">",
"      Adler CH, Galetta SL. Oculo-facial-skeletal myorhythmia in Whipple disease: treatment with ceftriaxone. Ann Intern Med 1990; 112:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/105\">",
"      Simpson DA, Wishnow R, Gargulinski RB, Pawlak AM. Oculofacial-skeletal myorhythmia in central nervous system Whipple's disease: additional case and review of the literature. Mov Disord 1995; 10:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/106\">",
"      Selhorst JB, Schwartz MA. Cerebral manifestations of Whipple's disease. Mayo Clin Proc 1988; 63:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/107\">",
"      Hausser-Hauw C, Roullet E, Robert R, Marteau R. Oculo-facio-skeletal myorhythmia as a cerebral complication of systemic Whipple's disease. Mov Disord 1988; 3:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/108\">",
"      Rajput AH, McHattie JD. Ophthalmoplegia and leg myorhythmia in Whipple's disease: report of a case. Mov Disord 1997; 12:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/109\">",
"      Schwartz MA, Selhorst JB, Ochs AL, et al. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol 1986; 20:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/110\">",
"      van Bogaert, L, Lafon, R, Pages, P, Labauge, R. Sur une enc&eacute;phalite subaigu&euml; non classable, principalement caract&eacute;ris&eacute;e par des myorhythmies oculo-facio-cervicales. Rev Neurol 1963; 109:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/111\">",
"      Knox DL, Green WR, Troncoso JC, et al. Cerebral ocular Whipple's disease: a 62-year odyssey from death to diagnosis. Neurology 1995; 45:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/112\">",
"      Grotta JC, Pettigrew LC, Schmidt WA, et al. Oculomasticatory myorhythmia. Ann Neurol 1987; 22:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/113\">",
"      Amarenco P, Roullet E, Hannoun L, Marteau R. Progressive supranuclear palsy as the sole manifestation of systemic Whipple's disease treated with pefloxacine. J Neurol Neurosurg Psychiatry 1991; 54:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/114\">",
"      von Herbay A, Ditton HJ, Maiwald M. Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsies. Gastroenterology 1996; 110:1735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/115\">",
"      Lynch T, Odel J, Fredericks DN, et al. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Ann Neurol 1997; 42:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/116\">",
"      Riggs JE. The evolving natural history of neurologic involvement in Whipple disease: a hypothesis. Arch Neurol 1988; 45:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/117\">",
"      Bronstein AM, Gresty MA, Mossman SS. Pendular pseudonystagmus arising as a combination of head tremor and vestibular failure. Neurology 1992; 42:1527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/118\">",
"      Verhagen WI, Huygen PL, Nicolasen MG. Pendular pseudonystagmus. Neurology 1994; 44:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/119\">",
"      FORSYTHE WI. Congenital hereditary vertical nystagmus. J Neurol Neurosurg Psychiatry 1955; 18:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/120\">",
"      Funahashi K, Kuwata T, Yabumoto M, et al. Congenital vertical pendular nystagmus in sisters. Ophthalmologica 1988; 196:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/121\">",
"      Averbuch-Heller L, Dell'Osso LF, Leigh RJ, et al. The torsional component of \"horizontal\" congenital nystagmus. J Neuroophthalmol 2002; 22:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/122\">",
"      Cogan DG. Congenital nystagmus. Can J Ophthalmol 1967; 2:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/123\">",
"      Yee RD, Wong EK, Baloh RW, Honrubia V. A study of congenital nystagmus: waveforms. Neurology 1976; 26:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/124\">",
"      Dell'Osso LF, Daroff RB. Congenital nystagmus waveforms and foveation strategy. Doc Ophthalmol 1975; 39:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/125\">",
"      Abadi RV, Dickinson CM. Waveform characteristics in congenital nystagmus. Doc Ophthalmol 1986; 64:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/126\">",
"      Reccia R, Roberti G, Russo P. Spectral analysis of pendular waveforms in congenital nystagmus. Ophthalmic Res 1989; 21:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/127\">",
"      Optican LM, Zee DS. A hypothetical explanation of congenital nystagmus. Biol Cybern 1984; 50:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/128\">",
"      Harris C, Berry D. A developmental model of infantile nystagmus. Semin Ophthalmol 2006; 21:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/129\">",
"      Tusa RJ, Mustari MJ, Das VE, Boothe RG. Animal models for visual deprivation-induced strabismus and nystagmus. Ann N Y Acad Sci 2002; 956:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/130\">",
"      Gresty MA, Bronstein AM, Page NG, Rudge P. Congenital-type nystagmus emerging in later life. Neurology 1991; 41:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/131\">",
"      Price MJ, Judisch GF, Thompson HS. X-linked congenital stationary night blindness with myopia and nystagmus without clinical complaints of nyctalopia. J Pediatr Ophthalmol Strabismus 1988; 25:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/132\">",
"      Abadi RV. Visual performance with contact lenses and congenital idiopathic nystagmus. Br J Physiol Opt 1979; 33:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/133\">",
"      Jacobs JB, Dell'Osso LF. A hypothetical fixation system capable of extending foveation in congenital nystagmus. Ann N Y Acad Sci 2002; 956:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/0/1034/abstract/134\">",
"      McLean R, Proudlock F, Thomas S, et al. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol 2007; 61:130.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5111 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-3BFBD2B80D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1034=[""].join("\n");
var outline_f1_0_1034=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7763686\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACQUIRED PENDULAR NYSTAGMUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5901046\">",
"      Causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PENDULAR NYSTAGMUS FROM VISUAL LOSS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SPECIFIC VARIANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Spasmus nutans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Oculopalatal myoclonus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      See-saw nystagmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Oculomasticatory myorhythmia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pendular nystagmus mimics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CONGENITAL NYSTAGMUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Associated signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Etiology/differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7763686\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5111\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5111|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/49/18206\" title=\"figure 1\">",
"      Causes of see saw nystagmus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5111|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/3/11324\" title=\"table 1\">",
"      Features spasmus nutans",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20246?source=related_link\">",
"      Internuclear ophthalmoplegia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/61/8153?source=related_link\">",
"      Overview of amblyopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39273?source=related_link\">",
"      Posterior circulation cerebrovascular syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/35/11833?source=related_link\">",
"      Whipple's disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_0_1035="Sonographic findings ovarian CA";
var content_f1_0_1035=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Sonographic findings suggestive of malignancy in patients with a pelvic mass",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Solid component that is not hyperechoic and is often nodular or papillary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Septations, if present, that are thick (&gt;2 to 3 mm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Color or power Doppler demonstration of flow in the solid component",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Presence of ascites (any peritoneal fluid in postpostmenopausal women and more than a small amount of peritoneal fluid in premenopausal women is abnormal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peritoneal masses, enlarged nodes, or matted bowel (may be difficult to detect)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1035=[""].join("\n");
var outline_f1_0_1035=null;
var title_f1_0_1036="Differential diagnosis of pemphigoid";
var content_f1_0_1036=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of mucocutaneous lesions in pemphigoid disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Aphthous stomatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beh&ccedil;et syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bullous impetigo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bullous lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bullous mastocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic eczema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contact dermatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dermatitis herpetiformis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug-induced bullous disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermolysis bullosa acquisita",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythema multiforme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Human immunodeficiency virus-associated mucosal lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lichen planus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Linear IgA bullous dermatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pemphigoid (herpes) gestationis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pemphigus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Porphyria and pseudoporphyria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stevens-Johnson syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxic epidermal necrolysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urticaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Viral infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Herpes simplex virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Varicella-zoster virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &nbsp;Wells' syndrome",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1036=[""].join("\n");
var outline_f1_0_1036=null;
var title_f1_0_1037="Positive predict value ETT";
var content_f1_0_1037=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Estimated positive predictive value of exercise test",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 168px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The positive predictive value of an ECG exercise test is related to the pretest probability of coronary heart disease (CHD), ie, the prevalence of CHD in the population studied.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1037=[""].join("\n");
var outline_f1_0_1037=null;
var title_f1_0_1038="MRD inv16 AML";
var content_f1_0_1038=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F50902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F50902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Minimal residual disease in acute myeloid leukemia with inv(16)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 322px; background-image: url(data:image/gif;base64,R0lGODlh5gFCAdUAAP///7u7uwAAAICAgF1dXaCgoCAgIEBAQMDAwDAwMBAQEHBwcFBQUJCQkPDw8ODg4LCwsNDQ0GBgYHR0dBcXF93d3SMjI1FRUQsLC0ZGRqOjo5eXl2lpaS4uLq+vr66urjo6OgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADmAUIBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycrLzM3Oz9DR0loIEUMOBQMFDkMQAw0P0+LjVxEDAgdDCegCCUIL7QoK4eT19kwHAuhCEAIMAAwEQHAgQAGABgIW3FvIsAiCfQDODYgoYMDDdBeFIEDQsCO5jBQnSswIcsBEjyijgUSoEF6DCO0A9PsX8WTKm8siIEyAwMED/wEGEBgQEG4ohIAFhJjEGa1AUnv59AngWGCogacR1ilQqNQm02YGDHxdsnQsswL6npo1UnZtsqFAhTgdMleu2o5t3RpDKLUBAAPzhACmFzZlXr3E+OprgDZmY3eN7zI8jHiYVAF/pS6AmxCuWI+UK/eCAOHg5aiXU/dlsrG1EGzauAFw0MDi6567QovexWCeYnaqg/tdklrIunzuABqQIMDagM+6dO/OpSCm58z6Nmu+zkSf65kABQKoOH7AAwWlc3udvgtm9sgAHsfX5447cXQMOEoMCWArwQYSHADBAQL6ccBJC9A0h3TsuYKASRAOEJBm+kCojwQmXcicVBhGaP8bEQwMwNw8++23gAIJKPBQPwvAI1seDzx34AAJpEMHgw2y8qCHG17YIoQJJACkkD0K0GGEHB2RDwIsAeCSEA/0FOBDG021x0OprQcHjjnKYt9rCnzmQJiC6QNdEggQWZBPQAlFFBEPRfCTU2/q4UCaEmxkTR1cdgkLfCCmFZ4ASQGqxAPrtLNnVUBJdoAE71TH1S19+vlKYUQ01qhUn2E6SgHV6WPjglpaWktdQ/zGmQB+oSpKdQQeMKkclZpKC2eMCnrKVnnUaqssjf0TbCoLQIqHr7+ygqo+sgH2oimoQURqsrqM+RmgrpqyQKyy8lkqtbJMmNSXq9xprrfg3qL/qQG/DbdKY2nOGgey6Zai6mXuqmJAAkENMCqt39brCq7kpjLVAQhsi67AtAxr6CrLCcnrjQEzzIqzgp25Sj/6BEaxxQ2rle0q5oBjB70gp2yFhAA8UODHKsc8hgJPBYhGNddks80QKMvscxNWRvSvGOZIe1xMXf2sNBdBkjYxGVHZCF5A6fW89NVEcFwQPWWURN5+NWEtdhUxmnyG1yKRFza4dZE2NhcErrFSQk6ymjS11grRG9dvX+GvGjq109NPQQ1Fj9VjiUsQ0n1fAU+s8oYRLVVWqYU4U+sqFnnjUUQ79JYVs/dborpy7sjlTBEslWSmP+HAthEwkN601Dqs/4+CrUcxIQIS4D5v6A1i/JcCz+b+BKsI/w1z7SKzbjzQAyJwgO+gP2+8BPIM5bwbqFufrgMBPU279+SPX/7bWRW0+Rvdn2/rUAesA3wa7btvqXgAfc7+/PaDrI1SxjJf/5YWLVEJcIA/2xa3ugUwcLkNgYioH0r2BsFDSLAji0tOBQlxwYZoboMc5F9lNEUoEB6Kbw2kFq5MiCZ0JCmFyRoWC5HgAH/ZDYbJEt4MD3VAU41shw2Y3ux6uMN0wUMqQ/xdEVNGHvDpj3siXGKO8Kew5UmxXgGJ3w3bgDOeRfGK0wGf+txQtH91EIytixoRzohGhhwgAgok0PrMAJK7tf/xVwc7jRvquDaBPfCOcpNWH7HoMRYu4Cm1aUPgeCIbNpJjZBlk4Z0SkCcEMOCJZZicHf3kqVRpxoRYukwAcZijh81ndSCMkQFm1IDiVc9SBcPVD48Am50R4U6t2ZNGcNMyk9AjSpaSU6++yJR2xecpwxpME46mQY3oUS7eEYICCGQQADzKUqCSCibZ4MhpGNNTzpLPEqaGP2fypIvniSaVqASBQuYoLOhQwCiVuJYdechDlxHRhUwSpOdIJUQeeiF/wObMaUqAHrGyEkxI0xwDmGR6upyOQDBTrIWZxZ73hNCGMJRPIKVGSEha49fUJoQIYAg5B5nHkowTlgSACi3/BYjfFNMkoW2uoZviKIwxhfCbEiahSU86gj6smZokRYAjDj0HRUxRS1ea43+zaU0X5UDJc9DNil2ay07LlJ0lEM5N4diHhGyYjqOmiVXPeg42iCIBjYWCmUa4jEJCKcg5NCBfpDQVucS5BEZdRQj7gABcGPCslV6DZrMJ3/Y6Qc4kJsU9AHjIOSMKhxYN01R/NOXwUBiNEpGUCISLbEEexVk32OxYxGQKBTN2hFk+w7OlohoATGrDZsKhAQqA0GK5mVqcVEeDrq0HULf4mnywbqhz8JxFc+Seq+Lkq4YbTzoQhQ5fjjUfNk2DWfW03DwEdxVWLd1N/PqUfdB1KoK9/50rU4FTLXQyFiTEKyC7ewfNXspM89VDe7FQsFfA549tjABltzSjjBr4wAhOsIKLdCQFO/jBEI6whCd84ArRKLcUzrCGN8zhDnv4wwcWqBvidqMOEODEKE6xilfM4ha7+MUpzsBlMgDjGtv4xjjOsY53TIALXODEUuGxkIdM5CIb+chIdvEH5EDiBREgAFCOspSnTOUqW/nKWA6ASaBMAX1QIMtgDrOYx0zmMpt5yhuQygXOzOY2u/nNcI6znK1cATZESao14tOT58xnEGBAAwGYgD4mwOdCG/rQUSbAZQiN6EY7+tGQJnOdb6qa7NJvz5EuMwYEYAEufznToA61lP8FLRUOiPrUqE51mSethpgucI7cxLSqq5xmfVzAAxj486x3XeguC+DTvA62sEHNalMMQNbDVrRULKCPTg/72WYmNaMnwGhoW/vabC42Gx4k4nkhW9ikVs2asU1uK1Pg07jWdbnXze4pa/sMDgCMYpK4pW8L29eqqXa7yZ2BDEAZBM3et8DL/W4zKMahCqAe++wdbGnjWwD6Hji0zx3oy4xb4hgPdsHLQCMACEloeiY3xcMd8Yw3fNAcSE3JTc7yTG+cDM+Rkb8sjYYBmDjJOCeABSwAZE7n/OdAD7qvKaDsZQf96EhPutJhvGRKp4bmZ/AXiKeeISMN4Ef8LDDVt87/9Q6Trh09WkDXx072sptdwd2m4z13i4Wm0hIBfNuvEn4oH1StFliXGZdPi3gnMcDVIQHxityTgKk/cmYzgYnkMWMxIZp8d4C8qysXGlsEqQi+t1qADwV7Sh/TZCdvsBgT8aSoyk+CAbZs+ezgj+CZSHL+PZdJFNtN8fgBKmYd9OYC6otA0EGm4TeoWcDigpOry7g1v1xwuxHuxLWnzj7qbRpP2rcwXPn2fvVFAH7sOZWaXK1KvsjXwt/hFPghyFUO6W1H0MAA3TdBJPJ58qIbrhMcokyIUI0h3gprH34nUJ4IlkcXs4VccsA7oQJrWEBegGUjxbFJamBVA9BcqdFK/4JyHXBRTe/Vf1WweyK1HqFVB9iQZ1iVBp4RXt0XGdrXF/algVHAgTzzWeGRe3KwXlDUBqNzGreDHeyCg33RXywIBdWXejbhAMY1BwtQWiN4Bu1Cf82xhPjlGVv1g1LQfmFlI/DHEdQ1I0iYBqLyfLw1f/gVGY9BQnRSQkdUhuIlhVGggNIFWJchWpcxfWlAG0MhTwP2SmwAH5FxeI13Su4QEJ/Rh2oICgbYDrZET22AKauCL513eNUhJvJAg4OoCSG4fniYh0nxetkhFV93fos3iaQgTHnFBpoodvXXfaDYENinBJ7RGGKhNQXBifiSiqSgPES0BvBhFXpzO/Lhg/+0aAkYNXP0NX+fcYY62A+BsYK/WAkmaEBJ2AZ1AYWXUR3ukoHLeAkPEBYQ0mSjeFvTqBrA5YXX+Ai2aIvd+AYkFCqpgYDj2FmYNwaNp47RIo7tuAyr6ASiF0pisUL1GArmiIh2IAEctToy1I+aEIzcCJB1EBbxNTzcAGAGSQnNKHn7gwd7iF+feHcROQnZmFTC+Ixw0Iq6Uhe/tZGWUI5QZwb3yATt0nl/IRbNxY4mSQwr2VrIJFeaERkmSI8z6Qs1WQSiRw+NZ4KhYgCwyJM9+Qeuxi0yWXPvyAUTkhxoQTwkhC+CmJSnU2nD2GrnFxDDsYiLIXqSiJWGcGdBwl3/IIkGPcUXyXGG3MF/ZEkICXmLJLh9XaWLyhiXiWCWk7UFygdatTFEzLdGT7kFmoKG/hCGaaiXjDCRKbkE4wcl8rAOXGFJqleYW6A9XLWOvsiYh7CUkKMF//cOdlMd3BCA8icHqFKVwuGZjnCHWuCCK2VY14eZYAAYE4lKrtmYQfEFsmkltHmZ3qV32XGVu6kIwTKWUxCEQyBb67AntckH8iGWx9kIDxA+cqQFVNiGaCE7cRFZzBF/DogHyvSJ1dmY8miYlbOAkaIobigVqbkHcHmegeAmCYGWdEmfNIkOsKmQ+okMjLEHP/mfk2GbBBoLjrmVByoMCZqWC/oLEYBd/0ipkgb6oK/wAPBQTQpqob9QQ0OhcJeYBxDJoYLQGAdQAPh5jnSgkSQaCA2an3JQki06CMEIVTAKBzE5o78woE2wkzpKo5hxBzzKBEf5o4LwEKjVB8ZppH6ApEJaoWFAnUwKCBGapH0wn1M6g7zkoFkqC7EjfNWhAP35hV26C1HRT/K0oWUaCwKxUCDHpWvqCnaDGwgwoWIwpHGKCEXijDeap+USR9kJp36qCsCkX1A6qJmgVHOpoogKXpixqFDwl0PwAIE5qZUKJxGFp40qCIr6mEYQmS0zmXRzHihyVWVEmJs6Cy8KBaNZN35hmk9imkQlSJqaqn+wqk/wmxyxJP+zGTR8VKu2igm6SlTSA5y+SquHGqzA+CFSwJy7WBrP6ZzN4UxmlKzKCgnxpgDzNgXbuQ/d2Q9i8a3fuUi8BKzXmgcHNwAJRwVsCBEn4p5O8lt7okm+d66o0HEf948haq+nEHOr9JF9yq+dgKv7KrCkUKN2GgbmarCwsLAMGwdokR79kLCnZ60PewgMcCYGAKJt4LAXO2L/Aqkda7EfSwgBsScwwbFkWrKigCUEog8yOLIsSwrZVCEnQ7IzS6NbKqg5Cw0e27O1iLNAmws/O7T+KLRGawtFm7SesLRMywmHMaJPqwx5ASoxO7XG0BbYM6ZYWwxLAT4JoJxfsJrNQxf/ZWueZNu1LjoADpAAhLUG4AQdcTsEiugx5WmNatsrvTFPZ6CHguK3JSSGnVd3i5m3eAAPFHsFFviEjBsXnnF4kIuRhqsHVlsEUvsFKSgqPKi5p1h/4AeUOiMbMWIeUCKHk1sFW1sElVsGmQscnPu6nTuBTPB303QA1XRNp6sFYFs8qTsG0di4+wi8Ohi52dGZ/OAPMbhO6OVOuVsFbfu218AAYVsGygS4hfK32It/g7u9e5cEsLVQ/RABSQVRzUsFEZCmt+S2YjsFwbghamJ1G6VP8LtPG+W+8vu+DWYSIoZ6/LIvL0UoMlW+UdBOknG+fLsFwWh8+bTAlsfAqrEq/6tyTyLGnEf1FxmyVALMqklEwEp4ip6zua4bu7N4KG0SXTxjAGv1AG2VwVaAFk2pBZoYwh+sTSKsGp+bKet5WEkhRojFwlOAPSFSl8UrvIvruGZCvJ2BkVjqw34pvTWEtJnCvdcbuNk7xWUIGVLMWkw8h+pbr76bxdZ7SlZMuI5RxVt8BgYcn2ZAvMFrxG7cxvA0xHIMx2dcBhysxmQQwzMMuwVUw9Fyw3Usmkm0enoMwntcw7ALyIHsm1BMt9tBxJAMFEisHW+8yEkwIBS7LXHXyNBUxlT8yVYsxmSMxaBsybQ0TVcQb9WaBmQcymEsuJ5MyqFsyrxXJ9lwFAywKP8EMhwOECD6C00vhH1srIPEXMRxnMRzTMy0TAQiSFT7EhfwkCB2Q5nMYRPORcgebMggjMh/vMzmZxP5YByYESYZgjBGIlrgPCqrx5ocIkru3M6IDM+Fu8gkFc5ENR4eiaLk8RDpjMdkcH8F0IcCnYMD7Q8AfdAEnYPeLBgKYs/hHHh1yrZtAg82gb5eLAbDF9CCIi6DkhQcLS4TIhYh3dGDYlu0jD2y4dCY0cthOhHZlA8n8RCWw8mnFItmsi44zSmaoo4yrNOe6M0/8cLxsRGyZU1ngn2aCMEKzH3xbCaouNDnII4b4lBCwBwCtYqcoY7Ft9Wq0zHfKBVavSqJu9D/SrCKwWI7yIvWwsKLBNnWaa2bZM3IcEuVZvzKaeGKpxSuuqKZcV2xuEicdGzMw/vIyWyefe0FNdm6h9zHIqzIh40Fia3NNDzZTe3Yj70yNF0Egr3ZR0zYyHx8l70FP2nXpQzLpCzLoa2wma3Z11LXVTzKYpzafu0Gv1vJxjzJxivbVICnir3NNWzZug0FvC3ZsIvIwB3cTqCpnP3GuC25yJ0FmkraY8y9qP3csbnahCe32k23nWK3dgva1j0FtZq2dmG25X3ehh3emK3erOC07F2D781eWnd29F3f9n3f+J3f+r3fIZUKNcrfAB7gAj7gBF7gVGe68Z3gCr7gDN7g/w7+4BAe4RI+4RRe4RZ+4dVJqd/AtVZwVFsoCRr+El9wZ1MFCSHO4VXgDRGYLiY6FAhOBYqHCS1uibF5GSr7maLi4l7QtnFILT8hpvwgJxYBAY8VIMLXS1hoETECAdtCb5ry4Y7w43sCAUKOAEQ+W0bODTGS5HA3AEz+Mi8o0UEa5QUx5VV+5SYlK1puG1u+5E1eBOHpALSB4qLRJHASiwdwHhLjDvyMzg/hUM9ZBCli55ZA6AWFDnqurny+zxXx5zQyrS8oKzC4CIYuWrCS6CiCzn4OFI8eUbJaL/shFVXCFQhRGvBwVIxuEeTRD17xEwf1nSdJHqL+EKQuHqfe5//83OesLlKrBBRQzkGy7h20zlO23hy43uir/lkEmC79gBHrUCUncQ76MRXHruoT0edDAA+9Xk6U0OyR9ezYLu0UAe2bfu2qN1LYPQbeflbkPu7jXu3VTgQ6PhvruxvrkCfgrjYpKxQGARO5BdMPge+QLk1JxRw33gj3zu7Yvu+AMYD/juwCn6lGclZjjQcJn+8nwfD9XhA2pOoRH8VbsRkvHkbYUxAMECUkxSgJsCfaXs1/XhB3wSKvwSyXwNImj/I2ofIsDxQuDxQwX8sdk+5kYPMJh/N0MRQrT5rLgex1yDoNMFi/vjTY/gtTbwtVj0BXzwtZPwtbj+Fe//VgH/YhYj/2ZF/2Zn/2aJ/2ar/2bN/2bv/2cB/3cj/3dF/3nBAEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this study, minimal residual disease in 21 patients with acute myeloid leukemia and inv(16) was studied by real-time polymerase chain reaction, using the ratio of the abnormal gene product (CBF&beta;-MYH11) to an uninvolved gene (ABL). Results are shown for three patient groups: Group A: samples obtained during or after treatment in patients who did not subsequently relapse; Group B: samples obtained at any time during follow-up prior to clinical relapse; Group C: samples obtained at the time of disease diagnosis or clinical relapse. When values of this ratio were lower than 0.12 percent, no subsequent relapse was recorded; when values were greater than 0.25 percent, relapse always occurred. Values fell within the intermediate gray zone (0.12 to 0.25 percent) for only 6 of the 121 samples. Median values of each group are shown with the solid bar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:&nbsp;Buonamici S, Ottaviani E, Testoni N, et al. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. Blood 2002; 99:443.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1038=[""].join("\n");
var outline_f1_0_1038=null;
var title_f1_0_1039="Clavicle fracture with callus";
var content_f1_0_1039=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Clavicle fracture with callus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This close up view from a plain radiograph shows a completely displaced middle third fracture, two weeks after injury. In this young male, early callus is already present along the periosteum between the two fracture fragments (arrow). Because the injury was two weeks old and healing was well underway, conservative treatment was instituted.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L Hatch, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_0_1039=[""].join("\n");
var outline_f1_0_1039=null;
